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ABSTRACT 
 Bacterioferritin B is an important protein for P. aeruginosa as it is capable of storing 
about 4000 Fe3+ ions in the form of ferric hydroxy phosphate in its core and releas  when it is 
required by the cell.  Our research was aimed at understanding the mechanisms and pathways of 
iron uptake and mobilization from Pa BfrB which are considered as two vi al processes of this 
protein molecule.  The recombinant Pa-BfrB was overexpressed and purified to homogeneity.  
The structural studies of Pa BfrB were carried out by solving four crystal structures: (1) crystals 
grown from Pa BfrB without a mineral core (as-isolated), (2) mineralized with ~600 iron atoms 
(mineralized), (3) crystals soaked in a Fe2+ solution and (Fe soak) and (4) Fe soaked crystals 
soaked in a crystallization solution (double soak).  Crystal structures revealed that it is composed 
of 24 subunits arranged as a sphere and can bind 12 heme molecules per protein.  Further, 
crystallographic studies elegantly showed that iron ions to be stored inside the cavity are taken 
into the inner cavity of the protein via the ferroxidase pores on the surface.  Both 
crystallographic and solution experiments provide evidence to show that these Fe2+ ions are 
oxidized at the ferroxidase center and subsequently internalized via a gated mechanism operated 
by the amino acid residue His130 at the ferroxidase center.   
 An interaction between BfrB and apo Bfd (Bcaterioferritin associated ferredoxin) was 
found to be necessary for efficient mobilization of iron from the mineral core of BfrB.  In 
addition, the thus far mysterious role of heme in bacterioferritins was revealed for the first time 
and was experimentally demonstrated that ferric ion mineral core of BfrB is reduced by the heme 
mediated efficient transfer of electrons from the reductase to the core.  Additional experiments 
show that Bfd binds to BfrB with a ratio of 12:1 to support the efficient mobilization of iron from 
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BfrB and it was found that Bfd is not functioning as a typical ferredoxin in the iron mobilization 
process of BfrB as it is the apo Bfd not the holo Bfd which is involved in the iron mobilization 
from the inner cavity of BfrB.  Crystallographic data suggest tha  four-fold pores may be the 
dominant route of iron release from the inner cavity of BfrB.  Results of the studies carried out 
with site directed mutagenesis and Elastic Network Model calculations provided experimental 
evidence suggesting that the main path way of iron release is through the four fold pores of BfrB. 
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Figure 3 
Red prismatic single crystals of recombinant (A) N148L 
and (B) G145V BfrB formed in compact Jr. sitting drop 
vapor diffusion plates. 
 
 
168 
Figure 4 Structure of (A) empty ferroxidase center and (B) iron 
bound ferroxidase center of WT BfrB showing two 
different conformations of the side chains of His130. 
 
 
171 
Figure 5 Change in ∆A320 upon subsequent additions of Fe
2+ 
aliquots (50 Fe2+ ions per BfrB molecule) to a solution of 
G145V BfrB (0.8 µM) in 100 mM potassium phosphate 
buffer, pH 7.6. 
 
174 
Figure 6 Time dependent plot of absorption intensity change 
measured at 523 nm upon addition of NADPH (1.5 mM ) 
 
xxiv 
 
 
 
 
 
 
 
 
 
 
 
 
 
to solutions containing 3.0 mM bipy, 15 µM FPR, 0.375 
µM (A) wild type BfrB and (B) G145VBfrB and apo-Bfd 
with Bfd/BfrB molar ratio of 40 (red), 30 (blue), 20 (pink), 
10 (green), and 5 (black).  Time dependent changes in the 
position of the Soret band brought about by the addition of 
NADPH (1.5 mM) to the solutions in figure A; 417.5 nm 
and 425 nm correspond to fully oxidized and fully reduced 
heme, respectively. 
 
 
 
 
 
177 
Figure 7 Bfd dependent iron release from G145V (red) and wild 
type (blue) BfrB. 178 
xxv 
 
LIST OF SCHEMES 
CHAPTER 1 
Scheme 1. Schemetic representation of siderophore-mediated iron uptake 
by (A) Gram-negative and (B) Gram-positive bacteria.                                   
 
4 
   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xxvi 
 
LIST OF APPENDICES 
 
CHAPTER 2 
Appendix I:  Protein Crystallization Conditions-Wizard 11 random sparse matrix  
       Crystallization Conditions       83 
Appendix II:  Protein Crystallization Conditions-Cryo 1 sparse matrix crystallization  
                      Conditions.         85 
 
CHAPTER 4 
Appendix I:  The alignment of the sequences of Bacerioferritin genes which are  
       located downstream to Bfd gene in the bacterial genome.  Acidic  
                      residues at the C-terminus of Bfr are highlighted in red.  The  
                      sequences were aligned with the aid of Clustal W.     154 
Appendix II:  Mutations of the four fold pores of Pa BfrB suggests a possible  
  pathway of iron release via the four-fold pores.    158 
           
 
 
 
 
 
 
xxvii 
 
ABBREVIATIONS 
ABC   ATP-binding cassette 
ALA   δ-Aminolevulinic acid 
Bfr    Bacterioferritin 
Bfd   Bacterioferritin associated ferredoxin 
DMSO   Dimethyl sulfoxide 
Dps   DNA binding protein from starved cells 
DTT   Dithiothreitol  
FAD    Flavin adenine dinucleotide  
FADH 2   Fully reduced flavin adenine dinucleotide 
Ftn   Ferritin 
FPR   Ferredoxin NADP reductase 
Hb   Hemoglobin 
HO   Heme oxygenase 
IPTG    Isopropyl-β-D-thiogalactopyranoside 
MES   2-(N-morpholino)ethanesulfonic acid 
NADPH   Nicotinamide adenine dinucleotide (phosphate) 
OD   Optical density 
Pa   Pseudomonas aeruginosa 
PCR   Polymerase chain reaction 
PDB   Protein data bank 
PMSF    Phenylmethylsulfonyl flouride 
SDS PAGE  Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SPR   Surface plasmon resonance 
TCEP   Tris (2-carboxyethyl)-phosphine hydrochloride 
Tris   Tris(hydroxymethyl)aminomethane 
UV-Vis   Ultraviolet-visible 
WT   Wildtype 
 
1 
 
CHAPTER I 
Introduction 
 Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that can cause 
severe nosocomial infections in immunocompromised patients.  For instance, P. aeruginosa 
causes chronic lung infections in ~90% of cystic fibrosis patients a d is also responsible for 
secondary infections in burn victims and cancer patients [1].  Furthermor , it has been recently 
found that approximately half of the known strains of P. aeruginosa have developed antibiotic 
resistance genes [2].  Recent findings, however, suggest that iron, particularly heme-iron, is 
essential for successful colonization (infection) of mammalian hosts [3].  The above finding 
implies that molecules capable of inhibiting iron/heme-iron acquisition pathways or interfering 
with iron trafficking mechanisms in P. aeruginosa may constitute a new class of antibiotics.  
Therefore, a molecular level understanding of iron acquisition paths, regulation mechanisms and 
metabolism is required, in order to rationally develop drugs to combat Pseudomonas infections.  
 Iron is the second most abundant metal and the fourth most abundant element in th  earth’s crust 
[4].  Because of its abundance and versatility, iron is considered as an essential element for virtually 
all forms of life.  It is found in many enzymes as an important cofactor in many electron transfer 
proteins [4].  Furthermore, since iron ions exist in several oxidation s ates they can act as catalysts in 
many cellular reactions such as DNA synthesis, nitrogen fixation and respiration [6].  Under 
physiological conditions iron possesses two readily interchangeable oxidation states, Fe (II) and Fe 
(III), and these are involved in many redox reactions [7].  The redox potential of Fe2+/Fe3+ fluctuates 
from -490 mV to +330 mV (Vs SHE) and mainly depends on the ligands that are coordinated to iron.  
Thus, as a very useful redox mediator in biology, iron can be found in proteins in many different 
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forms such as iron-sulfur clusters, heme groups, iron nickel clusters, and mono- or binuclear species 
[7].  In the early years of life, Fe2+ was considered as a biologically “friendly” metal.  However, with 
the advent of oxygen-rich environment the soluble Fe2+ (0.1 M at pH 7.0) became extremely 
insoluble Fe3+ (10-18 M at pH 7.0) and as a result this key nutrient became scarce and growth limiting 
for many organisms [6, 8].  In addition, cellular Fe2+ can react with metabolically produced H2O2 
and generate reactive hydroxyl radicals: 
                     	 

    ·   (Reaction 1; Fenton reaction) 
In addition, one-electron reduction of O2 by ferrous ions produces superoxide radicals which in 
turn reduce ferric ions to ferrous ions (Reaction 2). 
                
  
·  
  	    

      (Reaction 2) 
The sum of the above two reactions is called the Haber-Weiss reaction which generates hydroxyl 
anions, oxygen and reactive hydroxyl radicals as products.  It is noteworthy, however, that the 
Haber –Weiss reaction can take place only in the presence of catalyti  amounts of a redox active 
metal such as iron. 
                     
· 	   ·            (Reaction 3; Haber-Weiss reaction) 
Hydroxyl radicals are very reactive and can damage cells by inducing lipid peroxidation, 
degradation of biomolecules and breakage of DNA strands [9].  As a consequence of the 
insolubility of ferric ions and toxicity of ferrous ions, all living organisms were compelled to 
develop efficient ways of acquiring, storing and utilizing iron. 
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Iron acquisition by Bacteria.  
 Bacteria have adopted several mechanisms to acquire iron from the surroundings. 
Basically they use three methods to acquire iron [4].  (1) Lower th  external pH by releasing 
hydroxyl acids such as citrate and malate to make insoluble ferric ions more soluble [10].  (2) 
Organisms such as Listeria monocytogenes ecrete chemical species capable of reducing 
insoluble Fe3+ ions to soluble Fe2+ ions [11]. (3) Secrete ferric ion chelating compounds such as 
siderophores which are low molecular weight compounds (< 1000 Da) with a very high affinity 
(Kaff > 10
30) and specificity for ferric ions.  These molecules are synthesized and secreted by 
bacteria during iron starvation conditions.  Reduction and chelation are the two mostly employed 
methods to acquire iron [10].  Some E. coli strains can produce a type of siderophore called 
aerobactin at a very high concentration (200 mg L-1) [12, 13].  Once soluble siderophores are 
secreted to the outside environment, they form hexadentate octahedral complexes with ferric 
ions.  These iron bound siderophores are then taken into the cytoplasm via the cytosolic 
membrane (CM).  Gram-negative and Gram-positive bacteria employ two different mechanisms 
to internalize the iron bound siderophores (Scheme 1) [4].  Gram-negative b cteria have two cell 
membranes called outer (OM) and cytosolic membrane (CM) whereas Gram-positive bacteria 
have only one membrane (CM) surrounding the cytoplasm.  In Gram-negativ  bacteria, iron-
siderophore complexes are first received by specific OM receptor proteins such as FepA, FecA 
and FhuA prior to internalization.  Since these iron-siderophore complexes are too large to 
diffuse through OM channels, transport of these complexes across the OM requires energy.  As a 
result, these iron complexes are actively transported across the OM into the periplasm, using the 
energy-transducing TonB-ExbB-ExbD system [4].  Once the iron-siderophore complexes are in 
the periplasm, they are bound by the ATP-binding cassette (ABC) transporters found in the CM 
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and delivered to the cytoplasm (Scheme 1A).  On the other hand, in Gram-positive bacteria, 
ferri-siderophore complexes are transported through the CM by binding-protein-dependent ATP 
binding cassette permease proteins.  These ABC permeases are similar to ABC transporters of 
Gram negative bacteria except that these binding proteins are lipoproteins attached to the 
external surface of the CM (Scheme 1B).  Once these ferric ion omplexes are delivered to the 
cytoplasm, they are either reduced to dissociate as ferrous ions from the complex or in some 
organisms, siderophores are broken down to release iron ions [4, 8, 14]. 
 
 
 
 
 
  
 
 
 
 
 
 
`` 
Scheme1: Schemetic representation of siderophore-mediated iron uptake by (A) Gram-negative 
and (B) Gram-positive bacteria (4). 
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 In addition to siderophore mediated iron acquisition some bacteria have developed other 
efficient ways of acquiring iron from hosts.  As an example, Neisseria sp. have been identified to 
possess transferrin and lactoferrin receptors in their OM and which are induced under iron 
depleted conditions.  Transferrin and lactoferrin are mammalian iron binding proteins which 
maintain the free extracellular iron concentration at about 10-18 M.  Bacterial tansferrin and 
lactoferrin receptors are capable of identifying apo- and holo- transferrin/lactoferrin.  Once the 
holo lactoferrin/transferin is identified and bound by these receptors, ir n is detached from the 
protein at the cell surface and is internalized.  Subsequently, apo-lactoferrin/transferrin is 
released extracellularly [15, 16] 
 Heme is the most abundant form of iron in the body and unambiguously many pathogenic 
bacteria use heme as their main source of iron [4].  Extracellular pathogenic bacteria can access 
host heme, when heme and hemoglobin are liberated from the red blood cells by the catalytic 
action of enzymes such as hemolysins and proteases.  Once heme is r leased from hemoglobin, 
host proteins such as hemopexin and albumin can bind these heme groups or n the other hand, 
pathogenic bacteria may directly transport those hemes into their cells.  These bacteria have the 
ability to use heme, hemoglobin or hemopexin-heme complexes as their main sources of iron [4].  
The OM receptors of Gram-negative bacteria can bind heme or hemeompl xes and then the 
detached heme groups are internalized across the OM in a TonB-ExbB-ExbD dependent manner.  
In addition, some bacteria have the ability to secrete “hemophores” which can bind extracellular 
hemopexin and hemoglobin and transport these heme complexes to OM receptors.  Later, these 
heme groups are delivered to the cytoplasm across the CM via ABC permeases.  In the 
cytoplasm, heme is degraded by the enzyme heme oxygenase to release iron [17, 18].
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 Eventhough iron is an essential element for bacteria, a relatively high concentration of 
ferrous ions in the cytosol can cause severe damage to other biological ma romolecules.  
Therefore, to overcome the potentially toxic effects and the poor availability of free iron, bacteria 
have evolved efficient ways of storing and maintaining cellular iron n a safe form.  The most 
effective method utilized by many organisms including bacteria, is to store iron as an inorganic 
mineral inside a cavity of a special type of iron storage protein called ferritin or ferritin-like 
protein [19, 20]. 
Iron storage proteins 
 Bacteria and other organisms have evolved iron storage proteins to efficiently regulate 
their intracellular iron concentrations.  These iron storage proteins have the ability to oxidize 
soluble and potentially toxic Fe2+ ions to Fe3+ ions and store the latter as a stable ferric iron 
mineral.  When the extracellular iron becomes limited, the iron deposits contained inside iron 
storage protein can be mobilized to sustain metabolism.  Three typs of iron storage proteins 
have been identified and categorized into three sub-families, under the family of ferritins: the 
classic ferritins (Ftn), found in both prokaryotes and eukaryotes, the heme containing 
bacterioferritins (Bfr), present only in eubacteria (bacteria ch racterized by a rigid cell wall and, 
in motile types, flagella; the true bacteria) and the dodecameric fer itins (Dps, DNA binding 
proteins from starved cells) found only in prokaryotes [21].  Some organisms, however, have 
been shown to contain all three types of iron storage proteins and in some cases multiple ferritin 
and bacterioferritin genes exist.  Although these three types of iron storage proteins are 
evolutionary distantly related, they tend to have similar structural and functional features [4, 22]. 
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(1) Classic Ferritins (Ftn) 
 Ferritins, which are ubiquitous iron storage proteins found in both prokaryotes and 
eukaryotes, have evolved to sequester thousands of iron atoms in a mineralized, non toxic and 
bioavailable form.  These supramolecular nanostructures are cytosolic pr teins capable of 
oxidizing excess ferrous ions to ferric ions and storing them as an iron mineral.  When 
exogenous iron becomes limited, the stored iron is used for various cellular biochemical 
reactions such as respiration, photosynthesis, DNA synthesis and nitroge  fixation, [6].  Another 
favorable consequence of storing iron as a mineral is that the cells ar  protected from the 
detrimental reactive hydroxyl radicals generated by ferrous in  [23, 24].  Abdul-Tehrani and co 
workers found two phenotypes upon deactivating the iron storage protein Ferritin A gene (ftnA) 
of Escherichia coli: (a) reduced growth rate under iron depleted conditions and (b) low cellular 
iron content (50%) in the stationary phase under iron replete conditions.  These growth 
phenotypes were observed only when the medium was precultured with sufficient iron allowing 
ferritins to store iron during the post exponential growth.  Thus, stored iron could be used as an 
intracellular iron source during subsequent growth under iron starvation conditions.  Moreover, 
Ferritins from Campylobacter jejuni and Helicobactor pylori have also been found to play a role 
in promoting iron limited growth.  These observations are in agreement with the important iron 
storage function played by ferritins in the cell. [4, 25-27].  As mentioned before, classic ferritins 
are found in both eukaryotes and prokaryotes.  In the following, the well characterized 
eukaryotic ferrtin will be discussed first, followed by a description of the lesser understood 
bacterial ferritins and bacterioferritins. 
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 Ferritins are polymeric proteins, composed of 24 subunits arranged as a dodecahedron 
with 4,3,2 octahedral symmetry (Figure 1-1A) that forms a hollow spherical assembly with a 
central cavity capable of holding approximately 4500 iron atoms.  The diameter of the ferritin 
central cavity is ~8 nm and the external diameter is ~12 nm.  The thickness of the protein shell, 
surrounding the cavity is ~2 nm.  Each ferritin subunit is composed of five alpha helices (A-E) 
arranged in a four helix bundle (A-D) and a short C-terminal helix (E), which is perpendicular to 
the central axis of the four helix bundle (Figure 1-1B) [28-30]. 
 
 
 
 
 
 
 
 
Figure 1-1: Crystal structures of a (A) 24-meric ferritin molecule from E.coli [28] (B) subunit 
dimer of a horse spleen ferritin [29]. 
Mammalian ferritins are heteropolymers composed of two types of subunits called H 
(heavy) chain and L (light) chain subunits.  These two types of subunits are structurally 
homologous and have 55% of amino acid sequence identity.  The ratio of H chain / L chain of 
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ferritins varies depending on the tissue from which the ferritin is originated.  For example, the 
ferritins isolated from heart tissues have a high ratio of H chains / L chains whereas ferritins 
from liver tissues have a high ratio of L chains/H chains [31-34].  Eventhough these two types of 
subunits have a 55% amino acid sequence similarity, their functions are different.  The H chain 
subunits have a dinuclear iron center in the middle of each four helix bundle, called ferroxidase 
center where oxidation of Fe2+ to Fe3+ occurs in the presence of oxygen.  L chains do not have a 
ferroxidase center and therefore L-chain rich mammalian ferritins oxidize Fe2+ ions much slower 
than H-chain rich mammalian ferritins.  Consequently, it is thought that these L-chain rich 
ferrtins are involved in forming crystalline iron particles of different sizes (nucleation) to initiate 
the formation of iron mineral inside the inner core [24].  Mamalian ferritins have six 4-fold and 
eight 3-fold pores located along the 4-fold and 3-fold symmetry axes of the molecule, 
respectively.  These 3-fold pores have three highly conserved aspartate nd glutamate residues 
located at the base of the pore, which make these pores hydrophilic in nature [9].  In addition, 
various metal ions have been observed bound to these 3-fold pores and therefore, it is believed 
that these 3-fold pores may act as main routes of iron entry and exit into the eukayotic ferritin 
cavity [35, 36].  In agreement with this notion, it has been observed that when the conserved Asp 
and Glu in 3-fold pores of mammalian ferritins are mutated, the ferroxidase activity and iron 
incorporation have been decreased [35].  Interactions of four subunits of the ferritin molecule 
form six 4-fold pores and these pores are lined with hydrophobic residues such as Leu.  The 
function of these 4-fold pores in eukaryotic ferritins is not clear.  However, since these pores are 
hydrophobic in nature, it is believed that these may be involved in diffusion of oxygen and 
hydrogen peroxide molecules in and out of the ferritin molecule [24, 34, 35, 36]. 
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 The bacterial counterparts of ferritin are called bacterial ferritins. Their structure is 
strikingly similar to human H-chain ferritin, despite modest amino acid sequence identity, ~ 22% 
[38].  The most understood bacterial ferritin is the FtnA from E.coli.  Even though, there is 
another ferritin called FtnB in E.coli, it has not been well studied.  Similar to eukaryotic ferritins, 
the bacterial ferritins are also made of 24 subunits arranged in a nearly spherical molecule.  Each 
subunit has a ferroxidase center in the middle of each four helix bundle.  Further, there are six 4-
fold channels (diameter ~0.4 nm) aligned with the four fold axes of the molecule and are lined 
with hydrophobic residues in the central part and hydrophilic residues at both ends of the 
channels.  The eight 3-fold channels (diameter ~0.4 nm), lined with both hydrophobic and 
hydrophilic residues, are formed at the three fold symmetry axesof the protein molecule.  
Bacterial ferritins have another type of channel, the so called B pores which are absent in 
eukaryotic ferritins.  It is thought that the function of these B-pores may be similar to that of 3-
fold channels of eukaryotic ferritns [28, 39].  Ferritins from other bacteria such as 
Campylobactor jejuni and Helicobactor pylori have been isolated and the crystal structures of 
those two bacterial ferritins have been observed to have many structural simil rities to FtnA from 
E.coli [40, 41].  
 Recently two ferritins from the hyperthermophillic archea Archaeoglobus fulgidis and 
Pyrococcus furiosis have been structurally characterized.  The 4,3,2 symmetry and other 
structural features of P. furiosis are similar to bacterial ferritins.  However, the 24 subunits of A. 
fulgidis ferritins are arranged in 3, 2 tetrahedral symmetry instead of typical 4,3,2 octahedral 
symmetry found in other bacterial ferritins.  There are four channels i  these proteins, called 
super-pores which connect the mineral core with the outside environment.  B-channels have also 
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been identified in these archaeal ferritins.  However, as in other bacterial ferritins, the exact 
functions of these channels are not yet clearly known [42, 43]. 
(2). DNA binding proteins from starved cells (Dps) 
 Dps is another ferritin-like iron storage protein found in bacteria and archaea.  Similar 
to classic ferritins, these are also polymeric proteins.  Althoug Dps are distantly related to 
ferritin in terms of amino acid sequence, they share a few structural similarities with ferritins.  
Dps are composed of 12 subunits arranged in 4,3,2 octahedral symmetry (Figure 1-2A). Unlike 
the ferritin inner core, the Dps inner core can store only about 500 iron atoms and their 
ferroxidase centers are located between two adjacent subunits, where each of the two iron atoms 
of the ferroxidase center are coordinated by amino acid residues from two adjacent symmetry 
related subunits [19, 22].   
 
 
 
 
 
 
Figure 1-2: Crystal structures of (A) 12-meric Dps from Listeria innocua [44] and (B) a subunit 
dimer of Dps from Bacillus brevis [29]. 
 (B) (A) 
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 The first Dps protein identified was from E. coli, a dodecameric sphere with a 4,3,2, 
symmetry.  As is typical of Dps protein structure, the ferroxidase center of E.coli Dps is also 
located at inter subunit sites.  However, Dps from Listeria innocua has only one Fe3+ion at its 
ferroxidase center and the other Fe3+ ion site is occupied by a water molecule [4, 19].  The Dps 
protein isolated from Streptococcus suis uptakes iron through four hydrophilic pores found in 
that protein.  Similar to H chain ferritins, the incorporated Fe2+ ions are oxidized by molecular 
oxygen at the ferroxidase center [45].  The composition of the Dps mineral core has not been 
well studied yet.  However, X-ray absorption near edge structure (XANES) studies show that the 
mineral core of Dps from Trichodesmium erythraeum is comprised of octahedrally coordinated 
Fe3+ [46].  Dps is not considered as a major iron storing protein in the cell.  Its main function is 
to protect cellular DNA from different nucleases and oxidative ag nts [23].  Under nutrient-
limited conditions, such as during the stationary growth phase, cells do not have sufficient 
energy to synthesize new proteins or enzymes.  Therefore it is difficult for bacteria to survive 
oxidative stress conditions during the stationary phase.  Non-specific DNA-binding proteins such 
as Dps are expressed during the stationary phase and as a result, Dp  is the most abundant 
protein during that growth phase.  It has been found that Dps protects th  chromosomal DNA 
from reactive oxygen species (ROS) under oxidative stress conditions during the stationary 
phase.  Dps protein interacts directly with DNA and forms a stable, highly ordered 
nucleoprotein, called a biocrystal, by which DNA is protected from ROS [47].  On the other 
hand, Dps can also incorporate cellular free Fe2+ into its inner core as Fe3+ ions, thus limiting the 
production of hydroxyl radicals by fenton chemistry.  It has been fou d that all Dps proteins 
have the ability to bind and sequester Fe2+ ions but only a few bacterial Dps proteins such as Dps 
from E.coli and Mycobacterim smegmatis can bind both iron and DNA.  Eventhough no 
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relationship has been established between iron binding and DNA binding, all Dps proteins 
appear to function as DNA protecting proteins under oxidative stress conditions [48, 49]. 
(3). Bacterioferritins (Bfr) 
 Bacterioferritins are another group of bacterial iron storage proteins categorized under the 
broad family of ferritins [27].  As mentioned earlier, these proteins are heme containing iron 
storage proteins found exclusively in bacteria.  Similar to classic ferritins, bacterioferritins play a 
very important role in iron storage and detoxification in the bacterial cell.   
Discovery of Bacterioferritins  
Bacterioferritins were earlier known as cytochrome b1 and were originally discovered in E. coli 
by Keilin in 1934 [50].  The same protein was later purified independently from E. coli by Fujita 
et a.l [51] and Deeb et al. [52].  The purified cytochrome b1 was spectrophotometrically 
characterized by its reduced electronic absorption spectrum which exhibits a Soret, α and β bands 
at 425, 557.5 and 527.5 nm, respectively.  Consequently, this protein was also known as 
cytochrome b557.5.  The same protein was later purified from E.coli strain K-12 by Yarive et al. 
and this protein was observed to have similar structural features to the recombinant bacterial 
ferritin (FtnA) isolated from E.coli.  Therefore, this novel protein was named as bacterioferritin 
[53].  Subsequently, “cytochrome b1” isolated by the Deeb and Harber method and 
“bacterioferritin”, obtained via antibody precipitation method of Yarive, were independently 
expressed, purified and crystallized.  The crystallographic data of the two proteins were 
compared and it was concluded that both cytochrome b1 and bacterioferritin were in fact the 
same protein [52]. 
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Structure of Bacterioferritins 
 Bacterioferritins are polymeric proteins made of 24 subunits are arranged in 4,3,2 
octahedral symmetry to form a nearly spherical protein with a hollow cavity (Figure 1-3A).  
Each subunit is made of five alpha helices (A-E) in which four of the helices (A-D) are arranged 
parallel to each other and the C terminal short fifth helix (E) is perpendicular to the central axis 
of the four helix bundle (Figure 1-3B) [28]. 
 
 
 
  
 
 
 
Figure 1-3: Crystal structures of (A) 24-meric BfrB from P. aeruginosa and (B) a subunit dimer 
of Bfr from E.coli [71] showing the heme group located between two adjacent subunits and he 
two ferroxidase iron atoms in the middle of each subunit. 
Even though the Bfr subunits are structurally similar to H-chain ferritin subunits, their amino 
acid sequence identity is only 20%.  Bfrs are unique in the family of ferritins as they can bind 12 
heme groups per Bfr molecule.  These heme groups are located at inter subunit sites, coordinated 
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by two methionine residues (Met52) from two adjacent subunits related to one another by 2-fold 
symmetry.  The heme macrocylcle is attached to the protein by non-covalent interactions and the 
coordination of iron by Met 52 via a bis-thioether axial coordination.  Theheme iron is low spin 
in both oxidation states, suggesting a possible function of heme in electron transport [39, 54].  
Although most Bfrs contain iron-protoporphyrin IX (heme), Bfr from Desulfovibrio 
desulfuricans has iron-coproporphyrin III instead of heme [39].  The ferroxidase center of Bfr is 
located in the middle of each subunit and similar to bacterial feritins and mammalian H-chain 
ferritins, it is also a dinuclear ion center made of two iron ionscoordinated by six amino acid 
residues.  In contrast to the structure of the ferroxidase centers of mammalian and bacterial 
ferritins, however, the ferroxidase center of Bfr is symmetric (Figure 1-4).  As shown in the 
figure below, each His and Glu residues act as capping ligands to iron ions while the other two 
Glu residues act as bridging ligands to the two iron ions. 
 
 
 
 
 
Figure 1-4: Schematic representation of the structure of symmetric ferroxidase center in Bfr. 
 Similar to mammalian and bacterial ferritins, Bfrs also have eight 3-fold channels and six 
4-fold channels along the three fold and six fold symmetry axes of the molecule, respectively.  
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The 4-fold pores of bacterioferritins are hydrophilic whereas the 4-fold pores of mammalian 
ferritins are hydrophobic.  Similar to mammalian ferritins, 3-fold pores of Bfrs are hydrophilic.  
But the pore forming residues are not conserved between mammalian ferritins and Bfrs [39].  In 
addition to 4-fold and 3-fold pores, the B pores are located at the interface of two Bfr subunit 
dimers and these B pores are thought to have the same function as 3-fold pores of mammalian 
ferritns.  The amino acid residues Glu/Gln135, Glu132, Glu66 and Asn/Glu34, lining these B 
pores are well conserved among Bfrs (Figure 1-5) [70] 
Bfr from Pseudomonas aeruginosa 
 Bfrs have been isolated and characterized from many different types of bacteria such as 
E.coli, A.vinelandii, D.desulfuricans, and R.capsulatus; all these Bfrs are homopolymers.  
Bacteria such as Pseudomonas aeruginosa, Pseudomonas putida and cynobacterium 
Synechocystis, on the othr hand, were thought to have two types of subunits [39].  For example, 
early studies of Bfr from P. aeruginosa suggested that this protein is made of two subunits, 
called α and β.  The relative proportions of the two subunits, however, varied from preparation to 
preparation and the α-subunit was consistently the most abundant [38]. More recent studie  on 
Bfr from P aeruginosa have established that there are two genes coding for two Bfr proteins 
(BfrA and BfrB), termed bfrA and bfrB respectively [56].  When the amino acid sequences of 
BfrA and BfrB are compared with those corresponding to Bfrs from E.coli [57], Azotobacter 
vinelandii [58] and Mycobacterium smegmatis [59] (Figure 1-6), it is interesting to observe that 
the Met52 is absent from the sequence of BfrA.  This observation suggests that BfrA may not 
bind heme, although, the amino acid residues that coordinate the diiron ferrxidase center are 
conserved in all sequences shown in figure 1-6.  Hence, eventhough BfrA does not bind heme, it 
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may bind ferroxidase iron and exhibit the ferroxidase activity.  Consequently, the term 
bacterioferritin A (BfrA) may not be the correct term for this protein as it likely does not bind 
heme.  Therefore, it may be more appropriate to state that the bfrA gene likely codes for a 
bacterial ferritin but not a heme binding bacterioferritin.  Consequently, the only bacterioferritin 
from P. aeruginosa is called BfrB.  Our research was aimed at isolating, characte izing and 
understanding the mechanisms of iron trafficking and the role in cellular iron homeostasis of 
BfrB from P.aeruginosa. 
                                 10        20        30       40        50        60                                                                                                                            
                                  |         |         |        |         |         |         
Pa-BfrB   MKGDKKVIQHLNKILGNELIAINQYFLHSRMWNDWGLKRLGAHEYHESIDEMKHADKLIE 
A.vinelandii  MKGDKIVIQHLNKILGNELIAINQYFLHARMYEDWGLEKLGKHEYHESIDEMKHADKLIK 
E. coli   MKGDTKVINYLNKLLGNELVAINQYFLHARMFKNWGLKRLNDVEYHESIDEMKHADRYIE 
M.smegmatis   MQGDPDVLKLLNEQLTSELTAINQYFLHSKMQDNWGFTELAEHTRAESFEEMRHAETITD 
R.capsulatus  MKGDAKVIEFLNAALRSELTAISQYWVHFRLQEDWGLAKMAKKSREESIEEMGHADKIIA 
Pa-FtnA       MQGHPEVIDYLNTLLTGELAARDQYFIHSRMYEDWGFSKLYERLNHEMEEETQHADALLR 
 
                                 70        80        90       100       110       120                                                                         
                                  |         |         |         |         |         |         
Pa-BfrB      RILFLEGLPNLQDLGKLLIGENTQEMLQCDLNLELKATKDLREAIVHCEQVHDYVSRDLL 
A.vinelandii  RILFLEGLPNLQELGKLLIGEHTKEMLECDLKLEQAGLPDLKAAIAYCESVGDYASRELL 
E. coli       RILFLEGLPNLQDLGKLNIGEDVEEMLRSDLALELDGAKNLREAIGYADSVHDYVSRDMM 
M.smegmatis   RILLLDGLPNYQRLFSLRVGQTLREQFEADLAIEYEVLERLKPGIVLCREKQDATSARLL 
R.capsulatus  RILFLEGHPNLQKLDPLRIGEGPRETLECDLAGEHDALKLYREARDYCAEVGDIVSKNIF 
Pa-FtnA       RILLLEGTPRMRPD.DIHPGTTVPEMLEADLKLERHVRAALAKGIALCEQ HKDFVSRDI  
 
                                130       140       150       160        
      |         |         |         |          
Pa-BfrB       KDILESEEEHIDYLETQLGLIQKVGLENYLQSHMHEDD--- 
A.vinelandii  EDILESEEDHIDWLETQLDLIDKIGLENYLQSQMDE----- 
E. coli       IEILRDEEGHIDWLETELDLIQKMGLQNYLQAQIREEG--- 
M.smegmatis   EQILADEETHIDYLETQLQLMDKLGDALYAAQCVSRPPGSA 
R.capsulatus  ESLITDEEGHVDFLETQISLYDRLGPQGFALLNAAPMDAAE 
   Pa-FtnA       LKAQLADTEEDHAYWLEQQLGLIARMGLENYLQSQI 
Figure 1-5: Bacterioferritin sequences from different organisms aligned against P. aeruginosa 
BfrB and FtnA: Residues involved in the ferroxidase center, as well as Met-52 (highlighted in 
red), which coordinates the heme axially and the residues lining B pores (highlighted in blue) , 
are shown. The sequences were aligned with the aid of ClustalW [60]. 
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 BfrB from P aeruginosa (Pa-BfrB) has not been recombinantly overexpressed or 
characterized before.  It was overexpressed, isolated, purified and ch racterized for the first time 
in our laboratory [55], as part of the research description in chapter 2. Our investigations show 
that Pa-BfrB has a molecular architecture typical of bacteriofer itins, with an external diameter 
of ~118 Å and an internal cavity diameter of ~73 Å.  Pa-BfrB has an intra subunit ferroxidase 
center where two iron atoms (Fe1 and Fe2) are coordinated by four glutamate and two histidine 
residues.  The two ferroxidase iron atoms of Pa-BfrB are coordinate  to Glu18/His54 (Fe1) and 
Glu94/His130 (Fe2) and Glu51/Glu127 act as the bridging ligands connecting Fe1 and Fe2.  Since 
this coordination generates a highly symmetrical ferroxidase center, it is categorized as a class II 
dinuclear iron center, similar to the dinuclear iron centers found in the hydroxylase subunit of 
methane monooxygenase and R2 subunit of ribonucleotide reductase [61, 62].  The ferroxidase 
center ligands of many Bfr proteins are positioned to bind iron.  However, His 130 of P. 
aeruginosa has been observed to undergo a conformational change before it binds iro  [63].  
More details of the structure of ferroxidase center will be presented in chapter 2.  As is typical of 
Bfrs, Pa BfrB binds 12 heme groups.  These are located at inter subunit sites, coordinated by two 
methionine residues (Met52) from adjacent subunits.  The function of the hem groups in Bfrs 
were not known before.  The research carried out in our laboratory discovered the function of 
heme in Bfrs for the first time.  It has been found that heme in Pa-BfrB act to mediate electrons 
from a reductase into the inner cavity of the protein to reduce the ferric iron mineral [55].  More 
details of those experiments will be in chapter 3.  Similar to ferritins, the symmetric arrangement 
of BfrB subunits has generated several types of channels through the protein shell.  Pa-BfrB has 
eight 3-fold channels and six 4-fold channels.  In addition to these channels, there are twelve 
other channels called B-channels which are found where one subunit dimer meets the other.  
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However, the function of these specific channels is not yet clearly established [39].  
Nevertheless, it has been postulated that in P. aeruginosa, anions such as phosphate and cations 
such as iron are taken into the inner core via 3-fold and 4-fold channels respectively. 
General mechanism of iron uptake by Bacterioferritins  
 Bfr from E.coli (Ec-Bfr) is the most studied and well characterized bacteriofer tin.  
Therefore, in the following text, the iron uptake mechanism of Ec-Bfr will be presented, which 
previous to our investigations was considered to be the mechanism of iron uptake utilized by all 
bacterioferritins.  It is noteworthy, however, that our research uncovered a different mechanism 
for iron uptake by Pa-BfrB.  Details regarding of these findings will be present d in chapter 2. 
X.Yan and co workers have established the mechanism of iron uptake by Ec-Bfr.  According to 
their findings, this process is explained in three basic steps [64]:  
 (1) Binding of Fe2+ ions at the ferroxidase center (phase 1),  
 (2) Oxidation of Fe2+ to Fe3+ (phase 2) 
 (3) Mineralization of Fe3+ ions in the inner cavity (phase 3). 
 Phase 1 has been identified as the fastest phase (t1/2 ~50 ms) in the iron uptake mechanism. 
2      
  4   Phase 1 
Pz and [Fe2 – P]
 z  represent the apoprotein with a net charge Z and the diferrous complex at the 
ferroxidase center respectively, two Fe2+ ions are bound to the ferroxidase center forming a 
diferrous complex and releasing four protons.  Two of these protons are thought to be released 
from the deprotonation of two histidine residues, the source of the other two protons is not clear,  
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but could be derived from two of the four glutamate residues at the ferroxidase center.  Phase 2 
of the reaction corresponds to the oxidation of Fe2+ to Fe3+ at the ferroxidase center and is much 
slower phase than phase 1.  When Fe2+ ions are oxidized at the ferroxidase center, a diferric 
complex [Fe2O – P]
 z or most probably a µ-oxo-bridged diferic complex is thought to be formed. 
 
  
 


 	   
     Phase 2 
Phase 3 corresponds to the mineralization of Fe3+ ions in the inner core and is the slowest phase 
(t1/2 ~300 ms) in the model [64].  Therefore the overall reaction including the oxidation of Fe
2+ 
ions (phase 2) and the mineralization (pahse 3) can be written as follows, 
4    6 	 4  8
     
The three phases mentioned above in E. coli have also been identified in P aeruginosa.  
However, our investigations carried out with Pa-BfrB indicate that the rates of the phases of iron 
uptake are quite different from those of E.coli and also suggest a different mechanism of iron 
uptake [63].  The results of those investigations will be discussed in detail in chapter 2. 
Once Fe2+ ions are oxidized to Fe3+ at the ferroxidase center, they migrate to the inner core to 
form the iron mineral which is composed mainly of iron and phosphate.  The ratio of 
iron/phosphate, however, varies depending on the type of ferritin molecule.  Animal ferritins 
have been observed to have a higher ratio of iron/phosphate than that of bacerial ferritins and 
bacterioferritins [67].  In addition, high resolution electron microsopy and electron diffraction 
data have shown that phosphate rich cores of bacterioferritins are disordered, whereas the 
mineral cores of mammalian ferritin are ordered with diffraction properties similar to 
Ferrihydrite (5Fe2O3.9H2O) [67-69]. 
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Research Problem and Rationale 
 Iron is used as a cofactor in many important proteins such as cytochromes, electron 
transfer and respiratory proteins, by many bacteria including the opportunistic pathogen 
Pseudomonas aeruginosa.  Therefore iron is considered an essential element for successful 
colonization and infection of P aeruginosa in host organisms [65].  The concentration of free 
iron in the host cell, however, is very low (~10-9 M).  In addition, the iron concentration in 
extracellular fluid and on mucosal surfaces of mammalian hosts is very limited as these iron ions 
are sequestered by mammalian iron binding proteins, such as transferring and lactoferrin [66].  
To overcome the poor availability of this essential nutrient, many pthogenic bacteria including 
P aeruginosa have evolved efficient regulatory systems to sequester, uptake, and manage iron 
[65].   
 Recent findings suggest that iron, particularly heme-iron, is essential for successful 
colonization (infection) of mammalian hosts [3].  The above findings imply that molecules 
capable of inhibiting iron/heme-iron acquisition pathways or interfering with iron trafficking 
mechanisms in P. aeruginosa may constitute a new class of antibiotics.  Therefore, a molecular 
level understanding of iron storage proteins, iron acquisition paths, regulation mechanisms and 
metabolism is required, in order to rationally develop drugs to combat Pseudomonas infections  
In P.aeruginosa, BfrB, one of the iron storage proteins in the cell, is capable of storing thousands 
of iron atoms in the form of a ferric ion mineral, which can be rel ased in the soluble form (Fe2+) 
when needed for various cellular reactions.  However, as mentioned before, the mechanisms of 
iron uptake and release by Pa-BfrB, and its physiological partners involved in these processes are 
not so far known.  Consequently, our studies were focused on characterizing Pa-BfrB, 
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understanding its mechanisms of iron uptake and release, and identifying its physiological 
partners involved in these iron regulatory mechanisms. This fundamental work is expected to 
ultimately use for the elucidation of the protein-protein interactions that facilitate iron acquisition 
and subsequent iron-metabolism inside P. aeruginosa and the development of small molecules 
(antibiotics) that interfere with those protein protein interactions.  To this end, a series of ground 
breaking studies on Pa-BfrB were carried out in our laboratory and we believe that our findings 
are yielding important foundational understanding which paves the way tord the development 
of antimicrobials that target iron homeostasis. 
  BfrB from P. aeruginosa was first overexpressed and purified to homogeneity.  Then as 
chapter 2 reveals, the protein was biochemically characterized using UV-vis spectroscopy.  To 
elucidate the pathway of iron uptake by P. aeruginosa, apo and holo/mineralized BfrB were 
crystallized and their structures analyzed in detail by X – ray c ystallography.  To corroborate 
some of the findings obtained from iron uptake studies by crystallogrphy, iron incorporation 
assays were carried out in solution using stopped flow spectroscopy.  The results of these studies 
are presented in chapter 2 with a detailed discussion of the results.  Two other proteins from 
P.aeruginosa, namely, Ferredoxin NADP reductase (Fpr) and Bacterioferritin associated 
ferredoxin (Bfd) are believed to be involved as the physiological partners of BfrB in the release 
of iron from the mineral core.  In order to investigate the above hypot esis protein-protein 
interaction assays were carried out with BfrB, Fpr and Bfd, and these results are presented in 
detail in chapter 3.  The effect of Bfd on the rate of iron releas  from BfrB core was investigated 
by carrying out protein assays with different Bfd concentrations.  I  addition, the function of the 
heme group in BfrB was also established for the first time in our laboratory.  Details regarding 
these findings are presented in chapter 3.  As chapter 2 reveals, Pa-BfrB has six 4-fold, eight 3-
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fold and 12 B-pores connecting the mineral core with the outside environment.  The specific 
functions of these pores and their importance in iron regulation inside the cell are not yet clearly 
established.  However, some of our structural findings led us to hyp t esize that the four fold 
pores may be the routes of iron release from the inner core.  In order to investigate this 
hypothesis and to elucidate the pathway and the residues involved in movig iron out of the 
protein, site directed mutagenesis studies were carried out on possible iron coordinating amino 
acid residues in the 4-fold pore.  Iron mobilization experiments were carried out with one of the 
mutants of BfrB, truncated BfrB, and the rates of iron release wer  compared with those of wild 
type in order to gain a better understanding on the pathway of iron release from the inner core of 
BfrB.  Elastic Network Model calculations were also used to corrob rate our findings on the 
process of iron release.  Chapter 4 is devoted to a discussion of our experimental results in the 
context of the above findings.  However, further investigations are required to gain a molecular 
level understanding of iron regulatory mechanisms inside the cell which may lead to a discovery 
of an important approach to prevent or treat pseudomonas infections in the host. 
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CHAPTER II 
Biochemical and Structural Characterization of Bacterioferritin B Reveals a 
 Gated Mechanism of Iron Uptake  
Introduction 
 Iron storage proteins such as ferritins and ferrtin-like proteins are capable of 
solubilizing and storing large amounts of iron (III) in the form of a ferric mineral.  Consequently 
these proteins protect cells from the toxicity generated by free Fe2+ while providing a source of 
iron for cellular processes.  These iron storage proteins function by xidizing Fe2+ using oxygen 
as electron acceptors and storing the resultant Fe3+ as an iron mineral inside the inner core.  In 
the studies carried out with eukaryotic ferritins, two mechanisms of iron oxidation have been 
observed; at higher concentrations of iron, O2 is reduced to H2O and at lower iron concentrations 
(less than 50 Fe2+ ions/ferritin), O2 is reduced to H2O2 [1].  In addition, studies with 
bacterioferritins from Escherichia coli and Azotobactor vinelandii showed that O2 is reduced to 
H2O when Fe
2+ is oxidized to Fe3+ [2, 3]. 
 In the process of iron uptake, first Fe2+ ions are bound to the exterior surface of the 
protein and then these iron ions are transported to the interior of the protein to form a diferrous 
center called ferroxidase center, where Fe2+ ions are oxidized to Fe3+.  Mammalian ferritins are 
composed of two types of subunits; H-chains and L-chains.  However, the ferroxidase centers, 
which are essential for the iron mineralization process, are located only in the H-chain subunits 
[4].  In Bfr, the ferroxidase centers are located in the middle of ach subunit and have a 
symmetric architecture withe two bridging Glu ligands (Glu 51 and Glu 127) and two His and 
31 
 
Glu residues as capping ligands (Glu18/His54 and Glu94/His130) [2,5,6,7] (Figure 2-1A).  The 
arrangement of ligands in the Bfr ferroxidase center is similar to that of the diiron centers of 
diiron type II proteins such as soluble methane monooxygenase and ribonucleotide reductase [8].  
These diiron centers are stable and act as cofactors in the protein.  In contrast to the structure of 
the ferroxidase center of Bfr, in mammalian ferritin, only one iron of the ferroxidase center is 
coordinated by a capping His ligand and the two iron ions are bridged only by Glu62 [2, 7] 
(Figure 2-1B).  Bacterial ferritins, on the other hand have the distinctive di-iron ferroxidase 
center found in mammalian ferritins.  However, in addition to the di-iron center, there is another 
iron binding site, called C site which is unique to the bacterial ferritins (Figure 2-1C) (10). 
According to the kinetic and structural studies that have been carried out on the mineralization 
processes of ferritin-like proteins over the past two decades, two models of iron uptake have 
been postulated.  Each model is thought to consist of three distinct kinetic phases [5, 7, 9].  In the 
first model, phase 1 starts by binding Fe2+ ions to a vacant ferroxidase center followed by phase 
2 where Fe2+ ions are oxidized to form an unstable diferric species.  Phase 3 is the movement of 
the oxidized Fe3+ into the interior of the protein towards the inner core for mineralization.  
Another new cycle of iron uptake starts upon binding Fe2+ to the vacant ferroxidase center.  
Therefore, in the first model, the ferroxidase center acts as a substrate for the oxidation of iron 
and also a pore for iron internalization.  In the second model, the first two phases are similar to 
those in the first model.  In the third phase, however, a stable diferric center is created at the 
ferroxidase center that serves strictly as a cofactor.  Fe2+ ions are believed to enter the Bfr cavity 
via channels of the protein molecule. 
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              (B) 
 
 
 
              (C)  
 
 
 
 
Figure 2-1: Schematic representation of (A) the symmetrical ferroxidase center typical of 
bacterioferritin (B) the ferroxidase center of human H-chain ferritin and (C) the tri nuclear 
ferroxidase center of Ferritin A from E.coli. 
O
OH
Tyr24
Glu17
O
Glu94
His53
Gln127
OH-
O NH
Fe
O
O
N
N
O
Fe
O-
Glu50
Fe
-
Glu126
Glu49
Glu129
Glu130
33 
 
These Fe2+ ions are oxidized at the nucleating centers and the electrons released from their 
oxidation are passed to the ferroxidase center where these electrons are used to reduce O2 and 
H2O2.  Observations from the kinetic studies carried out with eukaryotic ferritins indicate that at 
low iron loads (<50 Fe2+ ions/ferritin molecule), the Fe2+ is oxidized by the ferroxidase center 
with a Fe2+: O2 stoichiometry of 2:1. However, at higher iron loads the stoichiometry of Fe
2+:O2 
changes to 4:1 [1].  Bfr from E. coli (Ec-Bfr) is the most studied Bfr so far and the information 
that have been derived from these studies are very important to elucidate the mechanisms of iron 
uptake in other bacterioferritins [2, 5, 7, 9].  Kinetic and structural data obtained from the 
mineralization studies of Ec-Bfr clearly indicate that the second model of iron uptake is operated 
in E. coli.  Additional information on kinetic studies of Ec-Bfr strongly suggests that the Ec-Bfr 
ferroxidase center is stable and not converted to apo form (without iron bound to the ferroxidase 
center) spontaneously [2, 5].  It has also been observed that the apo form of the Ec-Bfr 
ferroxidase center is pre formed, so that Fe2+ ions can bind to the ferroxidase center with 
minimal structural reorganization.  However, structural studies do not indicate any evidence of 
translocation of the oxidized iron from the ferroxidase center to the inner cavity.  Therefore both 
kinetic and structural observations made from the studies with Ec-Bfr suggest that the 
ferroxidsae center of Ec-Bfr acts as a true catalytic center, rather than a pore for internalization 
of iron [11]. 
The structures of Bfrs from Azatobactor vinelandii (Av) [12], Mycobacterium smegmatis (Ms) 
[13], Desulfovibrio desulfuricans (Dd) [14], Rhodobactor capsulatus (Rc) [15], also provide 
valuable information about possible processes of iron uptake operative in bacteria.  The 
ferroxidase center of Dd Bfr contains iron in the “as isolated” D  Bfr.  However, one ferroxidase 
iron ion is lost if the protein is reduced and allowed to oxidize in air.  This observation indicates 
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that Dd Bfr ferroxidase center may function as a pore for iron internalization [14].  In addition, 
the ferroxidase center of Ms Bfr has been observed to contain zinc instead of iron and the 
ferroxidase center of Rc-Bfr has been found to be devoid of iron or any other metal ion in the 
protein as isolated.  In the structure of Av-Bfr the ferroxidase center is occupied by iron.  
However, the Fe2 position (nomenclature as in figure 2-1A) tends to have a low occupancy 
which has been interpreted to suggest that the oxidized iron has been translocated from the 
ferroxidase center to the inner cavity [12].  It is important to note that in the ferroxidase center of 
Av-Bfr, the side chain of His130 has moved away from Fe2 whereas Glu47 has moved closer.  
This observation may suggest that the concerted motion of these side chains may function as a 
gate for the translocation of iron form the ferroxidase center to the cavity [12].  According to the 
observations made with the structures of Ec, Av and Dd Bfr, it is clear that the ferroxidase 
centers of Bfr proteins do not operate in the same manner.  Some Bfrs have stable ferroxidase 
centers which function strictly as cofactors for the oxidation of Fe2+ that entered the cavity via 
channels (yet to be determined) in the protein, whereas other Bfrs seem to have “unstable” 
ferroxidase centers which serve as a center for Fe2+ oxidation and also a pore for iron 
internalization.  Eventhough the function of the stable ferroxidase centrs such as in Ec-Bfr is 
known [10], the function of the “unstable” ferroxidase centers is yet to be established. 
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Experimental Procedures 
Cloning of Pseudomonas aeruginosa BfrB. 
 The gene encoding for P. aeruginosa BfrB (PA3531) was synthesized, subcloned into 
a pET 11a vector and sequenced (GeneScript Corp., Pisctaway, NJ).  The gene was engineered 
with silent mutations introducing codons favored by E. coli [16] and with Nde I and BamH I 
restriction enzyme sites at the 5’ and 3’ ends respectively for subcloning into the pET 11a vector 
(Figure 2-2).  The pET 11a vector harboring the bfrB gene was then transformed into E.coli 
Arctic express RIL competent cells (Stratagene, La Jolla,CA). 
Expression and purification of P. aeruginosa BfrB.    
 A single colony of E. coli Arctic express RIL cells harboring the recombinant pET11-
a/bfrB construct  was cultured overnight at 37 °C in 50 mL of LB medium containing 100 µg/mL 
ampicilin and 20 µg/mL gentamicin.  The cells were subsequently subcultured in 1 L of fresh LB 
containing no antibiotics and grown for 3 h at 37 °C.  Cells were then transferred to a shaker 
incubator pre-equilibrated at 10 °C and incubated for 30 min before protein expression was 
induced by addition of isopropyl 1-thiol-D-galactopyranose (IPTG) to a final concentration of 1 
mM.  Cells were cultured for additional 48 h at 10 °C before they w re harvested by 
centrifugation (4500 rpm for 10 min) and stored at -20 °C.  The cell paste was resuspended in 50 
mM Tris-HCl, pH 7.6 (2 mL/g cell paste) and PMSF (0.5 mM), DTT (5 mM), protease inhibitor 
cocktail (Sigma-Aldrich, St. Louis, MO) and DNAse (Sigma-Aldrich, St. Louis, MO) were 
added before the cells were lysed by constant cell disrupter (Constant Systems Ltd, LowMarch, 
Northants).   
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                                           5’ Nde1 
                     CATATG AAA GGC GAT AAA AAA GTG ATC CAG CAT CTG AAT AAA ATT 
                             M      K       G      D      K       K      V       I       Q       H    L       N      K        I 
 CTG GGT AAT GAA CTG ATT GCG ATT AAT CAG TAT TTT CTG CAT AGC CGC ATG 
         L      G       N      E        L       I    A       I       N      Q      Y      F      L     H       S       R      M 
 TGG AAT GAT TGG GGC CTG AAA CGT CTG GGC GCG CAT GAA TAT CAT GAA AGC 
                      W      N      D     W       G    L       K       R      L       G      A      H       E      Y       H      E        S 
 ATT GAT GAA ATG AAA CAT GCG GAT AAA CTG ATC GAA CGT ATT CTG TTT CTG 
        I        D      E       M      K      H    A      D       K      L       I        E       R       I       L      F      L 
 GAA GGT CTG CCG AAT CTG CAG GAT CTG GGC AAA CTG CTG ATT GGT GAA AAC 
         E       G      L       P       N      L     Q       D      L       G      K       L      L     I        G      E       N 
 ACC CAG GAA ATG CTG CAG TGC GAT CTG AAT CTG GAA CTG AAA GCG ACC AAA 
         T      Q       E       M      L       Q     C       D      L       N      L       E      L     K       A       T      K 
 GAT CTG CGT GAA GCG ATC GTG CAT TGC GAA CAG GTG CAT GAT TAT GTT AGC 
        D      L       R      E       A       I    V       H      C      E        Q      V      H       D      Y      V       S 
 CGT GAT CTG CTG AAA GAT ATC CTG GAA AGC GAA GAA  GAA CAT ATT GAT TAT 
         R       D      L      L       K       D    I       L      E        S       E       E      E      H       I       D      Y 
 CTG GAA ACC CAG CTG GGT CTG ATT CAG AAA GTG GGC CTG GAA AAC TAT CTG 
         L       E       T      Q       L       G     L       I       Q       K      V       G      L     E       N      Y       L 
               CAG AGC CAT ATG CAT GAA GAT GAT TAAG ATCC 
                       Q       S       H     M     H      E        D      D            BamH1  3’ 
 
Figure 2-2: DNA and corresponding amino acid sequence of bfrB from P. aeruginosa.  
Nde I and BamH I restriction endonuclease sites were constructed at the 5' and 3' ends for 
subcloning. 
Cell debris were pelleted by centrifugation at 4 °C and 19,500 rpm and the resultant supernatant 
was loaded onto a Q-Sepharose Fast Flow column (12 cm x 2.5 cm i.d.) equilibrated with 50 mM 
Tris-HCl (pH 7.6).  The column was washed with three column volumes of 50 mM Tris-HCl (pH 
7.6) before the protein was eluted using the same buffer with a linear gradient (0 mM - 600 mM) 
of NaCl.  Fractions containing BfrB were pooled and reconstituted with heme by titrating with a 
solution of hemin (2 mg/mL in DMSO) until the absorbance of the Soret band (418 nm) no 
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longer changed.  The resultant protein solution was dialyzed against 4 L of 50 mM Tris-HCl (pH 
7.6) for 12 h at 4 °C with at least two buffer changes.  The resultant solution was then applied to 
a hydroxyapatite Bio-Gel column (10 cm x 2.5 cm i.d.) and washed with approximately 5 
column volumes of 50 mM Tris-HCl (pH 7.6).  BfrB was eluted with a linear gradient of 
potassium phosphate (50 mM-800 mM, pH 7.6).  Fractions containing BfrB (red) were pooled 
and dialyzed overnight against 4 L of 50 mM Tris-HCl (pH 7.6) at 4 °C, with at least two buffer 
changes; the resultant solution was loaded to a second Q-Sepharose Fast Flow column (12 cm x 
2.5 cm i.d.) and eluted as described above for the first ion exchange column.  Fractions 
containing BfrB were loaded onto a second hydroxyapatite Bio-Gel column (10 cm x 2.5 cm i.d.) 
and the protein eluted using conditions identical to those described above for the first 
hydoxyapatite column.  Fractions with absorbance ratio A280/ 418 < 0.7 were pooled and 
dialyzed against 100 mM potassium phosphate (pH 7.6) and determined to be pure by 15 % 
SDS-PAGE. 
Analysis of heme in Pa BfrB.   
 The pure protein, as isolated, binds 12 heme groups per BfrB molecule.  The content 
of heme was determined by adding 100 µL of pyridine to 400 µL of BfrB in 1 mL of 50 mM Tris 
buffer (pH 7.6). The protein solution was then transferred to an anaerobic chamber (Coy Labs, 
Grass Lake, MI) and allowed to degas for 3-4 hours.  Excess sodium dithionite was added to the 
protein mixture to reduce the heme in BfrB.  The UV-visible spectrum of reduced heme was 
recorded and the average concentration of heme in BfrB was determined using the extinction 
coefficients of previously reported pyridine hemochromes at 525 nm and 555 nm (ε525 = 17.0 
mM-1 cm-1 and ε555 = 33.9 mM
-1 cm-1) (17). 
38 
 
Analysis of phosphate content in the Pa BfrB core. 
 BfrB mineral core is mainly composed of iron and phosphate. The phosphate content 
was determined by measuring the concentration of a complex formed between malachite green 
and phosphomolybdate.  A standard phosphate curve was prepared using 1, 3, 6, 9, 12 µM 
NaH2PO4.H2O solutions and used to calculate the phosphate concentration of the complex.  The 
reaction mixture contains 2.96 mL of protein sample or the standard phosphate olution, 240 µL 
of 24% (V/V) H2SO4, 400 µL of 0.1M Na2MoO4.H20 and 400 µL of malachite green [0.185 
mg/ml of 1% poly (vinyl alcohol)]. The reagents are allowed to react for ~ 10 hours and the 
absorbance of the green complex formed was measured at 623 nm. The concentration of 
phosphate was determined using the prepared standard curve [18]. 
Determination of molecular mass of Pa BfrB.  
 The molecular weight of BfrB was estimated with the aid of a high resolution size 
exclusion column (Superdex 200 16/60 Prep, GE Healthcare) equilibrated wih 100 mM 
potassium phosphate (pH 7.6) and 1 mM tris (2-carboxyethyl)-phosphine hydroc loride (TCEP).  
The column was calibrated with a set of molecular weight standards (GE Healthcare) that 
included ferritin (440,000 Da), aldolase (158,000 Da), conalbumin (75,000 Da) and ovalbumin 
(43,000 Da) and a calibration curve was prepared using their elution volumes.  A sample of pure 
BfrB was passed through the same column and the molecular weight of t e protein was 
determined by using its elution volume. 
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Mineralizaton of iron in the Pa BfrB cavity.   
 Pa-BfrB as isolated contains only a small amount of iron in its core (~ 5 – 10 iron 
atoms per molecule).  Therefore, protein to be used in experiments was incorporated with ~ 600 
iron atoms per molecule.  A solution of ferrous ammonium sulfate was prepared inside an 
anaerobic chamber (Coy Labs, Grass Lake, MI), placed in a continer capped with a rubber 
septum and removed from the anaerobic chamber. Concentrated HCl (50 µL/10 mL) was added 
to the anaerobic ferrous ammonium sulfate solution through the septum with the aid of a 
Hamilton microsyringe and a needle.  The resultant solution was added to a stirred solution of 
0.002 mM Pa BfrB and 5.0 mM TCEP in 100 mM potassium phosphate buffer, pH 7.6 in 
aliquots delivering 50 Fe2+/Pa BfrB, until 600 Fe2+/Pa BfrB had been added.  Ten minutes were 
allowed after the addition of one aliquot before the next was added.  The mineralization process 
was monitored spectrophotometrically following the absorbance near 320 nm with the aid of a 
USB 2000 spectrophotometer (Ocean Optics, Dunedin, FL).   
Analysis of non-heme iron in the Pa BfrB core.  
 1 mL of concentrated HCl was added to 1 mL of BfrB (0.003 mM) and the mixture 
incubated for 15 min, followed by addition of 1 mL of ascorbic acid (25 g/L) and 5 mL of 
saturated aqueous sodium acetate.  A purple color developed upon the addition of 1 mL of 
ferrozine (5 g/L) and after 15 min the concentration of iron was determin d from the electronic 
absorption spectrum using the absorbance at 562 nm (ε562 = 27.9 mM
-1 cm-1) [18]. 
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Crystallization and data collection.   
 Crystallization studies were carried out in the Protein Structu e Laboratory at the 
Delbert M. Shankel Structural Biology Center (University of Kansas, Lawrence, KS) and the 
structure of BfrB was solved by Dr. Scott Lovell.   
Mineralized or non-mineralized (as-isolated) Pa BfrB was concentrated to 10 mg/mL and 9 
mg/mL, respectively in 100 mM potassium phosphate pH 7.6, 5 mM TCEP for crystallization.  
Crystals were grown under aerobic conditions in Compact Jr. (Emerald biosystems) sitting drop 
vapor diffusion plates using 1µL of crystallization solution and 1 µL of protein equilibrated 
against 100 µL of crystallization solution at 20 oC.  Red prisms were obtained within 24 hours 
from the following conditions: Mineralized BfrB (Wizard 2 #2, Emerald biosystems) 35% (v/v) 
2-methyl-2,4-pentanediol, 100 mM MES pH 6.0, 200 mM Li2SO4 (Appendix 1), as isolated Pa 
BfrB (Cryo 1 #11, Emerald biosystems) 35% (v/v) 2-methyl-2,4-pentanediol, 100 mM Tris pH 
8.5, 200 mM (NH4)2SO4 (Appendix 2).  To prepare samples with iron bound ferroxidase center, 
crystals of mineralized BfrB were soaked aerobically for 15 min in crystallization solution (35% 
v/v 2-methyl-2,4-pentanediol, 100 mM MES pH 6.0, 200 mM Li2SO4) 50 mM FeSO4.  Doubly 
soaked crystals were prepared by aerobically soaking mineralized BfrB crystals in the same 
crystallization solution containing 50 mM FeSO4, followed by aerobically soaking for 15 min in 
the same crystallization solution without FeSO4.  Single crystals were transferred to a fresh drop 
of crystallization solution which also served as a cryoprotectant and frozen in liquid nitrogen for 
data collection.  Data were collected at 100 K at the Advanced Photon S urce (APS) beamline 
17-BM (IMCA-CAT) using an ADSC Quantum 210 CCD detector at λ = 1.0000 Å.  Additional 
data were collected from the same crystals for mineralized and Fe soak crystals at λ = 1.6314 Å 
in order to measure an anomalous signal from potentially bound Fe ions.  Although the X-ray 
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fluorescence K edge emission peak of Fe has a maximum approximately at 1.73 Å, at 1.6314 Å 
a prominent anomalous signal can be observed for Fe ions.  
Structure solution and refinement.   
 Intensities were integrated and scaled using the HKL2000 package [19]. Structure 
solution was carried out by molecular replacement with Molrep [20]  using the full 24 subunit 
assembly of Ec BfrB as the search model (PDB: 1BFR).  Rotation nd translation searches for 
the 24-subunit assembly yielded a clear solution with a correlation coefficient of 0.735.  The 
refined model of Pa BfrB was used as the search model for subsequent data sets.  For the as 
isolated Pa BfrB, a single subunit from the final mineralized Pa BfrB structure was used as the 
search model.  Six molecules were positioned with Molrep yielding a correlation coefficient of 
0.703.  Structure refinement and manual model building were performed with Refmac [21] and 
Coot [22] respectively.  Medium NCS restraints were applied to the double soaked model.  
Figures were prepared using the Ribbons [23] and CCP4mg [24] software packages.  Structure 
validation was performed with Molprobity [25]. 
Iron uptake in solution   
 Pa BfrB to be used in the experiments was prepared by extensively dialyzing the pure, 
as-isolated protein against 100 mM MES, 100 mM KCl, pH 6.5.  Fe2+ oxidation by Pa-BfrB was 
measured with the aid of a conventional diode-array UV-vis spectrophotometer (Ocean Optics, 
Dunedin, FL), following addition of 50 Fe2+/Pa BfrB molecule to a solution of Pa BfrB (0.8 
µM) at 30 °C in 100 mM MES buffer, 100 mM KCl, pH 6.5 in a 1.0 cm path length cuvette 
equipped with a stirring bar.  The process was also studied with the aid of a Applied 
Photophysics SX.18MV-R Stopped-Flow Spectrophotometer (Applied Photophysics Ltd., 
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Leatherhead, UK), which was used to study the iron uptake process by mixing solutions of 
ferrous ammonium sulfate and Pa BfrB in Fe2+:protein ratios of 30, 50, 100, 200 and 300.  
These experiments were also carried out at 30 °C in 100 mM MES buffer, 100 mM KCl, pH 
6.5; protein concentration was 1.0 µM (after mixing) and the path length was 1.0 cm.  Progress 
curves, monitored at 320 nm, were obtained from averaging 6 replicats for each Fe2+ 
concentration.  Rate constants were calculated by fitting the first 5 s of progress curves obtained 
upon addition of 30, 50 and 100 Fe2+ ions, which allowed distinction between the fast and slow 
phases, to a single exponential function. 
 
Results 
Overexpression, Purification and Characterization of Pa BfrB 
 BfrB expressed in E.coli Arctic express RIL cells was soluble and could be purified to 
homogeneity.  The pure BfrB protein produced a single band in the 15% SDS-PAGE gel which 
corresponds to an approximate MW of 18000 Da (Figure 2-3A).  This is in good agreement with 
the molecular mass of 18553 Da calculated from the amino acid sequenc  of a BfrB subunit.  In 
addition, the molecular mass of BfrB molecule, was estimated to be 447 ± 1 kDa from its 
average elution volume (Ve= 58.9 ± 0.05 mL) of a calibrated Superdex 200 column.  The 
estimated MW confirmed the oligomerization of the BfrB molecule as a 24mer and the MW of 
one subunit was calculated as 18.6 kDa.  The MW of a subunit estimated from both experiments 
is in good agreement with molecular mass of 18553 Da calculated from the amino acid sequence 
of a BfrB subunit.  The electronic absorption spectrum of pure BfrB has a Soret band maximum 
at 418 nm and α and β bands at 567 nm and 527 nm respectively (black trace of figure 2-3B).  
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The UV-vis spectrum of pure BfrB displays another characteristic weak band at 740 nm (inset of 
Figure 2-3B) which is consistent with axial methionine ligation of the heme group [26].  
 
 
 
 
 
 
 
Figure 2-3: (A) SDS-PAGE (15%) analysis of BfrB purified to homogeneity.  (B) Electronic 
absorption spectra of oxidized-BfrB (black trace) and reduced-BfrB (red trace) in 100 mM 
potassium phosphate, pH 7.6.  The inset shows the α and β bands in the visible region. 
The reduced spectrum of BfrB was obtained by adding sodium dithionite t pure, as isolated 
BfrB and has the Soret band, α and β bands at 425 nm, 567 nm and 527 nm respectively.  The 
reduced BfrB spectrum does not show the characteristic band at 740 nm, as expected [ ](black 
trace of figure 2-3B).  It is interesting to observe that te reduced spectrum of BfrB could be 
obtained only by adding dithionite to the BfrB devoid of a mineral core (~ 5-10 Fe/BfrB).  If 
BfrB contains a mineral core, it is difficult to reduce the heme group even upon addition of a 
large excess of dithionite under strict anaerobic conditions.   
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 Although pure BfrB was obtained in high concentration as judged by the SDS-PAGE, 
the pale red color of the protein indicates that BfrB does not have the full complement of heme.  
This observation suggests that when BfrB is overexpressed in E. coli, it may not have 
incorporated the full amount of heme.   
 
 
 
 
 
 
 
 
 
Figure 2-4: Spectral changes observed upon reconstituting recombinant BfrB with exogenous 
heme. 
Therefore, BfrB containing fractions eluting from the first ion exchange column (as explained in 
the experimental section) were reconstituted with heme (Figure 2-4). The initial spectrum of 
BfrB, before adding heme (black trace in Figure 2-4) has a A280/A418 ratio higher than 10.  
However, upon reconstitution with heme the intensiy of the Soret band increases and eventually 
the ratio of A280/A418 becomes less than 1(red trace in Figure 2-4).  This observation confirms 
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that the recombinant protein as isolated from E.coli has a low content of heme.  However, the 
analysis of the heme content after reconstitution revealed that one BfrB molecule can bind 12 
heme groups.  Therefore BfrB is thought to be structurally similar to other structurally 
characterized bacterioferritins which are able to incorporate 12 heme molecules axially 
coordinated by two Met ligands.  Further, analysis of the core iron in as isolated BfrB showed 
that it contains only 5-15 iron atoms per BfrB molecule.  In order to increase the iron and the 
heme content of the recombinant BfrB, the expression medium was supplemented with Fe(SO4)2 
(4 mg/L) and δ-aminolevulinic acid (ALA) (17 mg/L).  Nevertheless, ‘as isolated’ BfrB had a 
low content of iron and heme.  ALA was used to supplement the medium to increase the amount 
of heme produced during expression of BfrB, as it has been shown that the expression medium 
enriched with ALA increases the yield of heme bound proteins [27, 28].  The low content of iron 
and heme of overexpressed BfrB may be due to the fact that the host E.c li cannot supply all the 
required iron and heme for the overexpressing protein which in turn creates a strain on the iron 
uptake and iron homeostasis processes of the host E.coli strain.  On the other hand, an attempt to 
purify BfrB without heme was not successful as it did not produce properly assembled 24meric 
BfrB.  These results suggest that heme may be necessary for this protein to maintain its proper 
oligomerization and long term stability.  However, after few xtra purification steps, it was 
possible to purify BfrB without heme to homogeneity as judged by the presence of a single band 
at ~ 18 kDa in a 15% SDS-PAGE gel.  To determine the size of the purified BfrB devoid of 
heme, it was passed through a Superdex 200 column previously calibrated with molecular weight 
markers.  Interestingly, the peak corresponding to the molecular mass of  24-mer (447 kDa) was 
absent and three other peaks corresponding to molecular weights of masses of 30, 92 and 254 
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kDa were present.  These results indicate that the protein may have disassembled into several 
subunits due to the lack of stability provided by the heme. 
Preparation of Iron-loaded Pa BfrB 
 BfrB with iron-loaded inner core was prepared by titrating a solution of apo BfrB 
(BfrB devoid of iron in the inner core) with an anaerobic solution of ferrous ammonium sulfate 
[Fe(NH4)2(SO4)2] solution.  The experiment was carried out in air to allow the oxidation of Fe
2+ 
to Fe3+ to take place.  The oxidation of Fe2+ occurs by two competing reactions: In one reaction, 
Fe2+ is oxidized by apo BfrB using dissolved oxygen as the electron acceptor and the resulting 
Fe3+ is incorporated in the inner cavity of BfrB.  In the competitive process, the Fe2+ ions are 
rapidly oxidized by the oxygen dissolved in the protein solution and the resulting Fe3+ can be 
hydrolyzed into insoluble colloidal hydrous oxide.  Some of the protein molecules may be 
electrostatically attached to the iron colloid and precipitate ogether with the colloid which 
results in significant loss of protein.  To prevent protein precipitat on during mineralization, an 
aliquot of Fe2+ which is equivalent to 10% of the total iron to be loaded was added at a time.  The 
next aliquot of Fe2+ was added after 15 minutes allowing time for the previously added iron to 
oxidize and mineralize.  After each addition of iron the reaction mixture was centrifuged to 
separate any colloidal iron oxide formed.  The black trace in figure 2-5 shows the spectrum of 
BfrB containing 10 iron atoms per protein molecule in its core, before the addition of Fe2+ with a 
A280/A418 ratio of 0.69.  Upon addition of Fe
2+ into the protein solution a gradual increase in the 
intensity of the absorption near 280 nm was observed. 
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Figure 2-5: Family of electronic absorption spectra illustrating the intnsity changes brought 
about by reconstituting the core of Pa BfrB with iron. 
The intensity of absorption at 280 nm is increased because mineralized iron in the inner core 
shows absorption similar to band-edge bands displayed by polycrystalline semiconductors [28].  
The group of spectra in figure 2-5 also indicates that as the intensity of the band near 280 
increases the intensity of the Soret band remains almost constant; the small decrease of the 
intensity of the Soret band is due to minute losses of protein caused by the precipitation with the 
iron colloid formed after each addition of Fe2+.  In addition, the preservation of the baseline of 
the family of spectra provides good evidence on the fact that the centrifugation step carried out in 
between each addition of iron efficiently removes any colloidal iron formed.  This approach of 
mineralization yielded high recovery (85%) of protein with an iron content of 600 ± 40 iron per 
BfrB molecule. The phosphate to iron ratio of the BfrB mineral wasdetermined to be ~ 1-3 
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which corroborates the fact of typical bacterioferritins isolated from native sources having high 
phosphate content [30-34]. 
Crystallization of Pa-BfrB 
 Initial crystal screening trials of recombinant mineralized Pa-BfrB formed red prisms 
from various crystallization conditions (Figure 2-6).  These crystals were orthorhombic and 
composed of 24 Pa-BfrB molecules in the asymmetric unit.  It diffracted to the highest resolution 
of 2.1 Å (Table 2-1).  ‘As isolated’ Pa BfrB formed red crystal  of the form of Orthorhombic I, 
with six BfrB molecules in the asymmetric unit. 
 
 
 
 
 
 
Figure 2-6: (A) Red prismatic single crystals of recombinant Pa BfrB formed in compact Jr. 
sitting drop vapor diffusion plates. (B) A single crystal of recombinant Pa BfrB. 
The crystals from mineralized Pa-BfrB were soaked in the crystallization solution containing 50 
mM FeSO4 (Fe soaked Pa-BfrB) for 15 minutes and used to acquire diffraction data. In addition, 
the diffraction data were also collected from the crystals obtained after soaking the Fe soaked Pa-
BfrB crystals for 15 minutes in a crystallization solution which does not contain iron (double-
(A) (B) 
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soaked Pa-BfrB).  All the crystal structures solved from above exp riments had very similar 
properties.  However, important differences were observed in the processes of binding of iron to 
the ferroxidase center and the external and internal surfaces of the protein.  
           Table 2-1.  Crystallographic data for Pa BfrB. 
 BfrB  
(“as isolated”) 
BfrB 
(minearalized) 
BfrB 
 (Fe Soak) 
BfrB  
(Double Soak) 
Data Collection     
Unit-cell parameters (Å) a = 122.76  
b = 126.27 
c = 168.55 
a = 125.81 
b = 202.76  
c = 207.55 
a = 125.72  
b = 203.28 
c = 207.73 
a = 125.71  
b = 203.21 
c = 207.87 
Space group I222 P212121 P212121 P212121 
Resolution (Å) 50.0-2.07  
(2.14-2.07) 
50.0-2.10  
(2.18-2.10) 
50.0-2.25 (2.33-
2.25) 
50.0-2.80 
(2.90-2.80) 
Wavelength (Å) 1.6531 1.0000 1.0000 1.6531 
Temperature (K) 100 100 100 100 
Observed reflections 550,190 2,179,278 1,858,510 955,818 
Unique reflections 79,588 309,226 251,658 131,241 
<I/σ(I)>1 20.3 (2.4) 16.2 (2.0) 13.1 (1.9) 13.0 (2.3) 
Completeness (%)1 99.5 (97.8) 99.9 (99.4) 99.7 (98.5) 100 (100) 
Redundancy1 6.9 (5.3) 7.0 (6.3) 7.4 (5.6) 7.3 (6.5) 
Rmerge (%)
1, 2 9.0 (50.4) 10.9 (66.9) 13.5 (69.2) 17.0 (75.3) 
Refinement     
Resolution (Å) 50.0-2.07  50.0-2.10 50.0-2.25 50.0-2.80 
Molecules / asu 6 24 24 24 
Reflections (working/test) 75,351 / 3,973 291,584 / 15,512 237,971 / 12,585 124,548 / 6,600 
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Rfactor / Rfree (%)
3 19.7 / 24.5 19.3 / 24.4 17.3 / 22.6 19.5 / 23.7 
No. of atoms (protein / heme / 
Fe2+ / K+ / water) 
7703 / 172 / 0 / 2 / 
363 
30,491 / 516 / 0 / 
6 / 1,512 
30,932 / 516 / 96 
/ 6 / 1,648 
30,414 / 516 / 24 / 
6 / 0 
Model Quality     
R.m.s deviations      
Bond lengths (Å) 0.023 0.021 0.022 0.016 
Bond angles (o) 1.929 1.824 1.856 1.553 
Average B factor (Å2)     
All Atoms 38.8 27.3 25.3 39.5 
Protein 38.5 26.9 24.8 39.4 
Heme 39.6 27.8 28.8 46.6 
K+ / Fe2+ 25.3 23.9 / NA 29.5 / 30.4 31.4 / 49.4 
Water 44.2 35.8 33.2  
Coordinate error based on 
Rfree (Å) 
0.171 0.174 0.194 0.337 
Ramachandran Plot      
Favored (%)  99.8 99.6 99.3 
1) Values in parenthesis are for the highest resolution shell. 
 
2) Rmerge = ΣhklΣi |I i(hkl) - <I(hkl)>| / ΣhklΣi I i(hkl), where I i(hkl) is the intensity measured for the 
ith reflection and <I(hkl)> is the average intensity of all reflections with indices hkl.  
3) Rfactor = Σhkl ||Fobs (hkl) | - |Fcalc (hkl) || / Σhkl |Fobs (hkl)|; Rfree is calculated in an identical  
manner using 5% of randomly selected reflections that were not included in the refinement. 
 
These four crystal structures were used to structurally charaterize BfrB to aid in the elucidation 
of the mechanism of iron uptake.  According to the crystallographic data, Pa-BfrB consists of 24 
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subunits and is assembled as a nearly spherical molecule with external and internal diameters 
of~118 Å and ~73 Å respectively.  Each Pa-BfrB subunit is made of four α-helices which are 
arranged nearly parallel to each other and a short C-terminal α-helix almost perpendicular to the 
four-helix bundle.  One Pa-BfrB molecule can bind 12 heme groups and each h me group is 
located between two subunits and axially coordinated by a methionine (Met52) from each 
subunit (Figure 2-7). 
 
 
 
 
 
 
 
 
Figure 2-7: Heme group coordinated by two Met52 residues at the inter subunit site of two 
adjacent subunits of BfrB from P. aeruginosa. 
In the as-isolated crystal form, two of the heme molecules were located on the 2-fold 
crystallographic axes bisecting the CHA, Fe, and CHC atoms.  Heme molecule is not a 
symmetrical molecule.  Therefore, it should adopt two orientations in a 50:50 ratio and in Pa-
Met 52 
Met 52 
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BfrB, it is related by the 2-fold crystallographic axis.  In addition three and four fold axes 
traverse through the 3-fold and 4-fold channels in the molecule and potassium ions were 
observed in the 4-fold channels of all the solved structures of Pa-BfrB (Figure 2-8). 
 
  
 
 
 
 
 
 
Figure 2-8: Structure of recombinant Pa BfrB viewed along a (A) 4-fold axis and (B) 3-fold axis 
of the molecule. 
The ferroxidase center of Pa BfrB is unstable 
Ferroxidase center of Pa-BfrB is made of six amino acid residu  which are highly 
conserved among all bacterioferritins of known structure [30].  In Pa-BfrB, Glu18 and His54 act 
as terminal ligands to Fe1 and Glu94 and His130 act as terminal ligands to Fe2.  The two iron 
atoms are bridged by Glu51 and Glu127 (Figure 2-9A). 
(A) (B) 
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 (A) 
 
 
 
 
 
 
 (B) 
 
 
 
 
 
 
 
Figure 2-9: Structure of (A) empty ferroxidase center and (B) iron bound ferroxidase center of 
Pa BfrB showing two different conformations of His130. 
Fe2 Fe1 
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Even though the electron density maps for these residues in the structure solved from as-isolated 
Pa-BfrB were well defined, electron density due to metal ions in this site was not observed.  This 
clearly indicates that the ferroxidase center of as-isolated Pa-BfrB is empty.  It is important to 
note that eventhough most of the ferroxidase center residues are pre-arranged to bind iron,  His 
130 is rotated away from the ferroxidase center and would require a conformational change to 
bind Fe2 ion (Figure 2-9B).  As mentioned in the experimental procedures, anom lous Fourier 
analysis was carried out using data collected at 1.6314 Å.  These experiments generated a strong 
anomalous signal created from the Fe atoms at the heme sites.  However, negligible electron 
density was observed at the ferroxidase center, which confirms that the ferroxidase center of as-
isolated Pa-BfrB is empty.  A sample of as-isolated Pa-BfrB was reconstituted with ~ 600 iron 
atoms (mineralized) to prepare a protein sample to obtain a structure with an iron-filled 
ferroxidase center.  As figure 2-5 shows, upon addition of aliquots of iron to the protein, a 
gradual increase in the absorption near 320 nm was observed, which resulted from the growth of 
iron mineral in the core of ferritin-like molecules [29].  After adding the last aliquot of iron, the 
mineralized solution was incubated overnight at 4 ºC and then it  passed through a G-25 column 
to remove any non-mineralized excess iron.  The iron content of the min ralized protein was 
analyzed and a core of ~600 ± 40 was observed, signifying that the protein had been successfully 
mineralized.  The crystal structure of mineralized Pa-BfrB, which was solved to 2.1 Å resolution, 
is nearly identical to the structure obtained from the as-isolated Pa BfrB, including an empty 
ferroxidase center.  Moreover, the ligands which coordinate the two iron atoms at the ferroxidase 
center of mineralized Pa BfrB, have the same conformations similar to those found in the as-
isolated Pa BfrB together with the His130 side chain rotated away from the diiron center (Figure 
2-8A).  Eventhough the protein had been mineralized with ~600 iron atoms before the 
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crystallization; the ferroxidase center does not contain iron.  This observation indicates that the 
diiron center in Pa-BfrB is unstable. 
The Crystal form of Pa-BfrB is functional. 
 In the experiments carried out to incorporate iron to the ferroxidase center, crystals of 
mineralized Pa-BfrB were soaked in a Fe2+ solution for 15 minutes and then the Fe soaked 
crystals were flash frozen for data collection.  The structure of the Fe soaked Pa-BfrB revealed 
four types of iron bound to the protein.   
 
 
 
 
 
 
 
 
 
Figure 2-10: Views of a single subunit of Fe soaked Pa BfrB showing the iron atoms (gold 
spheres) located on the outer surface of the protein Feout, the inner surface Fein, and the 
ferroxidase iron atoms located in the center of the helix bundle. 
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The structure showed two iron ions bound to the ferroxidase center and iron ions bound to the 
exterior and the interior surfaces of the protein.  This observation suggests that Pa-BfrB is 
functional even in the crystalline form, where it is capable of internalizing iron from the external 
solution into the interior of the protein.  As a result, the Fe soaked crystal structure of Pa-BfrB 
can be considered as a representation of a snapshot of the iron uptake process.  As figure 2-10 
illustrates, the structure of a monomeric subunit of the Fe soaked crystal structure contains three 
types of iron: two iron ions at the ferroxidase center , located within the helix bundle, Fe bound 
to the external surface of the protein (Fe (out)) and iron bound to the internal surface of the protein 
(Fe(in)).  The Fe soaked crystal structure also revealed that the ferroxidase centre of Pa-BfrB is 
coordinated by Glu18, His54 (terminal ligands to Fe1), Glu94, His130 (terminal ligands to Fe2) 
and Glu51, Glu127 (bridging ligands of Fe1 and Fe2) (Figure 2-9).   
 The presence of these iron was demonstrated by the strong peaks in the electron 
density map (F0 - Fc), as well as a strong anomalous signal from data acquired at 1.6314 Å.  Each 
subunit of the Pa BfrB structure showed a nearly complete iron occupan y of their ferroxidase 
centers, which is reflected in anomalous peak intensities and B factors for Fe1 and Fe2 
comparable to those of heme iron (Table 2 and Figure 2-11).  
The average distance of Fe1 and Fe2 was observed to be 4.00 Å with a range of 3.96-4.04 Å, 
which are similar to the distances observed in the structures of Av B r [12, 35] and Dd Bfr [14] 
in their reduced form, and it is consistent with a di-Fe2+ oxidation state [8].   
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Figure 2-11: Single subunit of BfrB showing the anomalous difference map (green mesh) 
calculated from data collected at λ = 1.6314 Å contoured at 6σ.  Fe atoms are represented as gold 
spheres and the neighboring heme atoms are drawn as sticks. 
 
Table 2-2.  Anomalous peak heights and B-factors for Fe atoms in the Fe soaked structure.    . 
 Fe(out) Fe1 Fe2 Fe(in) Heme Fe 
Subunit B (Å2) Peak 
Heighta 
B (Å2) Peak 
Heighta 
B (Å2) Peak 
Heighta 
B (Å2) Peak 
Heighta 
Heme 
# 
B (Å2) Peak 
Height 
A 26.6 11.7 24.4 11.2 37.8 10.3 25.8 12.9 1 22.4 12.1 
B 32.9 8.1 25.9 12.4 35.0 11.1 25.4 12.5 2 22.5 12.7 
C 33.4 9.0 23.6 11.8 34.0 11.1 21.0 13.5 3 21.4 12.8 
D 37.5 8.0 26.4 12.2 35.4 9.2 24.4 12.9 4 22.2 14.1 
E 36.7 8.1 24.7 14.0 35.2 9.7 21.7 12.2 5 22.6 12.1 
F 32.1 7.9 27.1 11.9 33.2 9.1 24.5 12.8 6 26.4 12.5 
G 37.4 9.4 25.0 12.2 35.5 10.1 22.7 12.9 7 25.8 12.5 
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H 39.5 8.2 27.4 11.3 36.3 8.7 25.7 11.8 8 23.6 13.0 
I 35.4 9.0 27.3 13.1 38.2 8.6 25.3 11.7 9 23.5 13.3 
J 43.2 8.6 24.3 11.2 36.8 8.7 21.3 14.6 10 21.2 12.9 
K 31.9 10.7 24.0 14.3 31.8 10.7 24.5 14.3 11 26.1 12.8 
L 32.6 9.0 26.6 12.6 34.1 10.3 24.5 13.6 12 20.7 12.1 
M 42.7 7.5 28.6 11.0 35.1 9.4 24.6 13.2    
N 39.3 7.3 29.7 11.9 40.4 8.7 28.4 11.4    
O 45.2 7.6 31.1 11.3 40.0 8.1 24.2 12.7    
P 40.3 8.0 28.3 10.5 35.4 9.2 29.3 12.2    
Q 23.8 14.0 26.1 10.0 32.1 7.3 24.0 13.6    
R 29.2 9.9 24.1 11.6 33.1 8.2 26.0 13.3    
S 32.4 8.3 25.7 10.8 33.7 9.6 22.5 13.2    
T 33.5 9.3 23.0 12.0 36.5 9.2 22.0 12.8    
U 31.7 9.5 26.2 12.1 35.5 9.1 19.7 13.8    
V  34.3 11.0 23.1 11.7 32.5 8.5 21.2 11.7    
W 35.7 9.3 26.3 12.1 34.4 10.3 25.5 12.3    
X 42.1 7.4 28.3 11.2 39.2 8.6 28.2 12.1    
Avg.b 35.4 9.0 26.1 11.9 35.5 9.3 24.3 12.8 Avg. 23.2 12.7 
a Peak heights were determined from the anomalous Fourier difference ele tron density map 
from data collected at λ =1.6314 Å. 
b Average B-factors and peak heights for each Fe site 
Figure 2-12 shows a superimposition of the empty (green) and filled(magenta)ferroxidase 
centers illustrating the fact thet His130 is rotated away from the diiron center in the empty 
ferroxidase center and undergoes structural reorganization upon binding with iron.  
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Figure 2-12: Overlay of the mineralized (green) and Fe soaked (magenta) Pa BfrB structures 
showing their ferroxidase centers. 
As figure 2-12 depicts, in the presence of iron, His130 rotates towards the diiron center to 
coordinate Fe2.  This conformational flexibility shown by His130 is associated with the binding 
and oxidation of external Fe2+ at the ferroxidase center.  The oxidized Fe2 is released into the 
interior of the protein as the His 130 rotates away from the ferroxidase center to adopt its non 
coordinating conformation.  Therefore, the conformational flexibility of His130 may be 
important in gating iron from the ferroxidase center into the iron core.  In addition, when the 
mineralized and Fe soaked structures are superimposed, the residual lectron density from the Fe 
soaked structure fits closely to the His 130 of the mineralized structure, indicating that the His 
130 in the Fe soaked structure has two conformations.  One conformation would be that of His 
130 coordinated to Fe2 (70% occupancy) and the other similar to the conformation seen in the 
empty ferroxidase center (figure 2-12 green conformation).  According to these observations, it 
 
Fe2Fe1
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is clear that in the as isolated and mineralized structures, His130 adopts the non coordinating 
conformation and move to the coordinating conformation only in the presence of iron at the 
ferroxidase center.  Therefore, the Fe soaked structure represents a snapshot of the iron uptake 
process by the ferroxidase center in which His130 has been caught in the process of returning to 
its coordinative conformation.  To further investigate whether the oxidation of the protein in air 
would form a ferroxidase center with iron at the Fe1 position and nearly empty Fe2, the 
mineralized Pa BfrB crystals were soaked in an iron solution for 15 minutes, followed by a soak 
in crystallization solution for 15 minutes.  Then the crystals were flash frozen for data collection.  
The structure obtained (double–soaked) from these crystals showed a f rroxidase center 
completely devoid of iron.  The conformation of the side chains of the ferroxidase center ligands 
were observed to be identical to those adopted in the structures of as isolated and mineralized 
crystals, in which the side chain of His130 is in its non coordinative conformation.  Weak 
residual difference density was observed in the ferroxidase center due to the low-occupancy of 
iron.  In addition, relatively larger peaks were observed in the differenc  electron density maps at 
the Fe(in) sites.  Refinement of Fe ions with full occupancy at these sites resulted in B factors that 
were 2-3 times higher than those of the average value of the mod l.  The lengthened non bonded 
contacts between Fe(in) and His153/His155 at these sites and the relatively weak electron density 
compared to those of the Fe soaked structure most probably reflect the dynamic motions likely 
resulting in incorporation of Fe(in) in the core mineral.  Further, higher B factors relative to those 
of the overall model were observed due to the presence of potassium ions in the 4-fold pores 
refined with occupancy of 0.5.  All these unique observations and findings indicate the fact that 
the diiron center of this protein is relatively labile.  The observed dynamic behavior of the diiron 
center could be a property which allows Pa BfrB to uptake iron efficiently via the ferroxidase 
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center.  These ideas were further investigated with the aid of kinetic studies, an dthe 
corresponding observations and conclusions will be presented later in this chapter. 
Ferroxidase pore 
 The outer surface of the Pa BfrB structure reveals a pore that probably functions as a 
pathway for the translocation of Fe2+ from the outer surface of the protein to the ferroxidase 
center and oxidized iron (Fe3+) from the ferroxidase center to the inner core. 
 
 Figure 2-13: Stereo view of the ferroxidase pore viewed from the protein exterior.  The semi-
transparent surface representation (magenta) is constituted by residues lining the pore wall 
(Asn17, Ile20, Leu93, Lys93 and Ala97).  (A) The “gate-open” conformation of the Asp50 and 
His130 side chains allows a nearly unobstructed view of the interior cavity through the pore.  (B) 
The “gate-closed” conformation of Asp50 and His130 obstruct the bottom of thepore and poise 
H130 to coordinate Fe2.  The ferroxidase iron is not shown for clarity.  (C) View identical as in 
(B) but showing the ferroxidase iron ions as orange spheres.  The side chain is His130 is below 
Fe2, which is located at the bottom of the pore.  Fe1 in the interior can be seen through the semi-
transparent surface. 
H130
D50
(A) (B) (C) 
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 A semitransparent surface representation of the mineralized Pa BfrB structure 
(apoferroxidase) in Figure 2-13 shows a section of a pore that leads towards the ferroxidase 
center from the exterior of the protein.  The walls of this pore are made of the backbone and the 
side chain of Asn17, the side chain of Ile20, Leu93, the hydrophobic component of the Lys96 
side chain and the back bone of Ala97.  The carboxyl oxygens of Glu51 and Glu94 which are the 
terminal and bridging ligands in the ferroxidase center respectively can be observed at the 
bottom of the pore.  It can be clearly observed (Figure 2-13A) that the conformation of the 
His130 side chain in the mineralized structure does not obstruct the pore, which we termed the 
“gate open” conformation.  Figure 2-13B represents an identical view of the Fe-soaked structure 
(holo ferroxidase) where iron atoms are not shown.  In this structure the His 130 has adopted its 
“gate closed” conformation, serving as a cap at the end of the pore and also as a ligand to Fe2.  
Figure 2-13C is identical to the figure 2-13B, except that the ferroxidase iron ions have been 
added, clearly showing Fe2 at the bottom of the pore.  The Fe2 is coordinated by the ligands 
Glu94 and His130 and bridged to Fe1 by Glu51 and Glu127.  As illustrated in the above figure 2-
13, Fe2+ enters the ferroxidase center through the ferroxidase pore, where it is captured by the 
ferroxidase ligands including His130.  Upon binding with Fe2+, His130 moves from its “gate 
open” conformation to “gate closed” conformation.  This conformational change of His130 may 
be triggered by small conformational changes that occur when the di-F 2+ complex is formed.  
Subsequently, the di-Fe2+ complex is oxidized to di-Fe3+ at the ferroxidase center leading to a 
shorter inter nuclear distance [8], which in turn may trigger the His130 to change its 
conformation to gate open conformation.  In addition, this change of the conformation may have 
also been triggered by the subtle ligand rearrangement required to accommodate an µ-oxo or µ-
hydroxo bridged di-Fe3+ moiety.  Furthermore, in addition to the conformational change of 
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His130, another important change in the side chain of D50 was also observed.  As shown in 
figure 2-13A the side chain of D50 does not obstruct the pore. However, it may be contributing 
to cover the bottom of the pore in the gate closed conformation (figure 2-12C).  Therefore, it can 
be clearly seen that the concerted motions of D50 and His130 are very important in opening and 
closing the gate for the translocation of Fe3+ from the ferroxidase center to the interior cavity 
Three and four fold pores in Pa BfrB.   
 Figure 2-8 shows that the core of bacterioferritn is connected to the exterior of the 
protein by six 4-fold and eight 3-fold channels.  As is shown in the figure 2-14A, the entrance to 
the 3-fold channel from the outside, is formed by three Glu109 side chains which form salt 
bridges with three Arg117 side chains, thus restricting pore access.  The structure of iron soaked 
Pa BfrB reveals that the interior of the 3-fold pore the side chains of Lys 121 may be disordered, 
as there was no electron density observed beyond the β carbons (Figure 2-14B).  However, 
residual electron density was observed in the 3-fold pore which may be due to the presence of 
either sulfate or phosphate ions, subsequent refinements revealed that the residual electron 
density was due to a presence of a sulfate ion in the pore.  
 Sulfate ions are present in the soaking solution which is prepared using 50 mM FeSO4 
and also in the crystallization solution which contain 200 mM LiSO4.  Since SO4
2- ions were 
observed only in the Fe soaked crystal structure, it can be hypothesized that 3-fold pores may 
function as pathways of anion uptake in Pa-BfrB.  However, further studie  are required to 
confirm this idea of anion trafficking through 3-fold pores in Pa BfrB.   
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Figure 2-14: (A) Stereo view of a three-fold channel in the mineralized Pa BfrB structure, 
viewed from the interior cavity (O is in red and N in blue) (B) Identical view of a three-fold 
channel in the Fe-soaked structure.  The interior of the pore shows the pres nce of sulfate 
(magenta) and disorder in the side chains of Lys21. 
 There are six 4-fold pores in Pa BfrB, located along the four fold axis of the molecule.  
Figure 2-15 shows a 4-fold pore in the structure of mineralized Pa BfrB, with a potassium ion 
coordinated by the side chains of Asn148 and Gln151 residues.  Negligible anomalous difference 
density was observed in the 4-fold pore in a data set collected at 1.6314 Å, thus eliminating the 
possibility that the metal ion in the 4-fold pore is iron.  Further, when Fe ions or water molecules 
were modeled at these sites, residual negative or positive difference density was observed.  In 
addition, potassium ions were also observed in equivalent positions of the 4-fold pores in Fe 
soaked crystal structure.  The analysis of the data sets collected at 1.6314 Å, from the Fe soaked 
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Pa BfrB crystals, provides strong evidence to confirm that te Fe ions are absent in the 4-fold 
pores due to the absence of anomalous difference density in the 4-fold pore which contrasts with 
the strong anomalous signals observed from the heme iron, ferroxidase iron and Fe(in) and Fe(out) 
(Table 2-2). 
 
 
 
 
 
 
Figure 2-15: View of a 4-fold pore where a potassium ion (yellow sphere) is coordinated by 
Gln151 and Asn148.  The potassium ion in the four fold pore is present in the as isolated, 
mineralized, Fe-soaked and double-soaked structures. 
 The potassium ions observed in both Fe soaked and non soaked crystals are from th  
protein storage buffer which contains 100 mM potassium phosphate.  In addition to the structure 
of Pa BfrB, two independent structures of Av Bfr have also been observed to contain metal ions 
(Fe and Ba) in the 4-fold pores coordinated by Asn148 and Gln151 [11, 34]. These observations 
suggest that Fe ions may enter or exit the protein via the 4-fold pores in the molecule. 
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Iron bound to the Internal [Fe(in)] and external [Fe(out)] surface 
 In addition to the iron ions observed at the ferroxidase center, the min ralized Fe 
soaked crystal structure revealed the presence of two additional r  sites.  One site is located on 
the exterior surface of the protein, is termed Fe(out), and the other site was found on the internal 
surface, protruding into the internal cavity, termed as Fe(in). 
 
 
 
 
 
 
Figure: 2-16 (A) A four fold-pore and neighboring B pores in the Fe-soaked Pa BfrB structure 
viewed from the interior cavity.  The iron and potassium ions are represented by orange and 
green spheres, respectively.  (B) An identical view in CPK rendering, which facilitates 
visualization of the B pores and of the four Fe(in) ions surrounding the four-fold pore. 
Figure 2-16A depicts a part of the BfrB molecule including a 4-fold pore, viewed from the 
interior of the protein.  The 4-fold pore shown here is made of the subunits E, J, Q and V and the 
subunits I, F, R and U are also arranged with the 4-fold pore forming subunits to form a different 
type of pores, the so called B-pores [14].  Four of those B pores can clearly be seen in the CPK 
rendering in figure 2-16B.  In figure 2-16A, a potassium ion (green sphere) was observed in the 
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4-fold pore coordinated by Asn148 and Glu151.  In addition, four iron atoms were found 
surrounding each 4-fold pore and each iron atom is coordinated by His 155 and His153 from 
different subunits.  As figure 2-17shows the octahedral coordination of each iron atom is 
completed by the water molecules.   
 
 
 
 
 
 
Figure 2-17: Non-bonded contacts between Fe ions and histidine residues.  Fe ions and water 
molecules are represented as gold and red spheres, respectively.  Fein is coordinated by His 153 
from subunit J and His 155 from subunit E. 
According to the crystal structures analyzed, and as illustrated in figure 2-18, three pathways of 
iron entry into the Pa BfrB inner core can be postulated: (1) via the ferroxidase pore, (2) via the 
4-fold pores, and (3) via the B pores.  When iron enters via the ferroxidase pore a change of the 
conformation of His 130 from its gate open to its gate closed conformatin llows Fe3+ ions to 
move into the interior of the protein.  At this position, Fe3+ ion is thought to be interacting with 
Glu47, His46, His43 and/or Tyr133, through which the Fe3+ ion moves to its position in the 
interior of the protein.  
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Figure 2-18: Different possible routes for moving iron ions from the ferroxidase pore, four-fold 
pore or B pores to their Fe(in) position. 
 In addition to the conformational change observed in His 130, His 46 was also 
observed to have two conformations which may be associated with the translocation of iron from 
the ferroxidase center to the Fe(in) position.  Iron ions (likely Fe
2+) entering through 4-fold pores 
may be moved to the Fe(in) position in the interior of the protein through the interactions of 
Arg39 and His155 from different subunits.  Iron entering through the B pores are assumed to 
interact with the side chains of Asp34, Thr136, Asp132 which may form a coordinating path 
towards the position of Fe(in).  A study carried out with Ec Bfr has shown that the crystal form of 
Ec Bfr is also functional and can mineralize iron [11]. These iron ions have been observed in the 
interior of the protein, but at a different position from which was observed in Pa BfrB.  In Ec Bfr, 
Fe(in) has been observed directly below the ferroxidase center, coordinated by Asp50 and His46.  
Another iron site on the surface of the Pa BfrB (Fe(out)) was observed in the mineralized Fe 
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soaked crystal structure where it is coordinated by His10, His 107 and three water molecules 
(Figure 2-19B).   
 
 
 
  
 
 
 
 
 
Figure 2-19: (A) Stereoveiw of the location of Fe(out) on the external surface of the Fe-soaked 
structure, where it is coordinated by His10, His107 and three water mol cules.  Iron ions are in 
orange, nitrogen atoms are in blue, oxygen atoms in red and residues lining the external 
outermost layer of the pore are in magenta and in CPK rendering. (B) Non-bonded contacts 
between Feout and surface residues His 10 and His 107.  
 The position of Fe(out) is closer to the ferroxidase pore, which may allow relativey eas  
translocation of iron from the outer surface to the ferroxidase pore.  These Fe(out) sites show a 
near full occupancy in the crystal structure (Table 2-2) indicating a moderate to high affinity of 
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the Pa BfrB outer surface for iron and may be very important in capturing, coordinating and 
guiding iron ions towards the internalization pathway.  As figure 2-19A clearly illustrates Fe(out) 
may be moved towards the ferroxidase pore through the interactions of the hydrophilic side 
chains of His10, His 107, E103, D100 and K13.  Figure 2-19A shows the residues lining the 
ferroxidase pore in CPK rendering and the hydrophilic side chains which connect the Fe(out) with 
the pore in stick rendering.  The side chain of Lys96 makes a salt bridge with Asp100 and when 
an Fe ion reaches the ferroxidase pore from its Fe(out) position, it may induce a conformational 
change of Asp100 that breaks the salt bridge with Lys96.  Consequently, the conformation of 
Lys96 may also change, providing a pathway for the Fe2+ to enter the ferroxidase pore. 
Iron uptake in solution by Pa BfrB confirms the notion of a gated mechanism of iron uptake 
via the ferroxidase center. 
 The preliminary experiments on the iron uptake by as-isolated Pa BfrB were carried 
out using conventional diode array spectrophotometer.  Aliquots of Fe2+ solution containing 50 
Fe2+ ions per protein molecule were added while monitoring the change of abs rbance at 320 
nm.  These experiments were carried out at pH 6.5 at 30 ºC, in order t  compare the observations 
with those made with Ec Bfr [2, 5].  The results obtained with Pa BfrB were completely different 
from those obtained with Ec Bfr.  
 As figure 2-20 shows, upon addition of 50 Fe2+ ions to Pa BfrB, a rapid increase of the 
absorbance near 300 nm (plotted at 320 nm) is observed and then it reaches a plateau and 
remains constant thereafter.  The magnitude of the increase of absorb nce at 320 nm at every 
addition of an aliquot of iron was observed to be nearly constant, suggestin  that the ferroxidase 
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center of Pa BfrB is labile and once all the Fe2+ ions are oxidized at the ferroxidase center, it 
becomes empty.  
  
 
 
 
 
 
 
Figure 2-20: Change in ∆A320 upon subsequent additions of Fe
2+ aliquots (50 Fe2+ ions per BfrB 
molecule) to a solution of as isolated Pa BfrB (0.8 µM) in 100 mM MES buffer, 100 mM KCl, 
pH 6.5.  These observations are in good agreement with the fact that the ferroxidase centers of 
as-isolated, mineralized and double soaked structures are vacant.  Since the initial steps of the 
iron uptake process occurs very rapidly, a stopped flow spectrophotometer was used to 
investigate the iron uptake by Pa BfrB in detail.  To this end, a solution of Pa BfrB was mixed 
with solutions containing Fe2+ in different proportions (30, 50, 100, 200 and 300 Fe2+ ions/BfrB).  
The change of the absorbance at 320 nm was monitored to follow the mineralization process of 
Pa BfrB.   
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Figure 2-21: (A) Progress curves obtained after the addition of 30, 50, 100, 200 and 300 Fe2+ 
ions per Pa BfrB molecule in 100 mM MES buffer, 100 mM KCl, pH 6.5 and 30 °C.  (B) 
Progress curves corresponding to the addition of 50 and 100 Fe2+ ions in (A) are shown to more 
clearly illustrate the decrease in absorbance that follows the fast phase.  (C) A plot of the 
amplitude obtained at the end of 200 s for the progress curves in (A).  (D) A plot of the 
amplitude of the fast phase as a function of Fe2+ load; the amplitudes were obtained from fitting 
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the first 5 s of the progress curves in (A), obtained after the addition of 30, 50 and 100 Fe2+ ions, 
to a mono exponential expression. 
 As illustrated in figure 2-21A, when the iron load is ≤ 100 Fe2+ ions/BfrB, two distinct 
phases can be observed. The fast phase lasts for < 10 s and the slower phase becomes faster 
gradually, as the iron load increases. Upon addition of 200 and 300 Fe2+/BfrB the two phases can 
no longer be clearly distinguished.  It is noteworthy that in the plots obtained by adding 30 and 
50 Fe2+ ions / BfrB, the rapid increase at 320 nm corresponding to the fast ph e is followed by a 
decrease in absorbance before initiating the slower phase (Figure 2-21B).  This observation could 
be explained if the initial rapid increase in ∆A 320 (fast phase) corresponds to the oxidation of the 
di-Fe2+ center to form di-Fe3+ center which is most probably µ-oxo (or µ-hydroxo)-bridged.  The 
decrease of the absorbance at 320 nm observed after the fast phase is likely due to the migration 
of Fe3+ ions to the inner core where mineralization (slow phase) takes place.  However, upon 
addition of higher iron loads (200, 300 Fe2+/BfrB), the decrease of the absorbance at 320 nm 
cannot be observed as it is masked by the earlier onset of the slow r phase with a large 
amplitude.  Therefore, the results obtained from the structural studie  showing that the 
ferroxidase center of Pa BfrB is vacated when Fe3+ ions are moved to the interior core, were 
further confirmed with the observations made in the stopped flow experiments where a decrease 
in the absorbance at 320 nm after the first fast phase was observed upon addition of low iron 
loads (< 100) to the protein.  The iron uptake process of Pa BfrB with higher iron loads (> 200 
Fe2+/BfrB) takes ~100 s to complete, whereas that of Ec Bfr takes ~ 800 s at the same pH and 
temperature [5].  Further, unlike in Ec Bfr, a slow phase is observed in Pa BfrB with low iron 
loads which may correspond to the mineralization in the inner core.  When the progress curves 
obtained at similar low iron loads in Pa BfrB and Ec Bfr are compared, in Ec Bfr, only the fast 
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phase is observed since the iron at the ferroxidase center is not translocated into the inner cavity 
[5].  The mineralization phase in Pa BfrB with low iron loads (<50 Fe2+/Bfr) appears to take 
place very slowly and it does not seem to reach the completion even at 200 s.  Figure 2-21C is 
plotted with the amplitudes of the slow phase of each iron load at 200 sagainst the number of 
iron atoms added per Pa BfrB molecule.  It can be clearly seen that the amplitude of the plot 
obtained with 30 Fe2+/BfrB has relatively low amplitude than what was expected according to 
the trend of the amplitudes obtained at higher iron loads.  This slower min alization phase at a 
load of 30 Fe2+/BfrB could be due to the slow nucleation process resulted by the relatively small 
number of available Fe3+ ions.  The rate of mineralization increases with the addition of higher 
iron loads such that the distinction between the two phases cannot be observed.  The amplitude 
and the rate of the fast phase were calculated by fitting a monoexponential function to the first 5 
s of the progress curves of 30, 50, and 100 Fe2+/BfrB.  The plot obtained by plotting the 
amplitude of the fast phase as a function of the iron load clearly shows that the fast phase does 
not saturate at an iron load of 50 Fe2+/BfrB (Figure 2-21D).   
 In comparison, a similar plot obtained in Ec Bfr studies shows a saturation of the 
amplitude at the iron load of 50 Fe2+/Bfr, which has been interpreted to explain the notion that 
the Ec Bfr ferroxidase center is stable and does not regenerat (Figure 2-22) [5, 11].  When the 
values of the rate constants of the fast phase of Pa and Ec Bfr are compared, a higher rate can be 
observed in Pa BfrB (pH 6.5, 30 ºC), and protein concentration is 1 µM) than that of Ec Bfr [38].  
However, the above rates cannot be directly compared due to the fact that the Ec Bfr studies have 
been carried out with a lower protein concentration of (0.5 µM). 
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Figure 2-22: (A) Progress curves obtained 
per Bfr molecule from E.coli. (B) Plots showing the saturation of the absorbance at 340 nm after
adding 50 Fe2+ ions per Ec-Bfr molecule. Figures adopted from 
lettters,1993,(333),197-202 [5] 
 
Crystallization of BfrB 
 BfrB crystals were grown under aerobic conditions using itting drop vapor diffusion 
method (Figure 2-23).  This method formed crystals which were pure and l rge enough to obtain 
diffraction data to solve the structure of BfrB.  The process of formation of crystals can be 
explained using the solubility diagram (Figure 2
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Figure 2-23: Schematics of a sitting drop vapor diffusion method used to grow BfrB crystals 
 
 
 
 
 
 
 
Figure 2-24: A Schematic phase diagram showing the variation of the solubility of  aprotein as a 
function of the precipitant concentration [45]. 
 As the diagram illustrates the solubility curve separates the protein into two main 
concentration zones called, undersaturated (below the solubility curve) and supersaturated 
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(above the solubility curve) phases of the protein.  Supersaturated area is further divided into 
three areas where the crystals are expected to grow.  However, the crystals will not be formed in 
the undersaturation phase.  In the precipitation zone, the supersturation is very high that crystals 
will not be formed. However, protein can be seen to separate as large amorphous aggregates in 
this region.  The metastable region forms crystals at a veryslow rate unless seeding is 
introduced. In the nucleation zone, the saturation is optimal such that it forms crystals which may 
diffract well to obtain the structural data of the protein molecule [45]. 
 The crystal structure of mineralized Pa BfrB, solved to 2.1 Å resolution was nearly 
identical to that of as isolated Pa BfrB.  Both crystal structures did not show any metal] ions 
bound to the ferroxidase center.  The observations made on the above crystal st uctures clearly 
indicate that the diiron center of Pa BfrB is unstable.  However, th  crystal structures of Bfrs 
from other organisms were shown to bind metal ions at the ferroxidase center [12-14,35-37]. 
Pa BfrB has a gated mechanism of iron uptake. 
 The mineralized Pa BfrB crystals, devoid of iron at the ferroxidase center, were soaked 
in a Fe2+ solution for 15 minutes.  The resulted crystal structure (Fe soaked) contained a fully 
occupied ferroxidase center, confirming the fact that crystal form of Pa BfrB is functional.  As 
mentioned in the results, two different conformations of His130 were observed in the 
mineralized and Fe soaked crystal structures, in which His130 is thought to be important in the 
process of iron internalization.  Similarly, two different conformations (coordinative and non 
coordinative) of His130 have also been observed in the crystal structure of Av BfrB.  These 
observations are in good agreement with the findings of Pa BfrB and my suggest that His 130 
acts as a gate that allows the movement of iron from the ferroxidase center to the interior cavity 
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[12]. In addition, it has been shown that His130 side chain in Av Bfr changes its conformation 
from coordinative to non coordinative when the protein is reduced by dithionite [35]. This 
observation is in agreement with the hypothesis that the His130 side chain acts as a gate in the 
process of iron uptake by the ferroxidase center and iron internalization.  Most of the structures 
of Bfr that have been studied contained metal ions such as iron, zinc, or manganese at the 
ferroxidase center.  However, these metal ions showed a low occupan y at the Fe2 position 
relative to Fe1 [12-14, 35, 37].  In contrast to the previous observation, the as-isolated Dd Bfr 
structure showed a ferroxidase center fully occupied with iron.  When Dd Bfr was reduced by 
dithionite and oxidized in air, the Fe2 site of the ferroxidase center was observed to be empty 
[14].  Most of the Bfr structures that have been studied thus far showed a low occupancy at the 
Fe2 site, suggesting the notion that translocation of Fe2 from ferroxidase center to the interior 
cavity may be a part of the mechanism of iron uptake [12, 14, 35].  This interchangeable 
conformation of His130, observed in the process of iron internalization by Pa BfrB is clearly 
depicted in the figure 2-9.  In addition to the changes observed in theconformation of His130, 
side chain of D50 was also observed to have important conformational changes in opening and 
closing the gate of the ferroxidase pore for iron internalization.  In the investigations carried out 
with Ec and Dd Bfr, a similar pore has been observed on the external su face of the protein and it 
has been hypothesized to be a pathway of Fe2+ to enter the ferroxidase center [14, 36].  In Dd 
Bfr, when Fe2+ is oxidized to Fe3+ at the ferroxidase center, a relatively low occupancy of Fe2 sit  
is observed suggesting the moving of Fe3+ into the internal Bfr cavity [14, 38].  It has also been 
speculated that a concerted conformational change of the His59 and Glu131 side chains, which 
are assumed to act as a gate, is required to move Fe3+ ions from the Dd Bfr ferroxidase center to 
the interior cavity.  It is important to note that the structures of Pa BfrB with the concerted 
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motion of His130 side chain and its gate open and gate closed conformations, are the first 
experimental observations that shows a pathway of a pore leading from the exterior surface of 
the protein to the ferroxidase center.  Further, these structural s dies also provide the first time 
direct experimental evidence of the concerted motion of D50 and His130 which forms a pathway 
to move iron from the ferroxidase center to the interior cavity of the protein.  All these structural 
observations clearly indicate that the ferroxidase center of Pa BfrB is bifunctional, acting as a 
catalytic center and pore for iron internalization. 
Pa BfrB has eight 3-fold pores and six 4-fold pores 
 The function of 3-fold channels in bacterioferritins, which are lined with both 
positively and negatively charged residues, is not yet established.  However, the residual electron 
density data obtained from the structure of Fe soaked Pa BfrB crystals indicate the presence of 
sulfate ions in the 3-fold pores.  This observation suggests that the 3-fold pores may function in 
anion trafficking through the pores.  It is known that anions, especially the PO4
3- ions are 
essential to form a mineral core in the interior cavity of Pa BfrB as these ions may be involved in 
nucleating and catalyzing the growth of the iron mineral [27, 31].  Therefore, it is important for 
Pa BfrB to have pathways to move both iron and phosphate ions in and out of the Pa BfrB 
molecule efficiently.  Consequently, it can be hypothesized that the PO4
3- ions required for the 
growth of a stable mineral core in Pa BfrB may enter the protein molecule via the 3 fold pores. 
In eukaryotic ferritins, divalent cations have been observed in the 3-fold pores, which are lined 
with negatively charged amino acid residues [39].  Moreover, it has also been found that the 
replacement of these negatively charged residues in the 3-fold pores has a negative effect on the 
rate of iron uptake which may suggest that iron moves in and out of eukaryotic ferritins via the 3-
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fold pores [39-41].  Studies carried out with eukaryotic ferritins have further revealed that 
localized unfolding at or near the 3-fold pores can accelerate the proc ss of iron release from the 
eukaryotic ferritins.  These findings are in good agreement with the fact that iron moves in and 
out of the ferritins via the 3-fold pores [31, 42,43].  
Similar to 3-fold pores, the exact function of 4-fold pores of Pa BfrB is also not known.  
However, potassium ions were observed in the 4-fold pores of all the crystal structures obtained 
from Pa BfrB.  Therefore, it is believed that cations (more lik ly iron ions) may move in and out 
of the protein via these 4-fold pores.  No metal ion has been observed in the structures of Ec, Ms 
and Dd Bfr which may indicate that the structure and the function of the pores in all 
bacterioferritins are not the same [11, 13, 14, 36].  The molecular architecture of the 4-fold pores 
of Pa and Av Bfr are very similar.  Each 4-fold pore is made of tw  layers; the outer layer is 
formed by Asn148 and the inner layer is formed by Gln151.  In contrast to that, Ec., Ms, and Dd 
Bfr 4-fold pores are composed of three layers.  In Ec Bfr 4-fold p res, the outer layer is made of 
Asn148 whereas Glu151 and Arg155 form the central and inner layers, respectively.  The 
presence of metal ions in the 4-fold pores of Pa and Av BfrB structures, sharing the similar 
molecular architecture, is an indication of the function of 4-fold pores, which may be the 
trafficking of iron in and out of the protein molecule.  
The ferroxidase pore is an iron entry port in Pa BfrB 
 The crystals grown from the mineralized protein did not contain iron. However, 
soaking those crystals in an iron solution showed iron at the ferroxidase center and on the 
external (Fe(out)) and internal surface (Fe(in)) of the protein.  According to the above observations 
the ferroxidase pore leads to the ferroxidase center in which hydrophilic residues may move Fe2+ 
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from the outer surface to the ferroxidase center.  At the ferroxidase center, iron ions are moved to 
the interior of the protein by the gated mechanism of His130.  These findings suggest that the 
ferroxidase center is essential and plays a very important role in the process of iron 
internalization.  In order to get more experimental evidence on the iron uptake via th ferroxidase 
center, the crystals of the mineralized protein were soaked in a Fe2+ solution for 15 minutes, 
followed by soaking in a non Fe2+ containing crystallization solution for 15 minutes.  The 
resultant crystals did not have iron atoms in the structure and the ferroxidase center was also 
observed to be empty.  The structural features of the ferroxidase cent r were very similar to that 
of non iron soaked mineralized protein, where His130 was at 100% occupancy in the gate-open 
conformation.  These results show that the favored conformation of the empty ferroxidase center 
is the gate open conformation and confirms the hypothesis that iron ions are internalized through 
the ferroxidase center.  This idea was further investigated using solution experiments.  
  According to the pervious findings, the iron uptake process by Ec-Bfr is described in 
three kinetically resolved phases: first, Fe2+ binds the ferroxidase center (phase 1), followed by 
the oxidation of Fe2+ forming a µ-oxo-bridged di-Fe3+ moiety (phase 2). Third phase is the 
formation of the Fe mineral inside the core.  Phases 1 and 2 take place very fast (t1/2 is ~5 ms and 
15 s respectively) whereas the phase 3 occurs relatively slow (t1/2 = ~15min) [5].  Experiments 
carried out with Ec Bfr show that upon addition of ~ 50 iron atoms to the prot in, the absorbance 
at 340 nm saturates indicating that a stable di-iron center is formed at each subunit of Ec Bfr.  
When more Fe2+ ions are added, the absorbance at 340 nm increases relatively slowly indicating 
that phase 3 kinetics are being taken place [2, 5].  In contrast to the observations made on Pa 
BfrB, in Ec Bfr there is no structural evidence to indicate an exist nce of a clear pathway for the 
translocation of ferroxidase iron to the inner core.  The observations of the kinetic experiments 
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on Ec Bfr and the absence of structural evidence of showing a pathway of ferroxidase iron to the 
core may imply that the ferroxidase center of Ec Bfr does not act as a pore for iron uptake.  
Therefore in Ec Bfr, once the ferroxidase center is formed, other Fe2+ ions are taken into the 
protein through the other pores of the protein and subsequently these iron ions are oxidized by 
transferring electrons to the ferroxidase iron, which in turn reduce mol cular O2[11].  On the 
other hand, the observations of the experiments carried out with Pa-BfrB are strikingly different 
from those of Ec-Bfr.  Upon addition of 50 Fe2+ to Pa-BfrB, the absorbance ~ 300 nm does not 
saturate.  Alternatively, a rapid increase of the absorbance near 300 nm is observed which 
rapidly reaches a plateau and remains constant until the next aliquot of iron is added.  As seen in 
figure 2-20, the magnitude of the change in absorbance at 320 nm (∆A320) following the addition 
of each aliquot of Fe2+ remains nearly constant indicating that the ferroxidase center in Pa BfrB 
is indeed labile.  Once all Fe2+ ions are oxidized and internalized, the ferroxidase center is 
vacated and this observation is consistent with the fact that the ferroxidase center in the as 
isolated, mineralized and double soak structures is empty.  According to these results obtained 
from the solution phase suggest that, unlike in Ec Bfr, the ferroxidase center of Pa BfrB is labile 
and therefore corroborate the idea derived from the structural investigations that the ferroxidase 
center of Pa BfrB has a dual role of substrate oxidizing center ad pore for iron internalization.  
Results from both structural and kinetic studies carried out with Pa-BfrB suggest that, 
eventhough all bacterioferritins possess similar molecular architecture, their mechanisms of iron 
trafficking in and out of the protein are not the same.  The ferroxidase center of Ec-Bfr is stable 
and functions as a catalytic site but not as a pore for iron internalization.  In comparison, the 
ferroxidase center of Pa BfrB functions as the center of oxidation and internalization of iron 
enabling the protein to capture, oxidize and store iron with a higher efficiency. 
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Appendices 
Appendix I: Protein Crystallization Conditions-Wizard 11 random sparse matrix 
crystallization Conditions. 
1 10% (w/v) PEG-3000 acetate pH 4.5 Zn(OAc)2  
2 35% (v/v) 2-methyl-2,4-pentanediol MES pH 6.0 Li2SO4  
3 20% (w/v) PEG-8000 Tris pH 8.5 MgCl2  
4 2.0 M (NH4)2SO4 cacodylate pH 6.5 NaCl  
5 20% (v/v) 1,4-butanediol HEPES pH 7.5 NaCl  
6 10% (v/v) 2-propanol phosphate-citrate pH 4.2 Li2SO4 
7 30% (w/v) PEG-3000 Tris pH 7.0 NaCl  
8 10% (w/v) PEG-8000 Na/K phosphate pH 6.2 NaCl  
9 2.0 M (NH4)2SO4 phosphate-citrate pH 4.2 none  
10 1.0 M (NH4)2HPO4 Tris pH 8.5 none  
11 10% (v/v) 2-propanol cacodylate pH 6.5 Zn(OAc)2  
12 30% (v/v) PEG-400 cacodylate pH 6.5 Li2SO4  
13 15% (v/v) ethanol citrate pH 5.5 Li2SO4  
14 20% (w/v) PEG-1000 Na/K phosphate pH 6.2 NaCl  
15 1.26 M (NH4)2SO4 HEPES pH 7.5 none  
16 1.0 M sodium citrate CHES pH 9.5 none  
17 2.5 M NaCl Tris pH 7.0 MgCl2  
18 20% (w/v) PEG-3000 Tris pH 7.0 Ca(OAc)2  
19 1.6 M NaH2PO4/0.4 M K2HPO4 phosphate-citrate pH 4.2 none  
20 15% (v/v) ethanol MES pH 6.0 Zn(OAc)2 
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21 35% (v/v) 2-methyl-2,4-pentanediol acetate pH 4.5 none  
22 10% (v/v) 2-propanol imidazole pH 8.0 none  
23 15% (v/v) ethanol HEPES pH 7.5 MgCl2  
24 30% (w/v) PEG-8000 imidazole pH 8.0 NaCl 
25 35% (v/v) 2-methyl-2,4-pentanediol HEPES pH 7.5 NaCl  
26 30% (v/v) PEG-400 CHES pH 9.5 none  
27 10% (w/v) PEG-3000 cacodylate pH 6.5 MgCl2  
28 20% (w/v) PEG-8000 MES pH 6.0 Ca(OAc)2  
29 1.26 M (NH4)2SO4 CHES pH 9.5 NaCl  
30 20% (v/v) 1,4-butanediol imidazole pH 8.0 Zn(OAc)2  
31 1.0 M sodium citrate Tris pH 7.0 NaCl  
32 20% (w/v) PEG-1000 Tris pH 8.5 none  
33 1.0 M (NH4)2HPO4 citrate pH 5.5 NaCl  
34 10% (w/v) PEG-8000 imidazole pH 8.0 none  
35 0.8 M NaH2PO4/1.2 M K2HPO4 acetate pH 4.5 none  
36 10% (w/v) PEG-3000 phosphate-citrate pH 4.2 NaCl  
37 1.0 M K/Na tartrate Tris pH 7.0 Li2SO4  
38 2.5 M NaCl acetate pH 4.5 Li2SO4  
39 20% (w/v) PEG-8000 CAPS pH 10.5 NaCl  
40 20% (w/v) PEG-3000 imidazole pH 8.0 Zn(OAc)2  
41 2.0 M (NH4)2SO4 Tris pH 7.0 Li2SO4  
42 30% (v/v) PEG-400 HEPES pH 7.5 NaCl  
43 10% (w/v) PEG-8000 Tris pH 7.0 MgCl2  
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44 20% (w/v) PEG-1000 cacodylate pH 6.5 MgCl2  
45 1.26 M (NH4)2SO4 MES pH 6.0 none  
46 1.0 M (NH4)2HPO4 imidazole pH 8.0 NaCl  
47 2.5 M NaCl imidazole pH 8.0 Zn(OAc)2  
48 1.0 M K/Na tartrate MES pH 6.0 none  
All formulations are made with ultrapure ASTM Type I water and sterile-filtered stock solutions. 
Store at 4-25 ºC.  
 
Appendix II: Protein Crystallization Conditions-Cryo 1 sparse matrix crystallization 
conditions. 
1 40% (v/v) 2-methyl-2,4-pentanediol phosphate-citrate pH 4.2 none  
2 40% (v/v) ethylene glycol acetate pH 4.5 none  
3 50% (v/v) PEG-200 citrate pH 5.5 none  
4 40% (v/v) PEG-300 HEPES pH 7.5 0.2 M NaCl  
5 40% (v/v) PEG-400 citrate pH 5.5 0.2 M MgCl2  
6 40% (v/v) PEG-600 cacodylate pH 6.5 0.2 M Ca(OAc)2  
7 40% (v/v) ethanol Tris pH 8.5 0.05 M MgCl2  
8 35% (v/v) 2-ethoxyethanol cacodylate pH 6.5 none  
9 35% (v/v) 2-propanol phosphate-citrate pH 4.2 none  
10 45% (v/v) glycerol imidazole pH 8.0 none  
11 35% (v/v) 2-methyl-2,4-pentanediol Tris pH 8.5 0.2 M (NH4)2SO4  
12 50% (v/v) ethylene glycol acetate pH 4.5 5% (w/v) PEG-1000  
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13 30% (v/v) PEG-200 MES pH 6.0 5% (w/v) PEG-3000  
14 20% (v/v) PEG-300 phosphate-citrate pH 4.2 0.2 M (NH4)2SO4, 10% (v/v) glycerol  
15 50% (v/v) PEG-400 CHES pH 9.5 0.2 M NaCl  
16 30% (v/v) PEG-600 MES pH 6.0 5% (w/v) PEG-1000, 10% (v/v) glycerol  
17 40% (v/v) 1, 2-propanediol HEPES pH 7.5 none 18 35% (v/v) 2-ethoxyethanol imidazole pH 
8.0 0.05 M Ca(OAc)2  
19 35% (v/v) 2-propanol Tris pH 8.5 none  
20 30% (v/v) 1,2-propanediol citrate pH 5.5 20% (v/v) 2-methyl-2,4-pentanediol  
21 40% (v/v) 1,2-propanediol acetate pH 4.5 0.05 M Ca(OAc)2  
22 40% (v/v) ethylene glycol Na/K phosphate pH 6.2 none  
23 40% (v/v) 2-methyl-2,4-pentanediol Tris pH 7.0 0.2 M (NH4)2SO4  
24 40% (v/v) PEG-400 Na/K phosphate pH 6.2 0.2 M NaCl  
25 30% (v/v) PEG-200 Tris pH 8.5 0.2 M (NH4)2HPO4  
26 40% (v/v) PEG-300 CHES pH 9.5 0.2 M NaCl  
27 30% (v/v) PEG-400 CAPS pH 10.5 0.5 M (NH4)2SO4, 10% (v/v) glycerol  
28 30% (v/v) PEG-600 HEPES pH 7.5 0.05 M Li2SO4, 10% (v/v) glycerol  
29 40% (v/v) PEG-300 CHES pH 9.5 0.2 M sodium citrate  
30 35% (v/v) 2-ethoxyethanol citrate pH 5.5 none  
31 35% (v/v) 2-propanol citrate pH 5.5 5% (w/v) PEG-1000  
32 40% (v/v) 1,2-propanediol CHES pH 9.5 0.2 M sodium citrate  
33 25% (v/v) 1, 2-propanediol imidazole pH 8.0 0.2 M Zn(OAc)2, 10% (v/v) glycerol  
34 40% (v/v) 2-methyl-2,4-pentanediol imidazole pH 8.0 0.2 M MgCl2  
35 40% (v/v) ethylene glycol HEPES pH 7.5 5% (w/v) PEG-3000  
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36 50% (v/v) PEG-200 Tris pH 7.0 0.05 M Li2SO4  
37 40% (v/v) PEG-300 cacodylate pH 6.5 0.2 M Ca(OAc)2  
38 40% (v/v) PEG-400 Tris pH 8.5 0.2 M Li2SO4  
39 40% (v/v) PEG-600 phosphate-citrate pH 4.2 none  
40 40% (v/v) ethanol phosphate-citrate pH 4.2 5% (w/v) PEG-1000  
41 25% (v/v) 1, 2-propanediol phosphate-citrate pH 4.2 5% (w/v) PEG-3000, 10% (v/v) glycerol 
41 25% (v/v) 1, 2-propanediol phosphate-citrate pH 4.2 5% (w/v) PEG-3000, 10% (v/v) glycerol 
42 40% (v/v) ethylene glycol Tris pH 7.0 none  
43 50% (v/v) ethylene glycol Tris pH 8.5 0.2 M MgCl2  
44 50% (v/v) PEG-200 cacodylate pH 6.5 0.2 M Zn(OAc)2  
45 20% (v/v) PEG-300 Tris pH 8.5 5% (w/v) PEG-8000, 10% (v/v) glycerol  
46 40% (v/v) PEG-400 MES pH 6.0 5% (w/v) PEG-3000  
47 50% (v/v) PEG-400 acetate pH 4.5 0.2 M Li2SO4  
48 40% (v/v) PEG-600 imidazole pH 8.0 0.2 M Zn(OAc)2  
All formulations are made with ultrapure ASTM Type I water and sterile-filtered stock solutions. 
Store at 4-25 º 
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CHAPTER III 
Heme Mediated Mobilization of Core Mineral Iron from BacteriferritinB 
 
Introduction 
 Bacterioferritin B (BfrB) is considered as the main iron storage protein in 
Pseudomonas aeruginosa.  Pa BfrB functions by capturing excess cellular iron and storing them 
as a ferric iron mineral.  When the cellular iron concentration becom s low, it is thought that the 
stored iron is mobilized from the mineral core of Pa BfrB with the aid of another small protein 
called Bacterioferritin associated ferrodoxin (Bfd).  However, very little is known about the 
mechanism of iron mobilization from the Pa BfrB cavity when the cellular iron becomes limited 
 
 
 
 
Figure 3-1: Organization of the bfrB and bfd genes in the Pseudomonas aeruginosa genome. 
 In the genome of P.aeruginosa, the bfrB gene (PA3530) is located adjacent to bfd gene 
(PA3531) which codes for Bfd and may suggest that these two proteins ar functionally related 
(Figure 3-1).  Bfd from Escherichia coli and P.aeruginosa have been identified as small 
ferredoxins that can bind [2Fe-2S] clusters [1,2,3] and led to the suggestion that these proteins 
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may act as scaffolds for [2Fe-2S] assembly or involve in the mechanisms of uptake or release of 
iron from Pa BfrB.  In E coli it has been shown that Bfr form a complex with Bfd when these 
two proteins are in contact with each other [2].  As mentioned in Chapter 1 in detail, 
P.aeruginosa has two bacterioferritins called BfrB and BfrA (or FtnA).  A study carried out on 
the global transcriptional response of iron starved cultures of P.aeruginosa revealed that the 
mRNA levels of bfrB increased by 24-fold when iron was made available.  However, it has also 
been observed that the mRNA levels of bfrA remained unchanged [4].  Further, M.L.Vasil and 
coworkers found that in contrast to BfrB which is expressed under high iron conditions, BfrA 
from P.aeruginosa expressed constitutively [5, 6].  When the expression level of Bfd from
P.aeruginosa is considered, it has been found that bfd gene is upregulated ~200 fold under iron 
starvation conditions [7].  According to the above findings, it is apparent that bfrB and bfd genes 
are differentially regulated in response to cellular iron levels.  These findings suggest that Pa Bfd 
synthesized under iron limited conditions, may function to aid in the mobilization of iron stored 
in Pa BfrB molecules.  In P. aeruginosa, BfrB is the main iron storage protein and functions by 
capturing excess cellular iron and storing it inside the inner core in the form of a ferric hydroxy 
phosphate mineral.  When the cellular iron concentrations become low, the stored iron is 
mobilized from the inner core of Pa BfrB to meet the cellular metabolic demands.   
 Several investigations have been carried out to understand the mechanism of iron 
mineralization by bacterioferritins.  As explained in chapter one, mineralization starts by binding 
of two Fe2+ ions to the ferroxidase center.  Subsequently these Fe2+ ions are oxidized by O2 and 
resultant Fe3+ ions are moved to the inner core and mineralization is initiated [8-11].  
Nevertheless, the exact mechanism of iron mobilization from the bact rioferritin cavity is not yet 
known.  In the case of eukaryotic ferritins, it has been suggested that the stored Fe3+ ions in the 
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cavity is reduced by the electrons from NADPH shuttled via a flavin molecule [12].  Further, 
recent investigations carried out on eukaryotic ferritins reveal that millimolar concentrations of 
urea cause a reversible unfolding of the pores of ferritin and consequently the rate of iron release 
from the ferritin core is significantly increased [13-15].  Observations of these studies suggest 
that a specific flavoprotein may bind near the pores of ferritin causing a change in the dynamics 
of pore opening and closing.  As a result, the rate of the reduction of Fe3+ and mobilization of 
Fe2+ from the ferritin inner core is increased [16].  However, the exact mechanism of iron 
mobilization from Bfr is not yet known.  Eventhough, it is thought that heme groups in Bfr may 
play a role in reducing core Fe3+ and aid in mobilization of Fe2+ from the inner cavity, it has not 
been experimentally demonstrated [17].  The research we carried out in our laboratory clearly 
indicates the fact that the mobilization of iron stored in Pa BfrB inner cavity requires the 
presence of the small ferredoxin, Pa Bfd.  However, eventhough Pa Bfd is a [2Fe-2S] cluster 
containing ferredoxin which is thought to behave as a redox protein, in themobilization of iron 
from Pa BfrB, Pa Bfd does not function as a redox protein.  According to our observations, Pa 
Bfd devoid of the [2Fe-2S] cluster (apo-Bfd) promotes the rapid releas  of iron stored in the 
mineral core by binding to Pa BfrB.  In addition, our investigations reveal that formation of a 
complex between Pa BfrB and Pa Bfd affects the heme group in Pa BfrB and have also 
demonstrated that the heme cofactor in Pa BfrB mediate electrons to the mineral core only if the 
Pa Bfd is bound to Pa BfrB [17]. 
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Experimental Procedures 
Expression and purification of P. aeruginosa wild type and Cys43Ser Bfd.   
 Wild type and Cys43Ser Bfd proteins were expressed using E. coli Arctic express RIL 
cells (Stratagene, La Jolla,CA) harboring the recombinant plasmids, pET11-a/bfd and pET11-
a/C43S bfd respectively.  A single colony of freshly transformed cells was cultured overnight at 
37 °C in 50 mL of LB medium containing 100 µg/mL ampicilin and 20 µg/mL gentamicin.  The 
cells were subsequently subcultured in 1 L of fresh LB containing no antibiotics and grown for 3 
h at 37 °C.  Cells were then transferred to a shaker incubator pre-equilibrated at 10 °C and 
incubated for 30 min before protein expression was induced by addition of sopropyl 1-thiol-D-
galactopyranose (IPTG) to a final concentration of 1 mM.  Cells were cultured for additional 48 
h at 10 °C before they were harvested by centrifugation (4500 rpm for 10 min) and stored at -20 
°C.  The cell paste was resuspended in 50 mM potassium phosphate, (pH 7.0) (2 mL/g cell paste) 
and PMSF (0.5 mM), DTT (5 mM), protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) 
and DNAse (Sigma-Aldrich, St. Louis, MO) were added before the cells were lysed by using 
constant cell disrupter (Constant Systems Ltd, LowMarch, Northants).  Cell debris were pelleted 
by centrifugation at 4 °C and 19,500 rpm and the resultant supernatant was loaded onto a Q-
Sepharose Fast Flow column (12 cm x 2.5 cm i.d.) equilibrated with 50 mM potassium 
phosphate, (pH 7.0).  The column was washed with two column volumes of 50 mM potassium 
phosphate, (pH 7.0) before the protein was eluted using the same buffer and a linear gradient (0 
mM - 600 mM) of NaCl.  Fractions containing Bfd were pooled and concentrat d to a volume of 
~ 2 ml using centriprep filtration units with a molecular weight cut off 3000 kDa. The 
concentrated Bfd sample was passed down a G-50 column (1.5 cm x 100 cm) equilibrated with 
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50 mM potassium phosphate (pH 7.0), 100 mM NaCl and 1 mM DTT.  Fractions ontaining Bfd 
were pooled and determined to be pure by 18 % SDS-PAGE. 
Expression and purification of P. aeruginosa Fpr.  
 Pa-Fpr was expressed using E. coli Arctic express RIL cells (Stratagene, La Jolla, CA) 
harboring the recombinant plasmid, pET11-a/fpr.  A single colony of freshly transformed cells 
was cultured overnight at 37 °C in 50 mL of LB medium containing 100 µg/mL ampicilin and 20 
µg/mL gentamicin.  The cells were subsequently subcultured in 1 L of fresh LB containing no 
antibiotics and grown for 3 h at 37 °C.  Cells were then transferred to a shaker incubator pre-
equilibrated at 10 °C and incubated for 30 min before protein expression was induced by 
addition of isopropyl 1-thiol-D-galactopyranose (IPTG) to a final concentration of 1 mM.  Cells 
were incubated for additional 48 h at 10 °C before they were harvested by centrifugation (4500 
rpm for 10 min) and stored at -20 °C.  Cells were resuspended in lysis buffer (3 ml/g of cell paste). 
Deoxycholic acid (4 mg/g), Lysozyme (2 mg/g of cell paste), PMSF (32 µl/g of cell paste), MgSO4 
(4.2 mM final concentration), a pinch of Dnase were added to the cell suspension and stirred for 20 
min at 4 °C.  Cell suspension was then incubated at 37 °C for 20 min and stirred at ambient 
temperature for one hour.  Finally it was sonicated at 4 °C and the cell debris was separated from the 
protein containing supernatant by centrifuging at 19,500 rpm for 1 hour.  The supernatant was 
dialyzed against 4 L of 50 mM Tris-HCl (pH 7.5) at 4°C with at least three buffer changes over a 
period of approximately 16 hrs.  The resultant solution was applied to a Q-Sepharose Fast Flow 
column (10 cm × 2.5 cm i.d.) previously equilibrated with 50 mM Tris-HCl (pH 7.5).  The column 
was washed with 3 volumes of 50 mM Tris-HCl (pH 7.5) and the protein was eluted using the same 
buffer with a linear gradient (0 mM to 600 mM) of NaCl.  Fractions containing Fpr (yellow) were 
pooled, concentrated and then loaded onto a Sephadex-G75 column (3.0 cm x 100 cm) equilibrated 
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with 100 mM sodium phosphate buffer containing 150 mM NaCl (pH 7.0) and protein was eluted 
using the same buffer.  Fractions with absorbance ratio A
280
/A
450 
less than 6 were pooled and pa-Fpr 
was determined to be pure by 12% SDS PAGE. 
Expression and purification of P. aeruginosa BfrB  
 Expression and purification of Pa BfrB was carried out using the methods described in 
the experimental section of Chapter 2. 
Mobilization of core iron from Pa BfrB.   
 Experiments to investigate the mobilization of core iron from Pa BrfB were carried out 
in an anaerobic chamber.  Mineralized Pa BfrB was prepared as described in chapter 2.  Iron 
mobilization reactions were conducted in a 1.0 cm path-length cuvette equipped with a magnetic 
stirring bar and monitored by electronic absorption spectroscopy using an Ocean Optics 
(Dunedin, FL) 2000 spectrophotometer.  A few µL from stock protein solutions were added to a 
cuvette containing 3 mM 2,2, bipyrydil (bipy) in 1.5 mL of 20 mM potassium phosphate buffer 
(pH 7.6), to make a solution 15 µM in Pa Bfd, 15 µM in Fpr and 0.375 µM in Pa BfrB.  The 
reaction was initiated by addition of NADPH to a final concentration of 1.5 mM and the progress 
of the reaction was monitored by following the time-dependent changes i  intensity of the band 
at 523 nm that is formed when bipy binds Fe2+ to form the [Fe(bipy)3]
2+ complex.  Experiments 
with apo-Pa Bfd were conducted with a simple modification of the above procedure: Apo-Pa Bfd 
was prepared in situ from holo-Pa Bfd.  To this end, holo-Pa Bfd (15 µM final concentration) 
was added to a stirred cuvette containing 3 mM bipy in 20 mM potassium phosphate buffer (pH 
7.6).  Sodium dithionite (5 mM) was added stoichiometrically to reduc the Fe3+ in holo Bfd to 
Fe2+.  Capturing of the ferrous ion by bipy was monitored by the tim-dependent increase in the 
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523 nm absorbance, which was followed until it reached a plateau with intens ty corresponding 
to the theoretical value calculated from the amount of holo Pa Bfd placed in the cuvette.  At this 
point, the solution containing apo-Pa Bfd was reconstituted with Pa Fpr and Pa BfrB (final 
concentrations of 15 µM and 0.375 µM, respectively) and the iron mobilization reaction initiated 
by the addition of NADPH to a final concentration of 1.5 mM.  
 
Results  
Expression and purification of wild type Bfd and Cys43Ser Bfd.  
 Pa Bfd was first expressed in E.coli BL21 (DE3) cells at 30ºC.  However, the protein 
produced using this procedure was not soluble and formed inclusion bodies.  Consequently, 
purification of Pa Bfd required first denaturation of the protein with 6M urea to solublize the 
protein and then reconstitution of the [2Fe-2S] in vitro [3].  Subsequently, the solubilized and 
reconstituted protein was purified using column chromatographic techniques.  Later it was found 
that expression of Pa Bfd in E.coli Arctic express RIL cells (Stratagene) produces soluble Pa Bfd 
with an intact iron sulfur cluster.  Nevertheless, the yield of the pure soluble Pa Bfd was very low 
(1-2 mg/L).  Poor yields have also been reported for the expression of recombinant Bfd from 
E.coli [2].  In addition, it was observed that the wild type Bfd from P. aeruginosa is fragile and 
has a tendency to gradually get damaged during the purification procedure and sometimes during 
storage.  As shown in figure 3-2, Bfd from P aeruginosa has seven Cys residues, four of which 
are conserved in other organisms.  The other three Cys residues (Cys22, 23 and 43) which are 
not conserved were mutated to Ser with the aim of increasing the yield of the expression and 
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stabilizing the iron-sulfur cluster of the protein.  Mutations at Cys 22 and Cys 23 did not produce 
detectable amounts of protein, as observed by 18% SDS-PAGE. 
 
 
 
 
 
Figure 3-2: Bacterioferritin-associated ferredoxin sequences from different organisms aligned 
against that from P. aeruginosa.  Conserved Cysteines forming the unique C-X-C-X31-32-C-X2-C 
arrangement (highlighted) are thought to bind iron in the [2Fe-2S] cluster of the holo-protein.  
The sequences were aligned with the aid of ClustalW [25]. 
 It is apparent that the above two Cys residues (Cys 22 and Cys 23) may have affected 
the proper folding of the protein.  With the aim of obtaining higher yields of recombinant Pa Bfd 
and avoiding the problems of fragility and low stability of the wild type Pa Bfd, the 
nonconserved Cys43 was also mutated to Ser.  In contrast to other two mutations, the C43S 
mutant could be isolated and purified to homogeneity (Figure 3-3A) with a reasonably higher 
yield (4mg/ml) which is approximately 2-fold higher than the wild type Pa Bfd.  The [2Fe-2S] 
cluster in wild type Pa Bfd is less stable than the C43S mutant as it tends to degrade during 
protein purification.  The degradation of the [2Fe-2S] cluster leads to oligomerization, likely via 
formation of disulfide bonds.  The iron sulfur cluster in the C43S mutant ws observed to be 
much more stable than that of wild type during purification, manipulation and storage of the 
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protein.  As shown in figure 3-3B, the UV visible spectra of wild type and C43S Bfd are 
identical, implying that the mutation has not impaired the folding of the protein or its ability to 
bind a [2Fe-2S] cluster.   
 
 
 
 
 
 
 
Figure 3-3: (A) 18% SDS-PAGE analysis of C43S Bfd (Bfd SM) purified to homogeneity. (B) 
Electronic absorption spectra of oxidized wild type Pa Bfd (black trace) and oxidized C43S Pa 
Bfd (red trace) in 50 mM potassium phosphate buffer, pH 7.0. 
Interactions with apo Pa Bfd unlock the iron Stored in Pa BfrB.   
 All the experiments designed to study the mobilization of core iron f om Pa BfrB 
mineral core were carried out under strict anaerobic conditions.  As mentioned in the 
experimental, NADPH (final concentration of 1.5 mM) was added to a mixture of Pa BfrB, Pa 
Fpr, Pa Bfd and 2,2-bipyridyl (bipy) to initiate the iron mobilizaton.  Fe3+ ions in the mineral 
core are reduced by Fpr which was first reduced by NADPH and released out as Fe2+.  Then 
these Fe2+ ions complex with bipy and make a ferrous bipy complex [Fe (bipy)3]
2+ which 
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exhibits an absorption maxima at 523 nm (Figure 3-4A).  The release of iron from Pa BfrB was 
monitored by following the formation of ferrous – bipy complex at 523 nm. 
 
 
 
 
 
 
Figure 3-4: (A) The electronic absorption spectra of ferrous – bipy complex {[Fe(bipy)3]
2+} and 
(B) Time dependent increase in the intensity of the 523 nm absorbance due to the formation of 
Fe[(bipy)3]
2+ upon addition of NADPH (1.5 mM final concentration) to a solution containing Pa 
BfrB (0.375 µM), Pa FPR (15 µM), bipy (3 mM) and no Pa Bfd (black), 15 µM wild type holo-
Bfd (red), and wild type apo-Bfd (blue). 
 The red and blue traces in figure 3-4B, correspond to the time dep ndent growth of the 
523 nm band upon addition of NADPH to a solution containing Pa BfrB (.375 µM), Pa FPR (15 
µm), holo and apo wild type Pa Bfd respectively.  In this experiment it is apparent that the 
presence of Pa Bfd (15 µM) causes a significant acceleration in the rate of iron release.  Further 
it was observed that in the presence of holo Pa Bfd the Soret band shifted from 417 nm to 425 
nm whereas it remained unshifted at 417 nm in the absence of holo Pa Bfd (Figure 3-5).   
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Figure 3-5: Family of electronic absorption spectra of [Fe(bipy)3]
2+ complex illustrating the 
intensity changes at 523 nm in the iron mobilization reaction of Pa BfrB (A) in the presence and 
(B) absence of WT Pa Bfd. 
These experimental results suggest that Pa Bfd plays an important role in the process of 
iron release from Pa BfrB mineral core either by changing the conformation of the Pa BfrB 
molecule or changing the redox potential of the heme group.  In addition, the above results 
suggest that the [2Fe-2S] cluster of holo Pa Bfd may be catalyzing the iron mobilization by 
shuttling the electrons to Pa Fpr from Pa BfrB using the iron sulfur cluster.  However, an 
experiment carried out with apo Pa Bfd, (Bfd without the iron sulfur cl ster) instead of holo Pa 
Bfd showed that Pa Bfd does not participate in the reaction by mediating electrons from Pa Fpr 
to Pa BfrB.  Consequently, all the later iron mobilization assays were carried out using apo Pa 
Bfd prepared in situ by incubating holo Pa Bfd with dithionite and excess bipy.  In this reaction, 
two Fe3+ ions in the iron sulfur cluster are reduced by dithionite and the reduced Fe2+ ions are 
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captured by bipy forming the pink [Fe(bipy)3]
2+ complex which absorbs at 523 nm.  The 
formation of apo Pa Bfd by this method is relatively slow (~170 min) and the growth of 
characteristic 523 nm band was spectrophotometrically monitored.  
 
 
 
 
 
 
 
Figure 3-6: Before the arrow : time dependent absorption changes in the intensity of the 523 nm 
caused by sequestration of the iron in the [2Fe-2S] cluster of (●) 15 µM wild type holo-Bfd and 
(○) 15 µM holo-C43S Bfd by bipy (3 mM); the solution contained 15 µM sodium dithionite to 
reduce the two iron ions in holo-Bfd.  After the arrow: the rapid time dependent increase in the 
523 nm absorption of the resultant solution containing 15 µM apo-WT Bfd (●) or apo-C43S-Bfd 
(○), 0.375 µM in BfrB and 15 µM in FPR after the addition of NADPH (1.5 mM). 
 The quantitative formation of apo-Pa Bfd was obtained by calculating the amount of 
[Fe(bipy)3]
2+ complex predicted to form if all the iron in the [2Fe-2S] is captured by bipy.  Once 
all the holo Pa Bfd is converted to apo Bfd, Pa BfrB and Pa Fpr were added and the iron release 
reaction was initiated by adding NADPH (marked by an arrow in figure 3-6).  Upon addition of 
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NADPH, a fast growth of the absorbance at 523 nm and a rapid reduction of heme were observed 
simultaneously.  Figure 3-4B compares the time dependent changes in the intensity of 523 nm, in 
the presence of wild type holo and apo Pa Bfd.  It can be clearly seen that the rate of iron release 
is slightly faster in the presence of apo Pa Bfd than that of hol  Pa Bfd.  These findings suggest 
that the [2Fe-2S] cluster of holo Pa Bfd is not necessary for the rapid mobilization of iron from 
the inner core and may not be functioning as a mediator to shuttle electrons to Pa BfrB.  
Consequently, it is thought that apo Pa Bfd may exert an effect on core iron mobilizatin from Pa 
Pa BfrB by binding to Pa BfrB molecule and inducing a conformation l change that enables the 
iron release.  Apo C43S Pa Bfd was prepared in the same way as apo wild type Pa Bfd.  When 
all the iron from the [2Fe-2S] cluster of C43S Pa Bfd was quantitatively captured, Pa BfrB, Pa 
Fpr and NADPH were added to the cuvette and the growth of 523 nm was monitored.  The time 
dependent release of iron with apo C43S Pa Bfd is nearly identical to that of with wild type apo 
Pa Bfd (Figure 3-6).  Therefore, all the experiments involving Pa Bfd were carri d out with C43S 
Pa Bfd because of its higher expression yields and enhanced stability.  For simplicity, hereafter 
the C43S Pa Bfd will be referred to as Pa Bfd in this text. 
 Experiments were carried out to probe the effect of apo Pa Bfd on the rate of iron 
release from Pa BfrB iron core and results are summarized in Figure 3-7A. In these experiments, 
the concentrations of apo Bfd were varied while maintaining Pa BfrB (0.375 µM), Pa Fpr 
(15µM), NADPH (1.5 mM), and Bipy (3 mM) concentrations constant.  As shown in figure 3-
7A, the growth of the 523 nm band was monitored in each of the experiments carried out with 
different apo Bfd/BfrB ratios ; 40:1 (green), 30:1 (red), 20:1 (purple), 15:1 (cyan), 10:1 (blue), 
5:1 (orange) and 0:1 (black).   
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Figure 3-7: (A) Time dependent plot of absorption intensity change measured at 523 nm upon 
addition of NADPH (1.5 mM ) to solutions containing 3.0 mM bipy, 15 µM FPR, 0.375 µM 
BfrB and apo-Bfd with Bfd/Bfrb molar ratio of 40 (green), 30 (red), 20 (purple), 15 (cyan), 12 
(orange), 10 (blue), and 5 (black).  (B) Time dependent changes in the position f the Soret band 
brought about by the addition of NADPH (1.5 mM) to the solutions in figure A; 417.5 nm and 
 
Time (min)
0 1 2 3 4 5 6 7 8 9 10 11
W
av
el
en
gt
h 
(n
m
)
417
418
419
420
421
422
423
424
425
Time (min)
0 10 20 30 40 50 60 70 80 90
W
av
el
en
gt
h 
(n
m
)
417
418
419
420
421
422
423
424
425 (B)
Time (min)
0 1 2 3 4 5 6 7 8 9 10 11
∆
A
 5
23
 (
nm
)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7 (C)
Time (min)
0 10 20 30 40 50 60 70 80 90
∆
A
 5
23
 (
nm
)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
1.1
(A)
(D) 
106 
 
425 nm correspond to fully oxidized and fully reduced heme, respectively.  (C) Zoomed view 
(initial 11 min) of the time dependent absorption changes corresponding to the plots in A.  (D) 
Zoomed view of the time dependent changes in the position of the Soret band corresponding to 
the plots in B. 
 It is clearly observed that when the Bfd/BfrB ratio is lowered the amount of iron 
released gradually decreases.  In addition, a significant change in th  rate of iron release can be 
observed when the Bfd/BfrB ratio is lowered from 5 to 0.  The time dependent change of the 
Soret band at 417 nm of each of the above experiments has been plotted in Figure 3-7B and it is 
evident that when the ratio of Bfd/BfrB is larger than 5, the heme group is reduced in an initial 
“fast phase” followed by a “slower” phase which continues until the heme group is completely 
reduced (Soret band at 425 nm).  It is important to note that in the absence of Bfd, Soret band 
remains unshifted at 417 nm (oxidized heme) throughout the experiment.  However, in other 
experiments where ratios of Bfd/BfrB are 40 to 5, a progressive slowing of the reduction of heme 
can be observed.  Figure 3-7C and 3-7D indicate a lag phase lastingpproximately 1-3 minutes 
in iron mobilization and heme reduction when the Bfd/BfrB ratio is 20 or lower.  The fact that 
the lag phases of both iron release and the heme reduction reactions o cur during approximately 
the same time, implies that the electrons sent by Fpr (the reductase) are channeled into the inner 
core via the heme group.  Additional experiments to confirm this idea have been carried out and 
will be discussed later in this chapter  In order to have a more quantitative comparison of the 
effect of apo Pa Bfd on iron mobilization from the Pa BfrB core, psudo rates of iron release 
were estimated by fitting each curve in figure 3-7A to an exponential function.  However, the 
data points corresponding to the initial lag phase in each curve were excluded in calculating the 
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pseudo rate of iron release.  The results are summarized in table 1 nd figure 3-8 indicating a 
clear Bfd–dependent iron release from the Pa BfrB inner core. 
 
Table 3-1: Pseudorates for the Pa Bfd-dependent release of core iron from Pa BfrB. 
 
 
 
 
 
 
 
 
 
  
aThe standard deviations were obtained from triplicate measurements usi g proteins obtained 
from two independent preparations and all the measurements were carried out at 25º C. 
 
Pa Bfd binds to Pa BfrB 
 The observations made on the previous experiments strongly suggest that Pa Bfd binds 
to Pa BfrB.  To further corroborate this idea an experiment was carried out with the aid of size 
exclusion chromatography. A sample of Pa BfrB and a mixture of Pa BfrB and Pa Bfd were 
passed through a size exclusion column and the elution volumes were obtained.  The average 
Bfd/BfrB 
molar ratio 
Pseudorate of iron release 
(min-1)a 
0 
5 
10 
15 
20 
30 
40 
    0.0087 ± 0.0002 
0.029 ± 0.001 
0.036 ± 0.002 
0.058 ± 0.008 
0.074 ± 0.008 
0.089 ± 0.007 
0.095 ± 0.004 
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elution volume (Ve) obtained upon loading a superdex 200 column with 1 mL of Pa BfrB 
containing 0.036 µmol is 58.9 ± 0.05 mL (open circle in figure 3-9A). 
 
 
 
 
 
 
 
Figure 3-8: Pa Bfd-dependent release of core iron from Pa BfrB. 
 This value was nearly identical to the elution volume obtained upon loading the 
column with a sample of horse spleen ferritin standard (MW 447 ± 1 Da). Subsequently, 1 mL 
sample containing a mixture of 0.0036 µmol of Pa BfrB and 0.084 µmol of PaB d was loaded 
on to the same column and obtained an elution volume (57.0 ± 0.6 mL) which corresponds to a 
molecular weight of 538 ± 30 kDa (open triangle in figure 3-9A).  Excess Pa Bfd was observed 
to elute later with an elution volume of 96.3 ± 0.3 mL.  The difference between the elution 
volumes of pure Pa BfrB and the mixture of Pa BfrB and Pa Bfd was 91 kDa which corresponds 
to approximately 12 Bfd molecules, each with a molecular mass of 7.82 kDa.  This observation 
clearly indicates that 12 molecules of Pa Bfd can bind to a molecule of Pa BfrB and more likely 
one Pa Bfd molecule may bind to one subunit of Pa BfrB.  Additional evidence for this 
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observation was obtained by analyzing the fractions corresponding to BfrB –Bfd mixture and 
excess Bfd eluted later by SDS-PAGE.  Figure 3-9B shows that the peak with an elution volume 
57.0 ± 0.6 mL (lane 2) indeed a mixture of Pa BfrB and Pa Bfd, whereas th  peak with an elution 
volme 96.3 ± 0.3 mL (lane1) contains only Pa Bfd. 
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Figure 3-9. (A) The calibration curve obtained to estimate the molecular weight of BfrB (○) and 
that of the BfrB-Bfd complex (∆) was constructed from the elution volume (Ve) obtained for each 
of the following standard molecular weight markers (●), ferritin (440 kDa), aldolase (158 kDa), 
conalbumin (75 kDa), and ovalbumin (44 kDa), loaded onto a Superdex 200 column.  (B) SDS-
PAGE (15%) analysis of the solution corresponding to a peak eluting with Ve 57.0 ± 0.6 mL 
(lane 2) and Ve 96.3 ± 0.3 mL (lane 1) upon loading the Superdex 200 column with a mixture of 
BfrB and Bfd in a Bfd/BfrB mole ratio of 24. 
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Figure 3-10: Chromatogram of Surface Plasmon Resonance experiment showing that molar 
ratio of the complex between Bfd and BfrB is 12. 
 In order to further exemplify the above notion of forming a complex between Pa BfrB 
and Bfd, one of our collaborators, Dr. Feimeng Zhou at California State University carried out a 
Surface Plasmon Resonance (SPR) experiment using Pa BfrB and Pa Bf .  Interestingly, SPR 
experiments confirmed the preliminary results we obtained using size exclusion chromatography.  
Dr Zhou was able to find out that the molar ratio of the complex formed between Pa Bfd and Pa 
BfrB is 12.  The chromatogram of the SPR experiment is shown in figure 3-10. 
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Binding of Pa Bfd to Pa BfrB enables heme mediation of electron transfer to the core. 
 The previous observation made on the fact that the electron transfer from the reductase 
to the core mineral in BfrB is mediated by heme was further confirmed by carrying out an 
experiment where a limiting amount of NADPH (15% of the total reducing equivalents n eded to 
reduce all the iron in the core) was added to a solution containing apo-Bfd, Fpr and BfrB in 
molar proportion of 40:40:1.  The above ratio of Bfd:BfrB (40:40) was chosen as there was no 
lag phase observed in the iron mobilization or heme reduction (Figure 3-7A).   
 
 
 
 
 
 
 
Figure 3-11: Time dependent changes in the intensity of absorption measured at 523 nm upo  
addition of aliquots of NADPH containing 15% of the total electron equivalents needed to reduce
all the ferric ions in the core of BfrB (600 Fe3+ ions/BfB) to a solution containing BfrB (0.375 
µM), Fpr (15 µM), apo-Bfd (15 µM ) bipy (3 mM) (blue trace, left axis) and time dependent 
changes in the position of the heme Soret band following addition of each NADPH aliquot (red 
trace, right axis). 
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 The results obtained from this experiment are summarized in Figure 3-11 and upon 
addition of each aliquots of NADPH a fast release of iron is observed.  Further, it is important to 
note that the amount of Fe2+ released (0.043 ± 0.002 µmol) with each aliquot of NADPH is in 
good agreement with the number of electron equivalents (0.044 µmol) delivered, signifying 
quantitative utilization of NADPH.  The plot of figure 3-10 also shows the shifting of the Soret 
band (red trace, right axis) following each addition of NADPH where it apidly shifts from 417 
nm to 425 nm and then shifts back to its original position.  This observation suggests a transient 
build up of heme which indicates the balance between reduction and subsequent oxidation of 
heme.  Further, it strongly implies that heme groups are reduced by the electrons from the 
reductase faster than it is reoxidized by sending those electrons to the iron core.  In addition, the 
transient concentration of reduced heme is gradually increases with time upon each addition of 
NADPH because of the less demand for the electrons from the heme by th core mineral which 
becomes progressively smaller.  Therefore, eventhough the electron flux from the reductase to 
the heme is similar after each addition of NADPH, the electron flux from the heme to the iron 
core decreases as the size of the iron mineral become smaller and can be clearly seen in the 
experimental observations summarized in Figure 3-10. 
 
Discussion 
 Iron mobilization studies of ferritins in hepatic cells have been carried out using 
NADH or NADPH as the electron source and the electrons were shuttled to ferritin via flavin or 
xanthine containing oxidoreductases [19].  Therefore, in these experiments FADH2 was utilized 
as the electron donor and in early work FADH2 was generated by NADH-flavin oxidoreductase 
113 
 
[20].  However, in more recent studies, FADH2 is generated by the beam of a spectrophotometer 
in the presence of NADH [21].  In comparison, early studies done on the core iron mobilization 
from Bfr have used small molecule reductants such as dithionite or methyl viologen [22].  
Prior to the investigations carried out on iron mobilization from Pa BfrB in our laboratory, there 
was no any information regarding either the mechanism or the physiological partners involved in 
the iron mobilization process in bacterioferritins.  The studies that we have carried out on iron 
mobilization from Pa BfrB core are based on the strong assumptions made on the information 
obtained by probing the global genetic response of P. aeruginosa to iron levels [7].  Among the 
genes reported which are positively regulated under low iron conditions, he genes coding for Pa 
Bfd and Pa Fpr were considered to be important because of their probable function in electron 
transfer [3].  From the previous studies on biochemical and structural characterization of Fpr, it 
was found that Fpr supports the catalytic activity of heme oxygenase by transferring the required 
seven electrons from NADPH to degrade heme and release its iron [3].  Pa Fpr with FADH2 as 
its cofactor was used as the reductase in iron mobilization reactions, because it is a product of 
one of the genes that are upregulated under iron starvation conditions.  Pa Bfd (Bacterioferitin 
associated ferredoxin) is the other putative electron transfer protein f the gene which is 
positively upregulated under iron starvation conditions.  Bfd proteins from P aeruginosa and E 
coli have been found to bind a [2Fe-2S] cluster [1-3], which allowed us to hypothesize that Pa 
Bfd may function as an electron transfer protein by mediating electron from the reductase to the 
iron core of Pa BfrB [1, 2] or may function in iron mineralization by transferring electrons from 
the Pa BfrB core to an external oxidant [2].  It is important to note that under iron starvation 
conditions, Pa BfrB gene is downregulated [4] and Pa Bfd gene is strongly upregulated [7], 
implying that Bfd is synthesized to aid in the mobilization of ir n from the Pa BfrB core to 
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sustain the metabolic activity inside the cell.  According to the above hypothesis, holo-Bfd is 
thought to mediate electron transfer from NADPH to iron core of Pa BfrB and results obtained 
from the experiments carried out to test the above hypothesis seemed to suggest that Bfd is 
involved in shuttling electrons from NADPH to the iron core of Pa BfrB.  However, additional 
experiments carried out to further test this idea, conclusively showed that apo- Pa Bfd is more 
effective than holo-Bfd, in transferring electrons from NADPH to the iron core to facilitate the 
release of Fe2+ from the Pa BfrB core.  Consequently, the [2Fe-2S] cluster in holo Pa Bfd is not 
essential for Pa Bfd to enable the iron release from BfrB, indicating that the protein-protein 
interactions between apo- Pa Bfd and Pa BfrB promote the effective mobilization of iron stored 
in the iron core of Pa BfrB. 
 These findings are in good agreement with the fact that under iron starvation 
conditions, the cell would not synthesize an iron containing co-factor to mobilize stored iron in 
BfrB which is a favorable strategy for the cell under low cellular iron conditions.  Therefore 
according to these observations, a cellular model for the efficient utilization of iron can be 
established: Downregulation of the bfrB gene indicates that synthesis of additional Pa BfrB 
proteins is not necessary during iron starvation.  However, additional mechanisms may utilize to 
maintain the sustainability of the cell.  At the same time, Pa BfrB makes a complex with Pa Bfd 
(stoichometry of 1:12) to efficiently mobilize the stored iron from the Pa BfrB core which in turn 
confirms the observation of strong upregulation of bfd gene under low iron conditions.  In 
addition, utilizing apo- Pa Bfd to mobilize iron from Pa BfrB is a good economical strategy 
employed by the cell under these low iron conditions as it does not need to synthesize [2Fe-2S] 
cluster for holo Bfd which requires already scarce iron. 
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Binding of Pa Bfd to Pa BfrB enables heme mediation of electron transfer. 
 As shown in figure 3-5, the heme group in Pa BfrB is reduced only in the presence of 
Pa Bfd, suggesting that formation of BfrB-Bfd complex facilitating the heme mediated electron 
transfer from the reductase protein to the Pa BfrB core.  The above observation is clearly 
illustrated in figure 3-11 where a transient build up of reduced heme is observed when limiting 
amount of NADPH (reducing power) is used. Eventhough the function of hemeas an electron 
mediator in mobilization of iron in bacterioferritins has been speculated [22]; it has not been 
experimentally demonstrated prior to our investigations.  Therefore, these findings from our 
investigations would be the first experimental evidence to establish the function of heme in 
bacterioferritins.  In addition, it is important to note that the exact function of heme can only be 
examined upon formation of the BfrB-Bfd complex because binding of the physiological partner 
proteins is essential to make the heme conductive.  The exact mechanism of making heme 
“conductive” by forming a BfrB-Bfd complex is not yet clear.  However, three probable 
mechanisms can be proposed, (a) formation of a complex with Pa Bfd positively shifts the 
reduction potential of the heme in Pa BfrB which enables it to accept el ctrons from Pa Fpr, (b) 
binding of Pa Bfd causes a conformational change which facilitate a cl ar electron transfer 
pathway from the surface to the heme, (c) conformational change resulted by the formation of 
BfrB-Bfd complex may both alter the redox potential of heme and enabl a pathway for electron 
conduction, (d) formation of BfrB-Bfd complex may induce the productive binding of Pa Fpr 
which may accelerate electron transfer to Pa BfrB which is channeled to the core via the heme 
group.  Additional work has to be carried out to determine the specific mechanism of iron release 
via the heme group of BfrB.  However, it is clear that the investigations, to probe the specific 
mechanism of iron mobilization of bacterioferritins have to be carried out in the presence of its 
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physiological partners in order to obtain more accurate results.  For example, it has been recently 
demonstrated that Bfd is necessary to mobilize iron from Bfr in Erwinia chrysanthemi cells [22].  
The recombinant Bfd protein from E.coli has been shown to bind a [2Fe-2S] cluster analogous to 
bacterial and plant ferredoxins [1, 2].  In addition, it has four cystein  which are conserved in the 
sequences of several Bfd genes, and led to its classification as a ferredoxin.  This ferredoxin gene 
is located upstream of the bfr gene and hence named as bacterioferritin-associated ferredoxin.  
According to the observations made on the iron mobilization studies of Pa B rB, it was clear that 
apo-Bfd can efficiently mobilize iron from Pa BfrB core, indicating that assembly of [2Fe-2S] 
cluster is not necessary.  These findings strongly suggest that Pa Bfd does not function in 
transferring electrons between proteins.  Consequently, Pa Bfd cannot be classified as a classic 
ferredoxin at least in these iron mobilization reactions in Pa BfrB.  Figure 3-2 shows the amino 
acid sequence of Bfd containing four cystein residues which act as ligands to the [2Fe-2S] cluster 
has a unique arrangement of C-X-C-X31-32-C-X2-C.  In addition the peptide of Pa Bfd is 
relatively shorter than (50 residues shorter) typical ferredoxins in Bacteria, plants, fungi and 
vertebrates, which also corroborate the idea that Pa Bfd does not function as a classic ferredoxin.  
The resonance raman spectrum of oxidized Pa Bfd is observed to be nearly identical to the [2Fe-
2S] cluster of the second domain of Nifu [1, 3], a mulitimeric protein ssential for the 
metallocluster in nitrognase [23].  This observation can be used to hypothesize that Bfds may 
function as a scaffold for the assembly of [2Fe-2S] clusters in other proteins and enzymes which 
require iron-sulfur clusters [1-3].  Having a transient [2Fe-2S] cluster in Pa Bfd may be 
important in the iron mobilization process in Pa BfrB, where iron released from the Pa BfrB core 
can be captured by the four cystein residues of apo-Bfd to form a mononuclear iron center.  
These mononuclear iron centers can deliver iron to where it is needed or these iron can be used 
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to form iron-sulfur clusters with the aid of iron sulfur cluster assemble machinery such as Isc and 
can be transferred to another new ferredoxin.  The assembly of a [2Fe-2S] cluster from a tetra 
coordinated mononuclear iron center is thought to be taking place at the amino-terminal in the C-
X-C motif (Figure 3-2) as it has the conformational freedom for Cys ligands to form a mono or 
di nuclear center. 
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CHAPTER IV 
Probing a Possible Pathway of Iron Release from the Mineral Core of 
Bacterioferritin B. 
Introduction 
 Ferritins are ubiquitous iron storage proteins and have an important ole in 
intracellular iron homeostasis [1, 2].  These proteins are capable of storing large amounts of iron 
and release it to the cytoplasm in times of iron deficit [3].  Iron is captured by ferritins in its Fe2+ 
oxidation state, oxidized at the ferroxidase center and subsequently internalized and mineralized 
inside the ferritin core.  Under iron starvation conditions these Fe3+ ions in the mineral core are 
reduced to Fe2+ ions and released to the cytoplasm to be used by the bacteria for its various 
metabolic processes.  Therefore, iron uptake and release from feritin-like molecules are vital 
processes to a cell, because they maintain iron homeostasis in the cell.  The mechanisms of iron 
oxidation and internalization of most of the ferritin members have been extensively studied and 
relatively well understood [4-7].  In comparison, very little is known about the mechanism of 
iron release from ferritins, particularly from bacterioferritins (Bfr).  Three models of iron release 
from ferritins have been speculated and investigated [8].  The first model proposes that iron is 
released from the ferritin core by subunit displacement [9].  Thismethod of iron release by 
subunit displacement is unlikely as the ferritin subunits show a high stability even at high 
temperatures, extreme pH, and denaturing agents such as urea [8].  The second model addresses 
iron release from eukaryotic ferritins and is based on the diffusion of molecules through the 3-
fold channels.  The 3-fold channels of eukaryotic ferritins, which are lined by negatively charged 
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amino acid residues, are believed to be involved in moving iron in and out of the ferritin [10].  It 
was initially thought that reducing and chelating agents diffuse through these pores to reduce the 
ferric ion core and chelate iron ions.  The third model describes the gated mechanism of iron 
release where it is assumed that ferritin channels regulate the moving of iron ions by opening and 
closing of these channels [8].  It has been experimentally shown that physiological 
concentrations (2-7 mM) of denaturing agents such as urea can unfold the pores of ferritin while 
the rest of the ferritin molecule shows a high stability at that urea concentration [12].  
Consequently iron is thought to be released through these unfolded ferritin po es suggesting that 
biological regulators can recognize these pores to regulate the opening and closing of these 
channels and subsequently release iron through these pores [13].  The oxidation and 
mineralization of iron by the bacterioferritins has been somewhat studied [14, 15].  However, the 
mechanism or the pathway of iron release from the inner core of bacterioferritins is not yet 
understood.  Bacterioferritins are the heme containing counterparts of ferritins and found only in 
bacteria.  In our laboratory, experiments were carried out to investigate the mechanism and the 
pathway of iron release from the mineral core of bacterioferritin B from P.aeruginosa (Pa-BfrB) 
and we were able to experimentally demonstrate that binding of a small ferredoxin called Bfd 
(bacterioferritin associated ferredoxin) facilitates the effici nt release of iron from the inner core 
of BfrB (Chapter 3 and [14]).  It was also found that electrons from the electron donor are 
transferred to the mineral core via the heme groups in Bfr, establishing the role of heme in 
bacterioferritins for the first time.  These interesting findings of the mechanism of iron release 
from Pa BfrB tempted us to discover the pathway of iron release from Pa-BfrB. 
 The crystallographic studies of BfrB presented in Chapter 2, 3-fold pores of BfrB are 
lined with both positively and negatively charged residues.  In addition, he Fe soaked crystal 
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structure of BfrB indicated residual electron density in the 3-fold pores and that revealed the 
presence of sulfate ions in these pores.  This observation may suggest that 3-fold pores are 
involved in traffick of anions in and out of the molecule, thus further experimentation is required 
to clearly elucidate the function of these 3-fold pores.  The B-pores f Pa BfrB, on the other 
hand, are lined with negatively charged amino acid residues such as asp rtates, suggesting a 
possible pathway for the translocation of Fe2+ ions out of the molecule.  However, no 
experimental evidence has been found yet to confirm the idea of cation trafficking through these 
B-pores.  Some important observations from the crystallographic studie  of Pa BfrB suggest that 
4-fold pores, which are lined with both negatively and positively charged amino acid residues, 
can be one of the possible pathways of iron release from the mineral core.  Crystal structures of 
mineralized and iron soaked (‘as isolated’ BfrB crystals, soaked in a Fe2+ solution) BfrB showed 
potassium ions in the 4-fold pores, coordinated by the side chains of A n148 and Gln151 (see 
figure 2-15 in Chapter 2) [17].  In addition, Bfr from Azatobacter vinelandii has also been 
observed to contain cations such as iron and barium in the four fold pores, which have relatively 
similar architecture as the pores in Pa BfrB [25, 26].  The presence of cations in the 4-fold pores 
of Pa-BfrB and Av-Bfr would suggest the possibility of carrying out similar functions like, 
mobilization of iron.   
 Based on the assumption that 4-fold pores may be the dominant pathway of iron 
trafficking, experiments were carried out to elucidate the precise pathway of iron release from 
the core of Pa BfrB by mutating some of the residues in the four fold pore which are believed to 
be crucial for the process of iron release.  In addition to the above observations, there is 
additional circumstantial evidence supporting the hypothesis that iron is released through the 4-
fold pores of Pa BfrB:  As mentioned in Chapter 3, we have experimentally demonstrated that 
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binding of Pa Bfd (a small ferredoxin called bacterioferritin-associated ferredoxin) facilitates the 
efficient release of iron from the inner core of Pa BfrB [14], suggesting that these two proteins 
function in concert to release iron from Pa BfrB.  In the absence of Pa Bfd, no significant amount 
of iron is released from the core, indicating that Pa Bfd is essential for efficient release of iron 
from Pa BfrB.   
 In addition to the iron storing protein Pa BfrB, P aeruginosa has another iron storage 
protein called Pa FtnA.  Our laboratory has shown that Pa FtnA, is a bacterial ferritin, which 
does not contain heme.  In the P aeruginosa genome, bfrB gene is located downstream to the bfd 
gene where as ftnA gene is located downstream to katA gene, which codes for enzyme catalase 
A.  Preliminary results of our studies on iron release from Pa FtnA revealed that Pa Bfd is not 
required for efficient release of iron from the inner core of Pa FtnA.  Since our hypothesis is 
based on the Pa Bfd facilitated iron release through the 4-fold pores, it is important to investigate 
to find out if there is any structural and hence functional difference between the 4-fold pores of 
Pa BfrB and Pa FtnA.   
 The 4-fold channel of Pa-BfrB is made of several amino acid layers.  The outer 
opening of the pore is made of an outer layer of Asn148 and inner layer of Gln151 followed by 
His153 and155 towards interior of the molecule [16] (Figure 4-1A).  The inner most end of the 
pore is believed to be made from side chains of Asp157 and 158 (Figure 4-1B).  However, these 
two residues are not visible in the crystal structure of Pa BfrB as these residues are disordered. 
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Figure 4-1: The structure of the 4-fold pore of Pa BfrB viewed from the interior of the protein. 
(A) The inner layer of Gln151 are shown in blue spheres and the Asp157 and Asp158 (last two 
residues at the C-terminus) which forms the inner end of the pore, however, are not visible in the 
crystal structure of BfrB. (B) Surface representation of the 4-fold pore of Pa BfrB (shown by the 
black arrow) showing the Asp157 and 158 residues (colored in bright orange) at th  C terminal 
modeled by the Elastic Network Model calculations. 
(B) 
Asp158 
4-fold pore 
(A) 
Gln151 
His155 His153 
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              10        20        30        40        50        60                                                                                                                            
                |         |         |         |         |         |         
Pa-BfrB  MKGDKKVIQHLNKILGNELIAINQYFLHSRMWNDWGLKRLGAHEYHESIDEMKHADKLIE 
Pa-FtnA  MQGHPEVIDYLNTLLTGELAARDQYFIHSRMYEDWGFSKLYERLNHEMEEETQHADALLR 
       
                            70        80        90       100       110       120                                                                                                                                   
                  |         |         |         |         |         |         
Pa-BfrB   RILFLEGLPNLQDLGKLLIGENTQEMLQCDLNLELKATKDLREAIVHCEQVHDYVSRDLL 
Pa-FtnA  RILLLEGTPRMRPDDIHPGTTVPEMLEADLKLERHVRAALAKGIALCEQHKDFVSRDILK 
 
                            130       140       150 
        |         |         |  
Pa-BfrB  KDILESEEEHIDYLETQLGLIQKVGLENYLQSHMHEDD--- 
Pa-FtnA     AQLADTEEDHAYWLEQQLGLIARMGLENYLQSQI 
Figure 4-2: Sequence of P. aeruginosa BfrB aligned against the sequence of FtnA.  The amino 
acid residues forming the outer part of the 4-fold pore (Asn148 and Gln151) are conserved in 
both proteins(highlighted in yellow).  The C-terminus of Pa BfrB ends with two negatively 
charged Asp residues whereas that of Pa FtnA ends with a hydrophobic Ile residue (highlighted 
in red).  The sequences were aligned with the aid of ClustalW [17] 
 According to the amino acid sequences of Pa BfrB and Pa FtnA (igure 4-2), the two 
Asp residues (157 and 158) at the C-terminus of Pa BfrB, which is thought to be forming the 
inner opening of the 4-fold pore, are absent in the sequence of FtnA, and instead of that Pa FtnA 
has a hydrophobic Ile residue at its C-terminus.  This observation suggests that the structure of 4-
fold pore of Pa BfrB and hence the iron release mechanism may be different from that of Pa 
FtnA.  It is possible that, the structural difference observed at the inner end of the 4-fold pore in 
Pa FtnA protein, likely the reason for the observed higher rates of iron release even in the 
absence of Pa Bfd.  That result circumstantially suggests that Bfd may have an effect of opening 
of the 4-fold pores of Pa BfrB.  Further, upon aligning the sequences of bfr genes which are 
located downstream to the bfd gene in the bacterial genome, it was observed that almost all those 
bfr genes end with negatively charged acidic residues (aspartates or glutamates) which are 
thought to be forming the inner end of the 4-fold pore (Appendix 1).  This alignment data 
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suggest that, similar to Pa BfrB, all the other Bfrs which are located adjacent to Bfd, may require 
Bfd to open the 4-fold pores and release iron from the inner core. 
 In order to test this idea of Pa Bfd facilitated iron release through 4-fold pores, the 
structure of the four fold pore of Pa BfrB was altered by removing Asp157 and 158 residues at 
the C-terminus of the protein (truncated Pa BfrB) by site directed mutagenesis.  Subsequently, 
the rate of iron release from the mineral core and the effect o  Pa Bfd on the rate of iron release 
from truncated Pa BfrB were compared with those of the wild typePa BfrB with the aim of 
establishing a precise pathway of iron release from Pa BfrB. 
 
Experimental Procedures 
Site directed mutagenesis of truncated (D157TAA) BfrB 
 Codone coding for residue Asp157 (GAT) was converted to a stop codon (TAA)and as a 
result protein will be expressed only upto the amino acid Glu156 (truncaed Pa BfrB).  Truncated 
bfrB gene was constructed using the recombinant pET11a plasmid harboring the gene coding for 
wild type Pa BfrB (Figure 4-3).  The sequences of the primers d signed for truncated BfrB are 
5`-CAG AGC CAT ATG CAT GAA TAA GAT TAA GGA TCC GGC TGC-3` and 5`-GCA 
GCC GGA TCC TTA ATC TTA TTC ATG CAT ATG GCT CTG-3`.  The GC content and the 
melting temperature (Tm) were calculated to be 46 %. and 75 ºC respectively.  The primers were 
synthesized by Integrated DNA Technologies, Inc (Coralvile, IA).  Mutagenesis was carried out 
using the QuickChangeTM mutagenesis kit (Stratagene, La Jolla, CA).  The recombinant 
constructs were then transformed into E.coli XL1 Blue supercompetent cells for DNA 
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amplification.  Once the mutation was verified by sequencing, recombinant DNA plasmids were 
transformed into E. coli Arctic express RIL cells (Stratagene, La Jolla, CA). 
 
                    5’Nde1 
             CATATG AAA GGC GAT AAA AAA GTG ATC CAG CAT CTG AAT AAA ATT  
                          M      K       G      D       K       K      V       I       Q       H      L      N      K        I 
CTG GGT AAT GAA CTG ATT GCG ATT AAT CAG TAT TTT CTG CAT AGC CGC ATG  
   L      G       N      E        L       I       A      I       N      Q      Y      F      L       H      S       R      M      
TGG AAT GAT TGG GGC CTG AAA CGT CTG GGC GCG CAT GAA TAT CAT GAA AGC 
   W      N      D     W       G      L       K    R      L       G      A      H       E      Y       H      E        S 
ATT GAT GAA ATG AAA CAT GCG GAT AAA CTG ATC GAA CGT ATT CTG TTT CTG  
   I        D      E       M      K      H       A     D       K      L       I        E       R     I       L      F      L 
GAA GGT CTG CCG AAT CTG CAG GAT CTG GGC AAA CTG CTG ATT GGT GAA AAC 
   E       G      L       P       N      L       Q     D      L       G      K       L      L       I      G      E       N 
ACC CAG GAA ATG CTG CAG TGC GAT CTG AAT CTG GAA CTG AAA GCG ACC AAA  
   T      Q       E       M      L       Q      C     D      L       N      L       E      L       K       A       T      K 
GAT CTG CGT GAA GCG ATC GTG CAT TGC GAA CAG GTG CAT GAT TAT GTT AGC  
   D      L       R      E       A       I       V      H      C      E        Q      V      H       D     Y      V       S 
CGT GAT CTG CTG AAA GAT ATC CTG GAA AGC GAA GAA  GA CAT ATT GAT TAT 
   R       D      L      L       K       D       I    L      E        S       E       E       E       H       I       D      Y  
 CTG GAA ACC CAG CTG GGT CTG ATT CAG AAA GTG GGC TG GAA AAC TAT CTG   
   L       E       T      Q       L       G      L       I       Q       K      V       G      L       E       N      Y       L 
CAG AGC CAT ATG CAT GAA TAA  GAT TAAGGATCC 
   Q       S       H     M      H      E            D            BamH1  3’  
 
Figure 4-3: DNA and corresponding amino acid sequence of truncated (D157TAA) bfrB from P. 
aeruginosa. D157TAA mutation is highlighted. Nde I and BamH I restriction endonuclease sites 
were constructed at the 5' and 3' ends for subcloning. 
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Expression and purification of truncated Pa BfrB. 
 The truncated Pa BfrB was expressed, lysed and purified following the same 
procedures as those of wild type, which are described in detail in he experimental procedures in 
Chapter 2.  The purity of the protein was determined by SDS-PAGE and the pure protein was 
then passed through a calibrated high resolution size exclusion column (Superdex 200 10/300, 
GE Healthcare) equilibrated with 100 mM potassium phosphate (pH 7.6) and 1 mM tris (2-
carboxyethyl)-phosphine hydrochloride (TCEP) to determine the size and confirm the 
oligomerization.  Once the oligomerization is confirmed as 24mers, the pure protein was 
concentrated, flash frozen and stored at -80 ºC.  
Mineralizaton of iron in the truncated Pa BfrB cavity.   
 Similar to wild type Pa BfrB, truncated Pa BfrB also contains  few iron ions in their 
cores (10-15 iron atoms per molecule).  Therefore, the protein to be used in experiments was 
incorporated with ~ 600 iron atoms per molecule.  The same mineralization procedure used for 
wild type BfrB, described in the experimental procedures in chapter 2 was followed for the 
mutant.  Anaerobic solution of ferrous ammonium sulfate was added in aliquots delivering 50 
Fe2+/Pa BfrB to a stirred solution of 3 µM truncated BfrB in 100 mM potassium phosphate 
buffer, pH 7.6, to obtain a core of ~ 600 Fe2+/Pa BfrB.  Any precipitation formed during the 
mineralization was removed by centrifuging the sample for 10 minutes at 4000 rpm.  The 
mineralization process was monitored spectrophotometrically following the absorbance near 320 
nm with the aid of a USB 2000 spectrophotometer (Ocean Optics, Dunedin, FL).   
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Analysis of non-heme iron in the truncated Pa BfrB core.  
 Non-heme iron analysis of truncated Pa BfrB was carried out using Fe-ferrozine assay 
in the same way as described for wild type Pa BfrB in Chapter 2.  The concentration of iron was 
determined from the electronic absorption spectrum using the absorbance at 562 nm (ε562 = 27.9 
mM-1 cm-1) [19]. 
Crystallization of truncated BfrB 
 Crystallization studies were carried out in the Protein Structu e Laboratory at the 
Delbert M. Shankel Structural Biology Center (University of Kansas, Lawrence, KS).  
Mineralized truncated Pa BfrB was concentrated to 20 mg/mL in 100 mM potassium phosphate 
pH 7.6, 5 mM TCEP for crystallization.  Crystals were grown under aerobic conditions in Clover 
Jr. (Emerald biosystems) sitting drop vapor diffusion plates using 1µL of crystallization solution 
and 1 µL of protein equilibrated against 100 µL of crystallization solution at 20 oC.  Red prisms 
were obtained within 24 hours from the crystallization condition, 35% (v/v) 2-methyl-2,4-
pentanediol, 100 mM MES pH 6.0, 200 mM Li2SO4 (Wizard 2 #2, Emerald biosystems). 
Iron uptake by truncated Pa BfrB in solution   
 Truncated Pa BfrB to be used in the experiments was prepared by extensively 
dialyzing the pure, as-isolated protein against 100 mM potassium phosphate, pH 7.6.  Aliquots of 
50 mM ferrous ammonium sulfate containing 50 Fe2+/BfrB molecule were added using a 
Hamilton microsyringe to a solution of truncated BfrB (0.8 µM) at 30 °C in a 1.0 cm path length 
cuvette equipped with a stirring bar.  Changes in the intensity of the absorbance at 320 nm were 
recorded for 10 minutes for each addition of iron with the aid of a diode-array UV-vis 
spectrophotometer (Ocean Optics, Dunedin, FL).   
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Mobilization of core iron from truncated Pa BfrB  
 Experiments to investigate the iron release from truncated Pa BfrB were carried out in 
an anaerobic chamber.  These reactions were conducted in a 1.0 cm path-length cuvette equipped 
with a magnetic stirring bar and monitored by electronic absorption spectroscopy using an Ocean 
Optics (Dunedin, FL) 2000 spectrophotometer.  A few µL from stock protein solutions were 
added to a cuvette containing 3 mM 2,2, bipyridyl (bipy) in 1.0 mL of 20 mMpotassium 
phosphate buffer (pH 7.6), to make a solution 15 µM in Pa Bfd, 15 µM in Pa Fpr and 0.375 µM 
in truncated Pa BfrB.  The reaction was initiated by addition of NADPH to a final concentration 
of 1.5 mM and the progress of the reaction was monitored by following the time-dependent 
changes in intensity of the band at 523 nm that is formed when bipy binds Fe2+ to form the 
[Fe(bipy)3]
2+ complex.  All the experiments were conducted with apo Bfd and it was prepared in 
situ from holo-Bfd as described in Chapter 3.  Experiments were carried out by varying the 
concentration of apo Bfd while maintaining Pa BfrB (0.375 µM), Pa Fpr (15µM), NADPH (1.5 
mM), and Bipy (3 mM) concentrations constant.  Iron mobilization experiments were also 
carried out using sodium dithionite as the reducing agent.  Excess of sodium dithionite (twice the 
required stoichiometric amount) was added into a solution of 0.05 µM truncated P  BfrB, 2 µM 
Pa Bfd and 0.4 mM ferrozine (Fe2+ chelating agent) and the iron release from Pa BfrB was 
monitored by following the time-dependent changes in intensity of the band at 562 nm which is 
formed due to the absorbance of the Fe-ferrozine complex.  In order t  compare the results with 
that of wild type BfrB, same experiment was carried out with wild type Pa BfrB under the same 
experimental conditions.  The initial pseudo rates of iron release of ach experiment were 
estimated by fitting each curve of iron release to an exponential function. 
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Iron mobilization from truncated Pa BfrB in the absence of Bfd. 
 Experiments to probe the effect of Pa Bfd on opening of the pore of Pa BfrB were 
carried out in an anaerobic chamber.  Excess of 3 mM sodium dithionite solution (twice the 
stoichiometric amount) was added to a solution of 0.05 µM mineralized truncated Pa BfrB in 20 
mM potassium phosphate buffer, pH 7.6 to reduce the iron core of Pa BfrB.  The experiment was 
conducted in a 1.0 cm path-length cuvette equipped with a magnetic stirring bar and monitored 
by electronic absorption spectroscopy using an Ocean Optics (Dunedin, FL) 2000 
spectrophotometer.  Excess of 20 mM ferrozine solution was added to the protein to a final 
concentration of 0.4 mM in order to chelate Fe2+ ions releasing from the iron core of the protein.  
The release of iron was monitored by following the absorbance of Fe-ferrozine complex at 562 
nm using an Ocean Optics (Dunedin, FL) 2000 spectrophotometer.  As a control, the same 
experiment was carried out with wild type Pa BfrB under similar experimental conditions.  
Reduction of the iron core of truncated Pa BfrB by dithionite. 
 Excess of sodium dithionite was added to a solution of 0.05 µM mineralized, truncated 
Pa BfrB in 20 mM potassium phosphate buffer (pH 7.6).  The experiment was carried out in a 
1.0 cm path-length cuvette equipped with a magnetic stirring bar in an anaerobic chamber.  The 
decay of the absorbance of dithionite solution at 314 nm was monitored using an Ocean Optics 
(Dunedin, FL) 2000 spectrophotometer.  As a control experiment, same amount of dithionite was 
added to a solution of non mineralized truncated BfrB of same concentration as mineralized, 
truncated Pa BfrB and monitored the decay of the absorbance of dithionite at 314 nm. As a 
control, another set of similar experiments were carried out with mineralized and non 
mineralized wild type Pa BfrB. 
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Results 
Protein expression and purification 
 The truncated Pa BfrB expressed in E.coli arctic express RIL cells is soluble and can 
be purified to homogeneity as judged by SDS-PAGE (Figure 4-4A).  The molecular weight of 
one subunit was ~18 kDa which is in agreement with the molecular mass calculated from the 
amino acid sequence of a truncated Pa BfrB subunit (18321 Da).  The electronic absorption 
spectrum of pure truncated Pa BfrB was similar to that of wild type with a Soret band maximum 
at 418 nm and α and β bands at 567 nm and 527 nm, respectively (Figure .4-4B).  The folding of 
the protein was confirmed as a 24 mer by using a previously calibrated Superdex 200 column. 
(10/300, GE Healthcare). 
 
 
 
 
 
Figure 4-4: (A) 15 % SDS-PAGE analysis of truncated Pa BfrB purified to homogeneity and (B) 
the electronic absorption spectra of truncated Pa BfrB (blue trac) and wild type Pa BfrB (red 
trace) showing the Soret, α and β bands at 418 nm, 567 nm and 527 nm, respectively. 
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Mineralizaton of truncated Pa BfrB  
An iron core of ~600 iron atoms could be formed by adding an anaerobic s lution of Fe2+ 
into a solution of truncated Pa BfrB in air.  Each time an aliquot of Fe2+ containing 50 Fe2+ ions 
were added to the protein solution.  However, after adding ~400 iron atoms a slight precipitation 
was observed and it was removed by centrifuging the protein at 4000 rpm for 10 minutes.  The 
family of spectra in figure 4-5 shows a small decrease in the intensity of Soret band which was 
due to the loss of a small amount of protein precipitated with the ferric iron colloid formed by the 
oxidation of Fe2+ in air. 
 
 
 
 
 
 
 
Figure 4-5: The family of electronic absorbance spectra showing the incorporation of iron into 
the core of truncated Pa BfrB.  The initial spectrum of truncated Pa BfrB is shown in blue and 
the final spectrum is shown in red. 
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The addition of iron was continued with the supernatant obtained after centrifugation until a core 
of about 600 iron ions is formed.  Subsequently, the protein solution was cleaned using a G-25 
column (Amersham biosciences) to remove Fe2+ ions not incorporated into the protein.  An iron 
core of 600 ± 20 iron ions was obtained when analyzed by the Fe-ferrozine assay described in 
Chapter 2.   
Crystallization of truncated BfrB 
 The recombinant mineralized truncated Pa BfrB was concentrated to 20 mg/mL and 
formed red prismatic crystals within 24 hours from the crystallization condition, 35% (v/v) 2-
methyl-2,4-pentanediol, 100 mM MES pH 6.0, 200 mM Li2SO4 (Wizard 2 #2, Emerald 
biosystems) (Figure 4-6). 
 
 
 
 
 
 
Figure 4-6: Crystals of recombinant truncated BfrB formed from the condition 35% (v/v) 2-
methyl-2,4-pentanediol, 100 mM MES pH 6.0, 200 mM Li2SO4 (Wizard 2 #2, Emerald 
biosystems) 
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Red prismatic crystals were also formed from the conditions of pHAT buffer screen.  Those 
crystals however, did not diffract well.  Therefore, studies on the crystal structure of truncated Pa 
BfrB are expected to be carried out using the crystals formed from the Wizard 2 #2 condition. 
Iron uptake in solution by Pa BfrB  
 The uptake of iron by as isolated (non-mineralized) truncated Pa BfrB was studied by 
adding aliquots of Fe2+ solution delivering 50 Fe2+ ions per Pa BfrB molecule.  A rapid increase 
of the intensity of the absorbance near 320 nm was observed and recorded using a diode array 
UV-vis spectrophotometer.  The observed results were similar to tha  of wild type BfrB [24], 
which showed a rapid increase of the intensity near 320 nm upon addition of Fe2+ ions and 
reached a plateau that remained constant until the next aliquot of iron is added (Figure 4-7).  
 
 
 
 
 
 
 
Figure 4-7: Changes in ∆A320 upon addition of Fe
2+ aliquots (50 Fe2+ions/BfrB molecule) to a 
solution of truncated Pa BfrB. 
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Aliquots of Fe2+ were added three times and the magnitude of the change of the absorbance at 
320 nm at each addition of iron was nearly constant.  These results show that the iron uptake 
mechanism of truncated Pa BfrB is similar to that of wild type Pa BfrB [16] and indicate that the 
mutation at the four fold pore region of truncated BfrB did not affect the function of the 
ferroxidase center.  As these results suggest, the ferroxidase center of truncated Pa BfrB 
functions as a labile ferroxidase center similar to that of wild type BfrB(see Chapter 2 and [16]. 
Mobilization of core iron from truncated Pa BfrB 
 All iron mobilization experiments of truncated Pa BfrB were carried out under 
anaerobic conditions and the experiments were carried out similar to those with wild type Pa 
BfrB as described in Chapter 3.  Iron release from truncated Pa BfrB was initiated by adding 1.5 
mM NADPH to a solution containing 3 mM 2, 2, bipyridyl (bipy), 15 µM apo Pa Bfd, 15 µM Pa 
Fpr and 0.375 µM truncated Pa BfrB and it was monitored by following the time–dependent 
formation of the ferrous bipyridine complex [Fe(bipy)3)], which absorbs at 523 nm (Figure 4-
8A).  Several iron mobilization experiments were carried out by var ing the concentration of apo 
Pa Bfd while maintaining the concentrations of truncated Pa BfrB (0.375 µM) and Pa Fpr (15 
µM) consant.  The amount of iron released upon addition of 1.5 mM NADPH to the protein 
solutions with Bfd/BfrB molar ratio of 50 (pink), 40 (green), 20 (red), 15 (cyan), 10 (blue), 5 
(dark yellow) and 0 (black) is shown in figure 4-8A.  Results from a similar set of experiments 
carried out with wild type BfrB are shown in figure 4-8B and color coded as in figure 4-8A.  A 
significant enhancement of the rate of iron release is observed in the presence of Pa Bfd in both 
sets of reactions carried out with wild type and truncated Pa BfrB.   
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Figure 4-8: Effect of Pa Bfd concentration on the time dependent process of iron mobilization 
from the iron core of (A) truncated Pa BfrB and (B) wild type Pa BfrB, measured upon addition 
of NADPH (1.5 mM ) to solutions containing 3.0 mM bipy, 15 µM Pa FPR, 0.375 µM truncated 
Pa BfrB and apo Pa Bfd with Bfd/BfrB molar ratio of 50 ( pink ), 40 (green), 20 (red), 15 (cyan), 
10 (blue), 5 (dark yellow) and 0 (black). 
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However, with truncated Pa BfrB, the rates of iron release of all the experiments with different 
Pa Bfd concentrations seem to be significantly higher than that of with wild type Pa BfrB. 
In order to compare the rates of iron release in a more quantitative manner, the initial 
pseudorates of iron release were estimated for each experiment with wild type and truncated 
BfrB by fitting the curves of iron release to an exponential functio .  The results are summarized 
in table 4-1 and in figure 4-9. 
 
 
 
 
 
 
 
Figure 4-9: Bfd dependent iron release from truncated (red) and wild type (blue) BfrB. 
 In truncated Pa BfrB the rate of iron release increases rapidly as the Bfd/BfrB ratio 
increases and plateaus when the Bfd/BfrB is above 10.  This suggests that once Bfd/BfrB ratio is 
12, i.e. once it reaches the stoichiometric ratio of 12 (Bfd:BfrB), [15] the reaction achieves the 
maximum rate of iron release.  These results imply that once Pa Bfd and Pa BfrB are reacting at 
a ratio below their stoichiometric ratio, the rate of iron release becomes sluggish, but when the 
two proteins reacts at or above the stoichiometric ratio the rate of iron release becomes 
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independent of the concentration of Pa Bfd.  In the wild type Pa BfrB, on the other hand, the rate 
of iron release gradually increases with increasing Pa Bfd concentratio , indicating that effect of 
Pa Bfd on the rate of iron release is different for wild type and truncated proteins, which are 
structurally different only at the 4-fold pore. 
Table 4-1: A comparison of the pseudorates of the Pa Bfd dependent release of core iron from 
wild type and truncated Pa BfrB 
 
 
 
 
 
 
   Further, upon addition of NADPH to initiate the reaction of iron release, the Soret band of wil  type BfrB was observed to sh
  However, the rate of the shift of the Soret band from 418 nm to 425 nm was also 
varied with varying concentration of Bfd.  The fastest shift was observed with Bfd/BfrB ratio of 
40 and the slowest shift was observed with the ratio of 5 and in the absence of Bfd, however, no 
shift of the soret band was observed (Figure 4-10).  The same trend of the shifting of the Soret 
band was observed with truncated BfrB, implying that the rate of electron transfer from the 
reductase to the inner core via the heme group is relatively similar in both proteins. 
 
Bfd/BfrB 
molar ratio 
Pseudo rate of iron release (min-1) at 25 ºC 
WT Pa BfrB Truncated Pa BfrB 
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    0.0087 ± 0.0002 
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0.136 ± 0.010 
0.136 ± 0.006 
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Figure 4-10: The shift of the Soret band in the (experiments shown in figure 4-8) reactions of 
iron mobilization from the iron core of (A) truncated Pa BfrB and (B) wild type Pa BfrB, 
observed upon addition of NADPH (1.5 mM ) to solutions containing 3.0 mM bipy, 15 µM Pa 
FPR, 0.375 µM truncated Pa BfrB and apo Pa Bfd with Bfd/BfrB molar ratio of 50 ( pink ), 40 
(green), 20 (red), 15 (cyan), 10 (blue), 5 (dark yellow) and 0 (black). 
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In the absence of Bfd, Fe2+ ions are trapped inside the Pa BrB core 
 Excess sodium dithionite was added to non mineralized, wild type Pa BfrB under strict 
anaerobic conditions and the decay of the intensity of the absorbance y sodium dithionite at 314 
nm was monitored.  The shift of the Soret band of Pa BfrB was monitored simulataneously 
(Figure 4-11A).  The absorbance of dithionite at 314 nm slowly decayed for ~60 minutes and 
eventually became relatively constant.  Non mineralized, wild type Pa BfrB usually contains few 
iron atoms in its inner core [14] and the electrons from the dithionite may have been used to 
reduce those few Fe3+ ions in the core which was indicated by the slow decay of the dition e 
absorbance at 314 nm.  The Soret band of wild type Pa BfrB gradually shifted from oxidized 
(418 nm) position to the fully reduced state (425 nm), showing the consumption of electrons by 
the heme group of Pa BfrB.  These observations indicate that electrons provided by the dithionite 
is transferred though the heme group of Pa BfrB and since there are no significant amount of iron 
in the BfrB core, a higher accumulation of reduced heme are observed.   
 A similar experiment was carried out using mineralized, wild type Pa BfrB under the 
same experimental conditions.  To this end, the non mineralized (as isol ted) Pa BfrB was 
reconstituted with iron (Figure 2-5 in Chapter 2 and [14]) in order to form a mineral core of ~ 
600 iron atoms.  The decay of the dithionite absorbance at 314 nm and the shift of the Soret band 
of mineralized wild type BfrB were monitored.  Contrary to the observations of non mineralized, 
wild type Pa BfrB, the dithionite absorbance at 314 nm decayed relatively fast and the Soret 
band shifted towards the reduced state very slowly (Figure 4-11B).  Unlike in non mineralized 
BfrB, the Soret band of the mineralized protein did not shift to the fully reduced state; is stayed 
at ~419 nm.   
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Figure 4-11: The reduction of the core of (A) non mineralized and (B) mineralized wild type Pa 
BfrB by dithionite.  Decay of the absorbance of dithionite at 314 nm is shown by the red trace 
and the shift of the Soret band is shown by the green trace.  (C) The amount of iron released 
from mineralized, wild type Pa BfrB, in the presence (red) and in the absence of Pa Bfd. (blue).  
(D) The amount of iron released from mineralized, wild type Pa BfrB, in the presence of Pa Bfd 
with sodium dithionite (red) and NADPH/Pa Fpr (green) as the reducing agent (molar ratio of 
Bfd/BfrB is 40). 
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These observations clearly indicate that the electrons provided by the dithionite are transferred to 
the large ferric ion mineral core of mineralized wild type Pa BfrB; consequently, only a slight 
accumulation of the reduced heme is observed.  The observations obtained from both 
experiments suggest that the mineral core of Pa BfrB can be reduced by the electrons provided 
by dithionite, transferred into the core via the heme groups. 
 Another set of experiments were carried out to investigate the ffect of Pa Bfd on the 
opening of the pores of Pa BfB.  Excess sodium dithionite was added to wild type, mineralized 
BfrB in the presence of the Fe2+ chelating agent ferrozine, and the release of iron from the Pa 
BfrB core was monitored by following the absorbance of the Fe-ferrozine complex at 562 nm.  
In the absence of Pa Bfd, wild type Pa BfrB released less than 10% of iron (Figure 4-11C (blue)), 
suggesting that although the mineral core is reduced by dithionite, the reduced Fe2+ ions are 
trapped inside the core (red).  However, in the presence of Pa Bfd, a significantly large amount 
of iron (~95%) is released from the core, indicating that Pa Bfd plays an important role in 
opening the pores of Pa BfrB.  Another experiment was carried out with mineralized, wild type 
Pa BfrB, using NADPH and Pa Fpr as the reducing agent instead of dithi nite.  Interestingly, the 
rate of the iron released was faster with dithionite as the reducing agent than that of with 
NADPH/Pa Fpr as the reducing agent (Figure 4-11D).  The fast r rates of iron released observed 
with dithionite may be due to the fact that the smaller reducing agents such as sodium dithionite 
can access the core iron by moving directly into the core throug  the pores of BfrB, may be 
using a similar trajectory taken by the reduced iron ions.   
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Experiments similar to those depicted in Figure 4-11A and B were car ied out with truncated Pa 
BfrB and the same results were obtained indicating that the mutation performed in the 4-fold 
pore of the truncated Pa BfrB did not affect the processes of electron transfer into the core or the 
reduction of the mineral core by the external reducing agents (Figure 4-12 A and B).  Similar to 
the experiment carried out with wild type Pa BfrB shown in figure 4-11C, sodium dithionite was 
added to mineralized truncated Pa BfrB in the presence of chelating agent, ferrozine.  As a result, 
~ 30% of core iron was released from the truncated Pa BfrB, showing that the pores of truncated 
Pa BfrB, which are thought to be involved in the release of iron formthe mineral core, has less 
control over the release of iron than that of wild type Pa BfrB (Figure 4-12C).  Relatively higher 
amounts of iron released, observed in the truncated Pa BfrB with structurally altered 4-fold pores 
(without the inner most two Asp residues), may be an important evidence to show that the 
reduced iron is released through the 4-fold pores of Pa BfrB.  In the presence of Pa Bfd, 
however, the rate of iron release was significantly high such that ~ 80% of core iron was released 
within ~5 minutes (Figure 4-12C).  These observations indeed show that Pa Bfd facilitates the 
opening of the pores of Pa BfrB to release core iron.  In addition, the higher rates of iron release 
observed in truncated Pa BfrB than that of with wild type Pa BfrB (in the presence of Pa Bfd) 
indicate the less resistance shown by the mutated 4-fold pores of truncated BfrB towards the 
process of iron release from the mineral core which can be considered as indirect evidence to 
support the idea of iron release through the 4-fold pores of Pa BfrB.  Similar to wild type Pa 
BfrB, truncated Pa BfrB also showed higher rates of iron releas  with dithionite as the reducing 
agent than that of with NADPH/ Pa Fpr.  However, the rates of iron release of truncated BfrB 
were observed to be faster than those with wild type Pa BfrB, suggesting that the altered 4-fold 
pores can release more iron than those of wild type BfrB.  
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Figure 4-12:  The reduction of the core of (A) non mineralized and (B) mineraliz d truncated Pa 
BfrB by dithionite.  Decay of the absorbance of dithionite at 314 nm is shown by the red trace 
and the shift of the Soret band is shown by the green trace.  (C) The amount of iron released 
from mineralized, truncated BfrB in the presence (red) and in the abs nce of Pa Bfd. (blue).  (D) 
The amount of iron released from mineralized, truncated BfrB in the presence of Pa Bfd with 
sodium dithionite (red) and NADPH/Pa Fpr (green) as the reducing agent.(molar ratio of 
Bfd/BfrB is 40). 
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Discussion 
 According to the crystal structure of wild type Pa BfrB, six 4-fold pores are 
symmetrically distributed on the Pa BfrB molecule, each located long 4-fold symmetry axis of 
the molecule [16].  Four individual subunits interact to form one 4-fold pore.  As shown in figure 
4-1A, the outer part of these pores are composed of an outer layer of Asn148 residues and an 
inner layer of Gln151 residues.  The interior of the pore is made of the C-terminus of each sub 
unit, (Asp157 and Asp158 from each subunit) which are also thought to be the inner most end of 
the pore (Figure 4-1B).  However, these Asp residues are not visible in th  crystal structure of 
BfrB, as their spatial arrangement is disordered [16].  In addition, here are two His residues 
(His153 and His 155) from each subunit located adjacent to the aspartates, which are believed to 
be functioning as gates in releasing iron through these pores.  
Truncated BfrB with an altered 4-fold pore. 
 In the mutation we performed, Asp 157 and Asp 158 have been removed and in the 
resultant truncated protein the C-terminus ends at Glu156.  Therefore, the 4-fold pores of the 
truncated protein are considered to be shorter in length than those of the wild type protein.  Wh n 
the structures of wild type and truncated Pa BfrB are considered, th  only structural difference 
observed so far is the absence of two Asp residues (Asp 157 and 158) at the C- erminus of the 
truncated Pa BfrB.  However, detailed structural studies of this protein are expected to be carried 
out in the future by X-ray crystallography.  Similar to wild type Pa BfrB, it has been 
experimentally proved that truncated Pa BfrB is properly folded as a 24 mer with a full 
complement of 12 hemes per protein, indicating that the mutation perform d did not affect the 
folding of the protein.  In addition, with the aim of investigating the fact that whether the 
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ferroxidase center of truncated Pa BfrB was functioning similar to that of wild type Pa BfrB, an 
iron uptake experiment was carried out under the same experimental co ditions as wild type Pa 
BfrB.  Our previous findings of wild type BfrB showed a gated mechanism of iron uptake via the 
ferroxidase center (Chapter 2 and [16]).  The experiment carried out with truncated Pa BfrB 
showed the same results (Figure 4-7) as wild type, where, upon addition of Fe2+ ions to a 
solution of truncated Pa BfrB a rapid increase (∆A=0.07) of the absorbance at ~320 nm was 
observed and then remained constant until the next aliquot of iron was added.  Upon addition of 
the second  and third aliquots of iron, relatively similar amounts of rapid increase (∆A=0.05 and 
0.06) at 320 nm were observed indicating that the ferroxidase center of truncated Pa BfrB also 
has the gated mechanism of iorn uptake similar to wild type Pa BfrB.  These observations show 
that the mutation performed at the 4-fold pore of the truncated Pa BfrB has not affected the iron 
uptake process.  Since the truncated Pa BfrB shows the same mechanism of iron uptake as wild 
type Pa BfrB, it is believed that the changes observed in the process f iron release in truncated 
Pa BfrB may be due to its structurally altered 4-fold pores. 
Truncated BfrB releases iron at a faster rate than wild type BfrB.  
 According to the results summarized in figures 4-8 and 4-9, significa tly higher rates 
of iron release were observed in the truncated Pa BfrB than that of wild type Pa BfrB, suggesting 
that by removing the Asp residues from the C-terminus of the protein, which make the inner 
entrance of the 4-fold pore, the process of iron release has been significantly affected.  Although, 
higher rates of iron release were observed with truncated Pa BfrB with a mutated 4-fold pore, it 
is somewhat difficult to conclude that the iron ions are released only through the 4-fold pores as 
there is a possibility that this mutation may have caused structural hanges to the other pores of 
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the protein which have not been identified yet.  Therefore, in order to support the idea that iron 
ions are released through the 4-fold pores of Pa BfrB, a careful and detaile  analysis of its 
structural and kinetic observations were carried out.  
 According to the figure 4-9 and table 4-1, when the ratio of Bfd/BfrB is lower than 5, 
the rates of iron release from both wild type and truncated Pa BfrB are relatively similar.  This 
observation may suggest that the rate of electron transfer from the reductase to the inner core via 
heme and/or the rate of iron release from the protein are relatively similar in both wild type and 
truncated Pa BfrB.  However, the higher rates of iron release of truncated Pa BfrB, observed at 
higher ratios of Bfd/BfrB (>12), indicates that either the rate of lectron transfer into the mineral 
core of truncated Pa BfrB or the rate of iron release from the cor  of truncated Pa BfrB has been 
increased by the mutation at the 4-fold pore.  However, if the electron transfer in truncated Pa 
BfrB has been increased by the mutation, the rate of iron release would have been increased in 
all the experiments including the lower concentrations of Pa Bfd.  Consequently, it can be 
strongly suggest that only the rate of iron release from the truncated Pa BfrB has been increased 
by the mutation and it also signifies the importance of 4-fold pore in the process of iron release 
from Pa BfrB.  
Pa Bfd opens the 4-fold pore of Pa BfrB. 
 According to the results of the experiment shown in figure 4-11 B and 4-12B, it is 
known that the mineral core of Pa BfrB can be reduced by reducing agents.  However, as figures 
4-11C and 4-12C show, although the iron core is reduced, in the absence of Pa Bfd Fe2+ ions are 
not released from the core.  Our previous studies have shown that the electrons from thereducing 
agent are first sent to the heme group [14] and subsequently these electrons are passed to the 
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mineral core to reduce the ferric ions.  It is also known that wen iron ions are released from the 
core, the heme groups of BfrB are also reduced, showing that electrons are passed into the core 
through the heme groups (Figure 4-10).   
  
 
 
 
 
 
 
 
Figure 4-13: Surface representation of the 4-fold pore showing the Asp 158 residues (colored in 
bright orange) of the 4-fold pore of wild type Pa BfrB. His 155 which is thought to be 
functioning as the gates of the 4-fold pores is shown in red.  The probable p thway of reduced 
iron ions moving towards the gate of the 4-fold pore is shown in black arrows. 
  As figure 4-13 depicts, it is believed that the ferric ions in the mineral, which are 
closer to the protein surface, are immediately reduced by the reduced heme groups of the protein 
and those reduced iron ions may be immediately captured by the negatively charged amino acid 
side chains such as Glu 18, Glu47, Asp50 and Glu 129 located closer to the heme group.  A 
nicely arranged network of negatively charged residues can be seen in the protein molecule 
Asp158 
His155 
Heme 
Asp50 
Glu44 
Glu129 
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making a pathway from heme towards the four fold pore.  As a result of this network of 
negatively charged residues, reduced iron ions are thought to be moving towards the 4-fold pore, 
possibly along the trajectory shown by the black arrows in figure 4-13.  Once these reduced iron 
ions reach the 4- fold pore, these iron ions are assumed to be captured by the side chain of 
His155 and His153 (Figure 4-1A and 4-13), which are beleived to be functioning as gates to 
release iron ions through the 4-fold pores.  There are experimental evidence to show that these 
coordinating His155 and 153 residues are mobile and function as ‘gates’ to open the four fold 
pores: (1) the Fe soaked crystal structure of wild type Pa BfrB revealed that each of the 4- fold 
pores of Pa BfrB is surrounded by four iron atoms coordinated by His153 and 155 [16](2).  
When the Fe soaked crystals are reduced by dithionite, some of the reduced iron ions have been 
observed to be captured by the His 155 and 153 (3).  Elastic Network Model (ENM) studies have 
also shown that His 155 and 153 around the four fold pores are highly mobile, particularly the 
His 155, suggesting that His 155 may be the residue that functions as a gate to open the 4-fold 
pores for the iron release.  As shown in figure 4-13, the inner most end of the four fold pore of 
wild type Pa BfrB, made of Asp157 and 158, is considered ‘closed’ as these Asp residues are 
projected toward the interior of the molecule making the inner entrance of the pore narrower and 
less accessible to reduced iron ions from the core.  Therefore, it is believed that the Fe2+ ions 
cannot directly go through this entrance of the pore.  In order to enter the 4-fold pores, these ions 
may have to move via the network of negatively charged residu and subsequently through the 
gate of the His155.  Our previous findings show that binding of Pa Bfd to Pa BfrB [14] facilitate 
the release of iron from the mineral core of BfrB.  In addition, experiments shown in figures 4-8, 
4-11C and 4-12C indicate that the rates of iron release are significantly accelerated in the 
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presence of Pa Bfd.  However, the mechanism by which the Pa Bfd facilitates the higher rates of 
iron release from BfrB had been a mystery. 
 The results of our kinetic and ENM studies presented in this text provide the first 
evidence for the most probable mechanism of Pa Bfd facilitated iron release from Pa BfrB core.  
As mentioned before, the 4-fold pore of wild type Pa BfrB is considered as ‘closed’ with the Asp 
residues at the C-terminus of the protein.  According to our preliminary studies, it is known that 
Bfd binds to the outer surface of Pa BfrB closer to the 4-fold pore.  Therefore, it is believed that 
due to the protein-protein interaction between Pa Bfd and BfrB, the amplitudes of the motions of 
Asp (157, 158) and His (155, 153) residues are significantly enhanced.  As a result of these 
increased motions, it is thought that the histidine gates are opened and the coordinated iron by 
these His residues are released to the 4-fold pores.  However, in the absence of Pa Bfd, the 
motions of the Asp and His residues are slower, such that the 4-fold pores remains ‘closed’ by 
the His gates and as a result iron ions are not released out of the protein.  These results are in 
good agreement with the results of our solution experiments showing that binding of Pa Bfd to 
Pa BfrB is essential to open the 4-fold pores of BfrB to release iron from the mineral core. 
 However, in the truncated Pa BfrB (without Asp157 and 158 residues at the end of the 
4-fold pore) the 4-fold pores are considered ‘open’ and have less control ve  the motions of His 
155 and 153.  As a result, reduced iron ions can enter the 4-fold pore directly through the 
opening made due to the absence of Asp residues as well as by the freely fluctuating His gates.  
In addition it has been shown by the ENM studies His 155 and153 of the truncated BfrB has 
more motions than those of wild type BfrB, suggesting that more ir n ions can be efficiently 
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moved by the Histidines towards the 4-fold pores.  Therefore, faster rates of iron release can be 
observed from the truncated Pa BfrB than that of from the wild type Pa BfrB. 
Elastic Network Model calculations further support the idea of iron release through the 4-fold 
pores. 
 To support the experimental evidence favoring the idea that iron is released from 4-
fold pores of BfrB, Elastic Network Model (ENM) calculations on truncated and wild type BfrB 
were carried out by Dr. A. Ruvinsky (Department of Bioinformatics, University of Kansas).   
  
 
 
 
 
 
 
Figure 4-14: Distribution of the amino acid residue fluctuations in the 4-fold pore calculated by 
Elastic Network Model are shown in different colors. Highly fluctuating residues are shown in 
red and less fluctuating residues are shown in blue. (A) Enhanced fluctuations of the residues can 
be seen in the inner side of the four-fold pore including Asp157 and 158 residues (iron atoms are 
shown as gold spheres). (B) Relatively low or no fluctuations are seen in the outer side of the 4-
fold pore. 
(B) (A) 
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 The structure of the 4-fold pore of BfrB with Asp residues at the C-t rminus was 
modeled by the ENM calculations and used to gain a clear insight for the elucidation of the 
mechanism of iron release through these 4-fold pores of Pa BfrB.  In addition, ENM calculations 
carried out on wild type Pa BfrB have revealed that equilibrium fl ctuations higher than the 
average fluctuations in Pa BfrB are mainly associated around the 4-fold pores, particularly with 
the terminal residues including Asp157 and 158 (Figure 4-14).  Moreover, the ENM studies have 
shown that His 155 has more motions in the energy minimized structures of Pa BfrB, suggesting 
that His 155 may play an important role in the release of iron from Pa BfrB.  To corroborate the 
observation of higher rates of iron release from truncated Pa BfrB than the wild type Pa BfrB, 
ENM studies have shown that the motions of histidiens are increased in the truncated Pa BfrB.  
Further, these observations suggest that the motions of His residues may be controlled by the 
Asp residues. 
 The results from our solution experiments and ENM studies show that the reactive and 
potentially toxic Fe2+ ions are released from the mineral core of BfrB, only when BfrB interact 
with its physiological partner Pa Bfd.  i.e. the nature has evolved a well controlled mechanism of 
iron release in order to protect the cells from harmful effects of reactive Fe2+ ions.  However, 
further studies are expected to be carried out to gain a further understanding of the mechanism of 
iron release from Pa BfrB. 
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Appendices 
 
 
Appendix I: The alignment of the sequences of Bacerioferritin genes which are located 
downstream to Bfd gene in the bacterial genome.  Acidic residues at the C-terminus of Bfr 
are highlighted in red.  The sequences were aligned with the aid of ClustalW. 
 
 
                                     10        20        30        40        50        60 
                                      |         |         |         |         |         | 
P.a BfrB                     MKGDKKVIQHLNKILGNELIAINQYFLHSRMWNDWGLKRLGAHEYHESIDEMKHADKLIE 
Vibrio.furnissiiCIP102972    MKGDPIIIQHLNKILGNELIAINQYFLHARMYKDWGLKHLADKEYHESIDEMKHADHLIE 
Aeromonas.salmonicidaA449    MKGDPKIIAHLNKVLANELIAINQYFLHARIYDDWGLKALGHKEYHESIDEMKHADELVK 
P.fluorescens SBW25          MKGDISVIQQLNKILANELVAINQYFLHARMYDDWGLEKLGKREYKESIKAMKDADALIK 
Sal.ente.sero.Ty. CT18       MKGDVKIINYLNKLLGNELVAINQYFLHARMFKNWGLTRLNDVEYHESIDEMKHADKYIE 
Sal.ente.sero.Para. AKU12601 MKGDVKIINYLNKLLGNELVAINQYFLHARMFKNWGLTRLNDVEYHESIDEMKHADKYIE 
Vib.parahaemoy.RIMD2210633   MKGDPIIIQHLNKVLGNELIAINQYFLHARMYKDWGLKHLADKEYHESIDEMKHADHLIR 
Vib.chole.O1biovarElTorN16961MKGDPVIIQHLNKVLANELIAINQYFLHARMYKDWGLKHLADKEYHESIDEMKHADHIVE 
Vibrio cholerae MAK 757      MKGDPVIIQHLNKVLANELIAINQYFLHARMYKDWGLKHLADKEYHESIDEMKHADHIVE 
Vibrio cholerae MJ-1236      MKGDPVIIQHLNKVLANELIAINQYFLHARMYKDWGLKHLADKEYHESIDEMKHADHIVE 
Vibrio cholerae MO10         MKGDPVIIQHLNKVLANELIAINQYFLHARMYKDWGLKHLADKEYHESIDEMKHADHIVE 
Enterobacter.Cloac.ATCC 13047MKGDVKIISYLNKLLGNELVAINQYFLHARMFKNWGLMRLNDVEYHESIDEMKHADKYIE 
Citrobacter koseriATCC BAA895MKGDVKIINYLNKLLGNELVAINQYFLHARMFKNWGLTRLNDVEYHESIDEMKHADKYIE 
Citrobacter rodentium ICC168 MKGDVKIINYLNKLLGNELVAINQYFLHARMFKNWGLKRLNDVEYHESIDEMKHADKYIE 
Yer.pestis biovar Micro.91001MKGDKKIIAHLNKLLGNELVAINQYFLHARMFKNWGLMRLNDKEYHESIDEMKHADKYIE 
Yer.pseudotuberculosisIP32953MKGDKKIIAHLNKLLGNELVAINQYFLHARMFKNWGLMRLNDKEYHESIDEMKHADKYIE 
Pecto.carot.brasil. PBR1692  MKGDKKVITHLNKLLGNELVAINQYFLHARMFKNWGLTRLNDHEYHESIDEMKHADRYIE 
Yersinia ruckeri ATCC 29473  MKGDKKIISHLNKLLGNELVAINQYFLHARMFKNWGLMRLNDKEYHESIDEMKHADRYIE 
Pecto. atrosepticum SCRI1043 MKGDKKVITHLNKLLGNELVAINQYFLHARMFKNWGLTRLNDHEYHESIDEMKHADRYIE 
Photorha.lumin.laumondii TTO1MKGDKKMIAHLNKLLGNELVAINQYFLHARMFKNWGLTRLNDKEYHESIDEMKHADRYIE 
Photorhabdus asymbiotica     MKGDKKIIAYLNKLLGNELVAINQYFLHARMFKNWGLTRLNEKEYHESIDEMKHADRYIE 
Serratia odorifera 4Rx13     MKGDKKIIAHLNKLLGNELVAINQYFLHARMFKNWGLMRLNDKEYHESIDEMKHADRYIE 
Proteus mirabilis HI4320     MKGDKKMIAHLNKLLGGELVAINQYFLHARMFKNWGFTRLNAMEYHESIDEMKHADKYIE 
P.alteromonas haloplan.TAC125MKGDKDVIAALNKVLANELVGINQYFLHARMFKDFGFSKLDKADYKVSIQKMKNADRLIE 
Photobacterium profundum SS9 MKADPKIIQHLNKILGNELVAINQYFLHARMYKDWGLKHLADKEYHESIDEMKHADHLIE 
 
                                     70        80        90       100       110       120 
                                      |         |         |         |         |         | 
P.a BfrB                     RILFLEGLPNLQDLGKLLIGENTQEMLQCDLNLELKATKDLREAIVHCEQVHDYVSRDLL 
Vibrio.furnissiiCIP102972    RILFLEGLPNLQDLGKLMIGEDTKEMLECDLKLELAAIPDLRDAIAYAEDIRDYVSRDLF 
Aeromonas.salmonicidaA449    RVLFLEGLPNLQDLGKLRIGETVEEMLRCDLSLEMDAIPDLKVAIAYAESVQDYISRDLF 
P.fluorescens SBW25          RILFLEGLPNVQDLGKLNIGEHTQEMISSDLGFERKSHSDLKAAIAHCETKGDFGSRELL 
Sal.ente.sero.Ty. CT18       RILFLEGIPNLQDLGKLGIGEDVEEMLRSDLRLELEGAKDLREAIAYADNVHDYVSRDMM 
Sal.ente.sero.Para. AKU12601 RILFLEGIPNLQDLGKLGIGEDVEEMLRSDLRLELEGAKDLREAIAYADSVHDYVSRDMM 
Vib.parahaemoy.RIMD2210633   -ILFLEGLPNLQDLGKLMIGEDTKEMLECDLKLEMAAIPDLKDAIAYAEDIRDYVSRDLF 
Vib.chole.O1biovarElTorN16961RILFLEGIPNLQDLGKLMIGEDVQEMLECDLKLELIAIPDLKEAIAYAEKVRDYVSRDLF 
Vibrio cholerae MAK 757      RILFLEGIPNLQDLGKLMIGEDVQEMLECDLKLELIAIPDLKEAIAYAEKVRDYVSRDLF 
Vibrio cholerae MJ-1236      RILFLEGIPNLQDLGKLMIGEDVQEMLECDLKLELIAIPDLKEAIAYAEKVRDYVSRDLF 
Vibrio cholerae MO10         RILFLEGIPNLQDLGKLMIGEDVQEMLECDLKLELIAIPDLKEAIAYAEKVRDYVSRDLF 
Enterobacter.Cloac.ATCC 13047RILFLEGIPNLQDLGKLGIGEDVEEMLRSDLRLELEGAKDLREAIAYADSVHDYVSRDMM 
Citrobacter koseriATCC BAA895RILFLEGIPNLQDLGKLGIGEDVEEMLQSDLRLELEGAKDLREAIAYADSVHDYVSRDMM 
Citrobacter rodentium ICC168 RILFLEGIPNLQDLGKLGIGEDVEEMLRSDLRLELEGAKDLREAIAYADSVHDYVSRDMM 
Yer.pestis biovar Micro.91001RILFLEGIPNLQELGKLNIGEDVEEMLKSDLALELSGATDLREGIAYADSIHDYVSRDLL 
Yer.pseudotuberculosisIP32953RILFLEGIPNLQELGKLNIGEDVEEMLKSDLALELSGAIDLREGIAYADSIHDYVSRDLL 
Pecto.carot.brasil. PBR1692  RILFLEGIPNLQDLGKLNIGEDVEEILRSDLQLELDGAKNLREAIAYADSVHDYVSRDLM 
Yersinia ruckeri ATCC 29473  RILFLEGIPNLQDLGKINIGEDVEEMLKSDLALELSGAKDLREGIAYADSIHDYVSRDLL 
Pecto. atrosepticum SCRI1043 RILFLEGIPNLQDLGKLNIGEDVEEVLRSDLQLELDGAKNLREAIAYSDSVHDYVSRDLM 
Photorha.lumin.laumondii TTO1RILFLEGIPNLQDLGKLNIGEDIEEMLKSDLQLELQGAKDLKEAIAYADSIHDYVSRDLM 
Photorhabdus asymbiotica     RILFLEGVPNLQDLGKLNIGEDIEEMLTSDLHLELQGAHDLREAIAYADSIHDYVSRDLM 
Serratia odorifera 4Rx13     RILFLEGLPNLQDLGKLNIGEDIEEMLRSDLALELDGAKNLREAIAYADSIHDYVSRDLM 
Proteus mirabilis HI4320     RILFLEGIPNLQDLGKLNIGEDVEEMLRSDLELELGGAKDLREAIAYADSIHDYVSRDLM 
P.alteromonas haloplan.TAC125RILFLEGLPNLQDLGRLRIGENSEEMIAANMSFELDTIDELRSAVKLAESKKDYITREAL 
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Photobacterium profundum SS9 RILFLEGLPNLQDLGKLNIGEDTQEMIESDLALEMAAIPDLRDAIAYSEEIRDYVSRDLF 
 
                                130       140       150 
                                                           |         |         | 
 
 
 
 
 
 
 
P.a BfrB                                          KDILESEEEHIDYLETQLGLIQKVGLENYLQSHMHEDD- 
Vibrio.furnissiiCIP102972                         QDILEDEEEHVDWLETQLGLIDMTGIENYLQAQFVDED- 
Aeromonas.salmonicidaA449                         QDILEDEEEHVDWLETQLDLIDRIGLENYQQSQLHHGSS 
P.fluorescens SBW25                               EDILEDQEEHIDWLETQLGLIDKVSLENYLQSQMGE--- 
Sal.ente.sero.Ty. CT18                            IEILADEEGHIDWLETELDLIAKLGMQNYLQSQIKVTD- 
Sal.ente.sero.Para. AKU12601                      IEILADEEGHIDWLETELDLIAKLGMQNYLQSQIKVTD- 
Vib.parahaemoy.RIMD2210633                        QDILEDEEEHVDWLETQLGLIEMSGIENYLQAQYVDEE- 
Vib.chole.O1biovarElTorN16961                     QEILEDEEEHVDWLETQLGLIDMTGIQNYLQAQFVDDE- 
Vibrio cholerae MAK 757                           QEILEDEEEHVDWLETQLGLIDMTGIQNYLQAQFVDDE- 
Vibrio cholerae MJ-1236                           QEILEDEEEHVDWLETQLGLIDMTGIQNYLQAQFVDDE- 
Vibrio cholerae MO10                              QEILEDEEEHVDWLETQLGLIDMTGIQNYLQAQFVDDE- 
Enterobacter.Cloac.ATCC 13047                     IQILADEEGHIDWLETELDLIGKIGLQNYLQSQIKVED- 
Citrobacter koseriATCC BAA895                     IEILTDEEGHIDWLETELDLIAKIGLQNYLQSQIKVDD- 
Citrobacter rodentium ICC168                      IEILADEEGHIDWLETELELINKMGIQNYLQAQIREEK- 
Yer.pestis biovar Micro.91001                     KEILVDEEEHIDWLETELSLIDRLGIQSYSQAQLAKD-- 
Yer.pseudotuberculosisIP32953                     KKILVDEEEHIDWLETELSLIDRLGIQSYSQAQLAKD-- 
Pecto.carot.brasil. PBR1692                       IEILADEEGHIDWLETELDLISRLGIQNYLQAQLKAE-- 
Yersinia ruckeri ATCC 29473                       KSVLTEEEEHIDWLETELSLIERLGIQNYSQAQLAKE-- 
Pecto. atrosepticum SCRI1043                      IEILADEEGHIDWLETELDLIARLGIQNYLQAQLKAE-- 
Photorha.lumin.laumondii TTO1                     IDILDEEEKHIDWLETQFELIERMGIQNYTQSQILEGE- 
Photorhabdus asymbiotica                          IDILDAEEGHIDWLETQLELIERMGIQNYTQAQILEGE- 
Serratia odorifera 4Rx13                          IEILADEEGHIDWLETELDLIARLGIQNYAQAQVLERKD 
Proteus mirabilis HI4320                          LEILTDEEGHIDWIETQLELIERIGLQNYLQAQMIEE-- 
P.alteromonas haloplan.TAC125                     DHILNEQEEQIDWLETQQLLIENTGLENYLQSQL----- 
Photobacterium profundum SS9                      QDILEEEEEHVDWLETQLGLIDKMGIANYNQAQIVDED- 
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Appendix II:  Mutations of the four fold pores of Pa BfrB suggests a possible pathway of 
iron release via the four-fold pores 
Introduction 
 The crystal structure of wild type Pa BfrB shows the presence of symmetrically 
distributed six 4-fold pores each located along the six 4-fold symmetry axis of the protein 
molecule.  These pores are built mainly in two layers of acid resi u s.  The inner layer is formed 
by four Gln residues whereas the outer layer is formed by four Asn residues.  In the crystal 
structure of wild type Pa BfrB potassium ions were observed in these 4-fold pores coordinated 
by the side chains of four Asn and Gln residues.  These potassium ions are thought to be 
incorporated into the protein from the protein storage buffer which is 100 mM potassium 
phosphate, pH 7.6.  The presence of metal ions in the four fold pores has also been observed in 
the structures of Bfr from other organisms.  For example, iron and B 2+ ions have been observed 
in two independent crystal structures of Av Bfr [1, 2].  These observations together with the fact 
that 4-fold pore being hydrophilic in nature, lead us to hypothesize that iron ions may exit the 
protein through 4-fold pores.  In order to test the above hypothesis, the structure of the four fold 
pore was altered by changing the amino acid composition of the pore using site directed 
mutagenesis.  To this end, coordinating Asn148 residue found in the outer layer of the 4-fold 
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pore was mutated to non coordinating Leu residues.  It is assumed that hydrophobic interactions 
between leucines may obstruct the pathway of iron and consequently the rate of iron release from 
N148L BfrB is expected to be lower than that of wild type Pa BfrB.  In addition, Gly145 which 
constitutes a part of the outer wall of the four fold pore was mutated to Val and subsequently the 
rate of iron release of G145V Pa BfrB was compared with that of wild type.
 
Experimental Procedures 
Site directed mutagenesis of N148L and G145V Pa BfrB 
 The N148L and G145V bfrb genes were constructed using the recombinant pET11a 
plasmid harboring the gene coding for wild type Pa BfrB.  The primers designed for the mutation 
N148L BfrB had a melting temperature (Tm) of 78.4 ºC and GC content of 49%.  The gene 
sequences of the primers used for N148L BfrB are, 5' CAG AAA GTG GGC CTG GAA CTG 
TAT CTG CAG AGC CAT ATG C 3', and 5' GCA TAT GGC TCT CAG ATA CAG TTC CAG 
GCC CAC TTT CTG 3'.  The melting temperature (Tm) and the GC content of the primers 
designed for the G145V BfrB mutation were 81 ºC and 49%, respectively.  The sequences 
corresponding to the forward and reverse primers of G145V BfrB are 5'-GGG TCT GAT TCA 
GAA AGT GGT GCT GGA AAA CTA TCT GCA GAG C-3 and '5-GCT CTG CAG ATA GTT 
TTC CAG CAC CAC TTT CTG AAT CAG ACC C-3'.  All the primers were synthesized by 
Integrated DNA Technologies, Inc (Coravile, IA).  Mutagenesis wa c rried out using the 
QuickChangeTM mutagenesis kit (Stratagene, La Jolla, CA) and polymerase chain re ction 
(PCR).  The recombinant constructs were then transformed into E.coli XL Blue supercompetent 
cells for DNA amplification.  Once the mutation was verified by sequencing, recombinant DNA 
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plasmids were transformed into E. coli Arctic express RIL cells (Stratagene, La Jolla, CA).  The 
sequences of the N148L and G145V BfrB genes with the restriction endonuclease sites are 
shown in figure 1 and 2, respectively. 
                                       5’ Nde1 
                CATATG AAA GGC GAT AAA AAA GTG ATC CAG CAT CTG AAT AAA ATT 
          M      K       G      D       K       K    V       I       Q       H      L       N      K        I 
  CTG GGT AAT GAA CTG ATT GCG ATT AAT CAG TAT TTT CTG CAT AGC CGC ATG 
                  L      G       N      E        L       I       A       I       N      Q      Y      F     L       H       S       R      M 
  TGG AAT GAT TGG GGC CTG AAA CGT CTG GGC GCG CAT GAA TAT CAT GAA AGC 
                 W      N      D     W       G     L      K       R      L       G      A      H    E      Y       H      E        S 
  ATT GAT GAA ATG AAA CAT GCG GAT AAA CTG ATC GAA CGT ATT CTG TTT CTG 
                  I        D      E       M      K    H       A      D       K      L       I       E       R       I       L      F      L 
  GAA GGT CTG CCG AAT CTG CAG GAT CTG GGC AAA CTG CTG ATT GGT GAA AAC 
                  E       G      L       P       N     L       Q       D      L       G      K       L     L       I        G      E       N 
  ACC CAG GAA ATG CTG CAG TGC GAT CTG AAT CTG GAA CTG AAA GCG ACC AAA 
                   T      Q       E       M      L       Q      C       D      L       N      L       E     L       K       A       T      K 
  GAT CTG CGT GAA GCG ATC GTG CAT TGC GAA CAG GTG CAT GAT TAT GTT AGC 
                  D      L       R      E       A       I       V       H      C      E        Q      V     H       D      Y      V       S 
  CGT GAT CTG CTG AAA GAT ATC CTG GAA AGC GAA GAA  GAA CAT ATT GAT TAT 
                  R       D      L      L       K     D       I       L      E        S       E     E       E       H       I       D      Y 
  CTG GAA ACC CAG CTG GGT CTG ATT CAG AAA GTG GGC CTG GAA CTG TAT CTG 
                  L       E       T      Q       L       G      L       I       Q       K      V      G      L       E       L      Y       L 
  CAG AGC CAT ATG CAT GAA GAT GAT TAAGGATCC 
                     Q       S       H     M      H      E        D      D            BamH1  3’ 
 
Figure 1: DNA and corresponding amino acid sequence of N148L bfrB from P. 
aeruginosa. N148L mutation is highlighted. Nde I and BamH I restriction endonuclease 
sites were constructed at the 5' and 3' ends for subcloning. 
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Overexpression and purification of N148L and G145V BfrB. 
 The wild type BfrB was expressed, lysed and purified as describ d in detail in the 
experimental procedures in Chapter 2.  Both N148L and Gi45V BfrB werealso expressed and 
purified in the same way as wild type protein.  The purity of the protein was determined by 15% 
SDS-PAGE.   
                              5’Nde1 
             CATATG AAA GGC GAT AAA AAA GTG ATC CAG CAT CTG AAT AAA ATT  
                          M      K       G      D       K       K      V       I       Q       H      L      N      K        I 
CTG GGT AAT GAA CTG ATT GCG ATT AAT CAG TAT TTT CTG CAT AGC CGC ATG  
   L      G       N      E        L       I       A      I       N      Q      Y      F      L       H      S       R      M      
TGG AAT GAT TGG GGC CTG AAA CGT CTG GGC GCG CAT GAA TAT CAT GAA AGC 
   W      N      D     W       G      L       K    R      L       G      A      H       E      Y       H      E        S 
ATT GAT GAA ATG AAA CAT GCG GAT AAA CTG ATC GAA CGT ATT CTG TTT CTG  
   I        D      E       M      K      H       A     D       K      L       I        E       R     I       L      F      L 
 GAA GGT CTG CCG AAT CTG CAG GAT CTG GGC AAA CTG CTG ATT GGT GAA AAC 
   E       G      L       P       N      L       Q     D      L       G      K       L      L       I      G      E       N 
ACC CAG GAA ATG CTG CAG TGC GAT CTG AAT CTG GAA CTG AAA GCG ACC AAA  
   T      Q       E       M      L       Q      C     D      L       N      L       E      L       K       A       T      K 
GAT CTG CGT GAA GCG ATC GTG CAT TGC GAA CAG GTG CAT GAT TAT GTT AGC  
   D      L       R      E       A       I       V      H      C      E        Q      V      H       D     Y      V       S 
CGT GAT CTG CTG AAA GAT ATC CTG GAA AGC GAA GAA  GA CAT ATT GAT TAT 
   R       D      L      L       K       D       I    L      E        S       E       E       E       H       I       D      Y  
 CTG GAA ACC CAG CTG GGT CTG ATT CAG AAA GTG GTG CTG GAA AAC TAT CTG   
   L       E       T      Q       L       G      L       I       Q       K      V       V      L       E       N      Y       L 
CAG AGC CAT ATG CAT GAA GAT GAT TAAGGATCC 
   Q       S       H     M      H      E        D     D            BamH1  3’  
 
Figure 2: DNA and corresponding amino acid sequence of G145V bfrB from P. 
aeruginosa. G145V mutation is highlighted. Nde I and BamH I restriction endonuclease 
sites were constructed at the 5' and 3' ends for subcloning. 
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Pure protein was then passed through a previously calibrated high resolution size exclusion 
column (Superdex 200, 10/300, GE Healthcare) equilibrated with 100 mM potassium phosphate 
(pH 7.6) and 1 mM tris (2-carboxyethyl)-phosphine hydrochloride (TCEP) to determine the size 
and confirm the oligomerization.  Once the oligomerization is confirmed as 24mers, the protein 
was concentrated, flash frozen and stored at -80 ºC.  
Mineralizaton N148L BfrB  
 Similar to wild type BfrB, N148L BfrB as isolated contains a few iron ions in its inner 
core (10-15 iron atoms per molecule).  Therefore, protein to be used in experiments was 
incorporated with ~ 600 iron atoms per molecule.  Anaerobic solution of ferr us ammonium 
sulfate solution (details in Chapter 2 experimental) was added to a stirred solution of 0.0027 mM 
N148L BfrB in 100 mM potassium phosphate buffer, pH 7.6.  The mineralization was carried out 
in a water bath, equilibrated at 42 ºC and the protein solution was also allowed to equilibrate at 
42 ºC before starting the mineralization.  Aliquots of Fe2+ solution delivering 48 iron atoms per 
protein molecule was added to a stirred solution of N148L BfrB.  Theresultant solution was then 
allowed to react for 15 minutes before the next aliquot of Fe2+ was added.  Total of 600 Fe2+ ions 
were added and the mineralization process was monitored spectrophotomterically, w th the aid of 
a USB 2000 spectrophotometer (Ocean Optics, Dunedin, FL).  The iron loaded prot in solution 
was incubated at 42ºC for three hours and cleaned to remove any excess iron ions using a G-25 
column equilibrated using 100 mM potassium phosphate buffer, pH 7.6.  The content of iro  in 
the core was determined using the previously described methodology (experimental procedures 
in Chapter 2). 
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Mineralizaton of G145V BfrB  
 The same mineralization procedure used for wild type BfrB, describ d in the 
experimental procedures in Chapter 2 was followed for this mutant.  A aerobic solution of 
ferrous ammonium sulfate solution was added to a stirred solution of 3 µM G145V BfrB in 100 
mM potassium phosphate buffer, pH 7.6 in aliquots delivering 50 Fe2+/Pa BfrB, until a core of 
600 Fe2+/Pa BfrB is formed.  Any precipitation formed during the mineralization was removed 
by centrifuging the sample for 10 minutes at 4000 rpm.  The mineralization process was 
monitored spectrophotometrically following the absorbance near 320 nm with the aid of a USB 
2000 spectrophotometer (Ocean Optics, Dunedin, FL).   
Analysis of non-heme iron in the BfrB core.  
 Non-heme iron analysis of N148L and G145V BfrB were carried out using Fe-
ferrozine assay in the same way as described for wild type BfrB in Chapter 2.  The concentration 
of iron was determined from the electronic absorption spectrum using the absorbance at 562 nm 
(ε562 = 27.9 mM
-1 cm-1) [4]. 
Crystallization of N148L and G145V BfrB 
 Crystallization studies were carried out in the Protein Structu e Laboratory at the 
Delbert M. Shankel Structural Biology Center (University of Kansas, Lawrence, KS).  
Mineralized N148L and G145V BfrB were concentrated to 16 mg/mL and 20 mg/ ml, 
respectively, in 100 mM potassium phosphate pH 7.6, 5 mM TCEP for crystallization.  Crystals 
were grown under aerobic conditions in Compact Jr. (Emerald biosystems) sitting drop vapor 
diffusion plates using 1µL of crystallization solution and 1 µL of protein equilibrated against 100 
µL of crystallization solution at 20oC.  Red prismatic crystals were obtained from both G145V 
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and N148L BfrB within 24 hours from the following condition  35% (v/v) 2-methyl-2,4-
pentanediol, 100 mM MES pH 6.0, 200 mM Li2SO4 (Wizard 2 #2, Emerald biosystems).   
Structure Solution and Refinement of N148L BfrB 
 Single crystals of N148L were transferred to a fresh drop of crystallization solution 
which also served as a cryoprotectant and frozen in liquid nitrogen for data collection.  Data 
were collected at 100K at the Advanced Photon Source (APS) IMCA-CAT, sector 17ID using a 
Pilatus 6M pixel array detector.  Data were collected at λ = 1.74013 Å which is near the Fe 
absorption edge.   
 Intensities were integrated and scaled using the XDS [5] and Scale [6] packages 
respectively.  Structure solution was carried out by Fourier synthesis by refinement of the protein 
only model of apo BfrB (PDB: 3IS7 [7]) against the processed diffraction data.  Structure 
refinement and manual model building were performed with REFMAC [8] and COOT [9] 
respectively.  Structure validation was performed using MOLPROBITY [10].   
Iron uptake in solution by G145V BfrB   
 G145V BfrB to be used in the experiments was prepared by extensively dialyzing the 
pure, as-isolated protein against 100 mM potassium phosphate, pH 7.6.  Aliquots of 50 mM 
Ferrous ammonium sulfate containing 50 Fe2+/ BfrB molecule were added using a Hamilton 
microsyringe to a solution of G145V BfrB (0.8 µM) at 30 °C in a 1.0 cm path length cuvette 
equipped with a stirring bar.  Changes in the intensity of the absorbance at 320 nm were recorded 
for 10 minutes for each addition of iron with the aid of a conventional diode-array UV-vis 
spectrophotometer (Ocean Optics, Dunedin, FL).   
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Mobilization of core iron from G145 BfrB 
 Experiments to investigate the iron release from G145V BfrB were carried out in an 
anaerobic chamber.  Several iron mobilization experiments were car ied out varying the 
concentration of apo Bfd while maintaining the concentrations of Fpr (15 µM), Bipiridyl (3mM) 
and NADPH (1.5 mM) constant.  Experimental conditions and the procedures we  the same as 
those of truncated BfrB explained in experimental in Chapter 4. 
 
Results and Discussion 
Overexpression and purification of N148L and G145V BfrB   
 Both N148L and G145V BfrB expressed in E.coli Arctic express RIL cells were 
soluble and could be purified to homogeneity.  The pure BfrB protein produced a single band in 
the 15% SDS-PAGE gel which corresponds to an approximate MW of 18000 Da.  The 
oligomerization of the proteins was confirmed as a 24mer by using a calibrated size exclusion 
column (Superdex 200, 10/300 column, Amersham Biosciences).  The electronic absorption 
spectra of pure N148L and G145V BfrB were similar to that of wild type BfrB and have a Soret 
band maximum at 418 nm and α and β bands at 567 nm and 527 nm respectively. 
Mineralization of N148Land G415V BfrB 
 Mineralization of G145V BfrB was carried out under same experimental conditions as 
for wild type (experimental Chapter 2).  However, a slight preci itation was observed in the 
solution after adding about ~ 400 iron atoms and was removed by centrifugi g the protein 
solution for 10 minutes at 4000 rpm.  Addition of iron was continued with the clear supernatant 
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obtained after centrifugation until an iorn core of ~600 iron ions was formed.  Then the protein 
was cleaned to remove any excess iron atoms using the same procedure as in wild type BfrB 
(experimental Chapter 2).  
 Mineralization of N148L, on the other hand, was carried out following a slightly 
different procedure than that of wild type.  First mineralization experiment of N148L BfrB was 
carried out at room temperature (25 ºC) under similar experimental conditions used in WT BfrB.  
Aliquots of anaerobic Fe2+ solution containing 48 iron atoms per molecule were added at a time 
with 15 minute intervals between two additions.  However after adding ~ 200 iron atoms, a slight 
precipitation was observed in the protein solution.  The solution was then centrifuged for 10 
minutes at 4000 rpm to spin down the precipitation.  A reddish-brown precipitate which may be 
colloidal iron (III) oxide formed from Fe2+ ions which did not oxidized and internalized by the 
ferroxidase center of the N148L BfrB, was observed at the bottom of the centrifuge tube.  In 
addition, some of the protein molecules may also have precipitated tog ther with the iron colloid 
as indicated by the lower intensity of the Soret band of the protin btained after centrifugation 
than that of the initial spectrum.  Mineralization was continued with the clear supernatant and a 
precipitation was formed again.  After several additions of Fe2+ and centrifugation steps, about 
600 iron ions were added to the protein and finally the protein sample was cleaned using a G-25 
column equilibrated using 100 mM potassium phosphate buffer, pH 7.6 to remove excess iron 
ions.  The content of iron was determined and only an iron core of ~ 300 Fe ions was observed.  
Most of the iron ions have been lost during the cleaning.  Several experimental parameters were 
changed in order to prevent significant loss of protein while mineralization and to obtain a core 
of ~600 Fe ions.  To this end, the pH of the solution was increased from 7.6 to 8.0 and 
mineralization was carried out at room temperature (25 ºC).  However, similar to the previous 
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experiment, a significant amount of iron and the protein were precipitated and the resultant core 
was only about ~350 Fe atoms.  In the next attempt, another sample of N148L BfrB in 100 mM 
potassium phosphate pH 7.6 was mineralized at a higher temperature, 37 ºC.  Under these 
experimental conditions, protein seemed to uptake Fe2+ more efficiently than the sample at room 
temperature.  A slight precipitation was observed after adding ~400 Fe2+ ions and more Fe2+ ions 
were added to the supernatant obtained after spinning down the precipitation to form a core of 
~600 iron ions.  Subsequently, the protein sample was incubated at 37ºC for two hours and 
cleaned in the same way as before using a pre-equilibrated G-25 column.  Nevertheless, a 
considerable amount of protein has been lost while cleaning and only a core of ~250 iron atoms 
was formed.  Eventhough a relatively small core was formed, uptake of iron at 37 ºC seemed 
faster and efficient.  Therefore, another sample of N148L BfrB in 100 mM potassium phosphate 
pH 7.6 was mineralized at 42 ºC, by adding aliquots of Fe2+ solution containing a 48 Fe2+ ions at 
a time.  The protein sample was incubated for ~ three hours and cleaned using a G-25 column 
(Pd-10, Amersham Biosciences).  The content of iron in the core was determined to be ~450 Fe 
atoms.  Since it was the best mineralized protein sample, those experimental conditions were 
considered as the optimized conditions for the mineralization of N148L BfrB.  Subsequently 
several mineralization trials with different amounts of proteins were carried out under these 
conditions to verify the method and all the samples were mineralized well. 
Crystallization of N148L BfrB and G145V BfrB 
 Both N148L and G145V BfrB formed red prismatic crystals from the condition, 35% 
(v/v) 2-methyl-2,4-pentanediol, 100 mM MES pH 6.0, 200 mM Li2SO4 (Wizard 2 #2, Emerald 
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biosystems).  Crystallographic studies of only N148L BfrB are discus ed in this text and the 
studies on G145V BfrB are expected to investigate in the future.  
 Few crystals of mineralized N148L BfrB were soaked in the crystallization solution 
containing 50 mM FeSO4 (Fe soaked Pa-BfrB) for 15 minutes and both mineralized and Fe 
soaked crystals were used to acquire diffraction data.  Crystallographic data for mineralized 
N148L BfrB are presented in table 1. 
 
 
  
 
 
 
 
Figure 3: Red prismatic single crystals of recombinant (A) N148L and (B) G145V BfrB formed 
in compact Jr. sitting drop vapor diffusion plates.  
 
 
 
(A) (B) 
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Table 1. Crystallographic data for Apo BfrB N148L refined to 2.0Å resolution. 
 Apo BfrB N148L 
Data Collection  
Unit-cell parameters (Å, o) a=125.73, b=203.35, c=208.27 
Space group P212121 
Resolution (Å) 50-2.00 (2.11-2.00) 
Wavelength (Å) 1.74013 
Observed reflections 2,270,194 
Unique reflections 356,578 
<I/σ(I)>1 10.7 (2.3) 
Completeness (%)1 99.7 (98.0) 
Multiplicity 1 6.4 (5.5) 
Rmerge (%)
1, 2 10.5 (62.6) 
Rmeas (%)
1, 4 12.9 (78.0) 
Rpim (%)
1, 4 5.1 (32.5) 
Refinement  
Resolution (Å) 50.00-2.00 
Reflections (working/test) 338,156 / 17,941 
Rfactor / Rfree (%)
3 18.6 / 21.8 
No. of atoms (protein / heme / 
sodium  / water) 
30,456 / 516 / 6 / 1,618 
Model Quality  
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R.m.s deviations   
Bond lengths (Å) 0.015 
Bond angles (o) 1.272 
Average B factor (Å2)  
All Atoms 33.4 
Protein 33.0 
Heme 36.7 
Sodium 32.5 
Water 38.9 
Coordinate error based on 
maximum likelihood (Å) 
0.10 
Ramachandran Plot   
Most favored (%) 99.9 
Additionally allowed (%) 0.1 
1) Values in parenthesis are for the highest resolution shell. 
2) Rmerge = ΣhklΣi |I i(hkl) - <I(hkl)>| / ΣhklΣi I i(hkl), where I i(hkl) is the intensity  
measured for the ith reflection and <I(hkl)> is the average intensity of all reflections with indices hkl.  
3) Rfactor = Σhkl ||Fobs (hkl) | - |Fcalc (hkl) || / Σhkl |Fobs (hkl)|; Rfree is calculated in an identical manner using 5% of 
randomly selected reflections that were not included in the refinement 
4) Rmeas = redundancy-independent (multiplicity-weighted) Rmerge[2].  Rpim = precision-indicating (multiplicity-
weighted) Rmerge[8]. 
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The ferroxidase center of N148L BfrB is different from WT BfrB 
 According to the crystallographic data of N148L BfrB, most of the structural features 
are similar to that of wild type BfrB except the structure of the feroxidase center.  Eventhough 
the six amino acid residues that coordinate the two ferroxidase iron ions in the WT BfrB are 
present at the feroxidase center of N148L BfrB, their spatial rr ngement is different.  In WT 
BfrB, Glu18, His54 and Glu94, His130 act as capping ligands and Glu127 and Glu51 act as 
bridging ligands for two iron ions (Figure 5A).  As explained in detail in chapter 2, one of the 
ferroxidase iron ligands, the side chain of His130, has two different conformations depending 
upon whether the ferroxidase center is vacant or occupied.  When the ferroxidase center is 
empty, the side chain of His130 is rotated away from the ferroxidase center (Figure 5A) whereas 
when it is occupied, the side chain of His130 is properly oriented to bind the ferroxidase iron ion 
(Figure 5B). In order to obtain structural details of N148L BfrB, the crystals of N148L BfrB 
were soaked in a crystallization solution containing 50 mM ferrous sulfate and the crystals were 
flash frozen to obtain diffraction data.  Interestingly, the conformations of the side chain of 
His130 in both iron soaked and non iron soaked crystal structures were the same.  In addition, 
eventhough the conformations of the side chains of Glu18 and His54 are similar to that of WT 
BfrB, conformations of the side chains of all the other four residues ar  different from those of 
WT BfrB. 
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(A) 
 
 
 
 
 
 (B) 
 
 
 
 
 
Figure 4: Structure of (A) empty ferroxidase center and (B) iron bound ferroxidase center of WT 
BfrB showing two different conformations of the side chains of His130. 
  It is apparent that the ferroxidase center of N148L BfrB is completely 
disorganized and the difficulties encountered in mineralizing this protein may be due to this 
defective ferroxidase center.  In the WT BfrB, the side chain of His 130 acts as a gate to uptake 
iron efficiently into the ferroxidase center and as a result the protein can be mineralized easily to 
obtain an iron core of ~ 600 iron ions.  However, in N148L BfrB, the side chain of His 130 
Fe2 Fe1 
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seems locked at one conformation (gate open conformation) and consequently the side chain of 
His 130 either may not be operating as a gate as in wild type BfrB in uptaking iron or may be 
functioning as a gate but at an extremely slower rate at the room temperature.  As previously 
explained, N148L BfrB, was difficult to mineralize at room temperature (25 ºC), but when the 
temperature of the protein solution was increased to 42 ºC, the protein c uld be mineralized 
without forming any precipitation.  When Fe2+ ions are added to the protein solution, they are 
oxidized by two competitive reactions: one is the oxidation of Fe2+ ions by the ferroxidase center 
in the protein using oxygen as the electron acceptor and the other procss is the oxidation of Fe2+ 
ions by oxygen in air which forms insoluble ferric hydroxide.  The formation of insoluble ferric 
ion colloid can lead to a significant loss of protein as protein molecules can also electrostatically 
attached to the iron colloid and precipitate.  In N148L BfrB, the first oxidation reaction by the 
protein may be extremely sluggish as side chain of His 130 is notfu ctioning as a ligand to bind 
incoming Fe2+ ions.  Consequently many Fe2+ ions are floating freely in the solution and 
eventually oxidized by air and form the insoluble ferric colloid.  In contrast to that, when the 
temperature of the reaction medium is increased, as the thermal nergy increases the motions of 
the residues, the side chain of His 130 may become more active nd start functioning as a gate to 
incorporate iron into the ferroxidase center.  Consequently, the oxidation of Fe2+ ions by the 
protein becomes the more dominant process than that of by oxygen in air.  Therefore no 
precipitation is formed in the reaction medium and protein could be mineralized with ~ 600 iron 
ions.  At the end of the mineralization, protein is passed through a G-25 column, to remove any 
excess iron that was not incorporated into the protein and analyzed for the iron content in the 
core.  Eventhough ~600 iron ions were added to the protein, only a core of about ~400 iron 
atoms was observed.  Some of the iron ions have not been mineralized inside the core and it may 
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be due to the abnormalities of other residues in this protein which have not been identified yet.  
Further refinement of the crystal structure of N148L BfrB may provide significant data to better 
elucidate this observation.  Nevertheless, it is apparent that the mutation in the 4-fold pore 
(Asn148Leu) has caused significant structural changes of the amino acid residues in the other 
regions of the protein molecule which may have affected not only the hypothesized mechanism 
of iron release by the 4-fold pores but also the iron uptake mechanism by the ferroxidase pores.  
These observations suggest an existence of a strong communication netwrk among the amino 
acid residues in this protein in which if one residue is affected, i  could impair most of the other 
vital processes of the protein molecule.  However, further detailed inv stigations are necessary to 
obtain experimental evidence to show that iron release is decelerated by changing the 
coordinating Asn residues to non coordinating Leu residues, suggesting that iron ions are 
released through 4 fold pores. 
 
Iron uptake by G145V BfrB 
 As figure 6 shows, upon addition of 50 Fe2+ ions to G145V BfrB, a rapid increase of 
the absorbance near 300 nm (plotted at 320 nm) is observed and then reaches a plateau and 
remains constant thereafter.  The magnitude of the increase of absorb nce at 320 nm at every 
addition of an aliquot of iron was observed to be nearly constant, suggestin  that the ferroxidase 
center of G145V BfrB is labile and functions similar to wild type BfrB.  Once all the Fe2+ ions 
are oxidized at the ferroxidase center, it becomes empty.  
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Figure 5: Change in ∆A320 upon subsequent additions of Fe
2+ aliquots (50 Fe2+ ions per BfrB 
molecule) to a solution of G145V BfrB (0.8 µM) in 100 mM potassium phosphate buffer, pH 
7.6. 
 These observations, similar to those observed in wild type BfrB (results in chapter 2) 
indicate that the ferroxidase center of G145V BfrB has not been aff cted by the mutation of 
G145V in the 4-fold pore region.  Consequently, G145V BfrB is believed to function similar to 
wild type BfrB except a possible change in the rate of iron releas  as it is hypothesized that iron 
ions from the inner core is released through the 4-fold pores. 
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Mobilization of core iron from G145 BfrB 
 As shown in figure 7A the growth of the 523 nm band was monitored in each of the
experiments carried out with different apo Bfd/BfrB ratios; 40:1 (red), 30:1 (yellow), 20:1 (pink), 
10:1 (green), and 0:1 (black).  It is clear that when the Bfd/BfrB ratio is incresed the amount of 
iron released gradually increases.  In addition, more iron is releas d in G145V BfrB than that of 
with wild type in the absence of Bfd which may be suggesting that there is less resistance to 
release iron from the inner core of G145V BfrB than that of from wild type BfrB.  Furthermore, 
similar to the observations made in the experiments with wild typeBfrB, the Soret band of 
G145V BfrB shifts from 417 nm (oxidized) to 425 nm (reduced) only in the presence of Bfd. 
However, it is important to note that in the absence of Bfd, the heme groups of both G145V BfrB 
and wild type BfrB do not shift to the reduced state and remain at oxidized state throughout the 
experiment. The time dependent change of the Soret band at 417 nm of each of the above 
experiments has been plotted in figure 7B and it is evident that in ll the experiments with 
different concentrations of Bfd, heme groups of G145V BfrB shift to the reduced state (425 nm) 
at similar rates.  In comparison, in the experiments with wild type BfrB, heme groups of BfrB 
with different concentrations of apo Bfd, shifts to the reduced state at different rates.  For 
example, the curve corresponding to the ratio of Bfd/BfrB is 10, the heme group of wild type 
BfrB takes about 40 minutes to shift to the completely reduced position whereas that of G145V 
BfrB takes only 20 minutes.   
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Figure 6: Time dependent plot of absorption intensity change measured at 523 nm upon additi  
of NADPH (1.5 mM ) to solutions containing 3.0 mM bipy, 15 µM FPR, 0.375 µM (A) wild 
type BfrB and (B) G145VBfrB and apo-Bfd with Bfd/BfrB molar ratio of 40 (red), 30 (blue), 20 
(pink), 10 (green), and 5 (black).  Time dependent changes in the position of the Soret band 
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brought about by the addition of NADPH (1.5 mM) to the solutions in figure A; 417.5 nm and 
425 nm correspond to fully oxidized and fully reduced heme, respectively.  
 These observations may suggest that in G145V BfrB the rate of electron transfer from 
the reductase to the heme group, does not depend on the concentration of Bfd as much as it does 
with wild type BfrB.  According to the results of SPR and size exclusion chromatography 
experiments carried out with Bfd and BfrB (details in chapter 3), it is known that Bfd binds to 
BfrB in 12:1 molar ratio [11] and in addition, results of our preliminary experiments suggest that 
Bfd binds closer to the 4- fold pore of BfrB.  The observation of the relativ y similar rates of 
heme reduction in G145V BfrB with any concentration of Bfd may suggest that, binding of Bfd 
causes conformational changes in G145V BfrB in a different manner than that occurs in wild 
type BfrB.  This conformational change may enable a fast transfer of electrons from the surface 
of the protein to the heme.   
Table 2: Pseudorates for the Bfd-dependent release of core iron from G145VBfrB. 
Bfd/BfrB 
molar ratio 
Pseudo rate of iron release (min-1) at 25 ºC 
WT BfrB G145V BfrB 
0  
10 
20 
30 
40 
 
    0.0087 ± 0.0002 
0.029 ± 0.001 
0.036 ± 0.002  
0.058 ± 0.008 
0.074 ± 0.008 
 
0.015 ± 0.001 
0.065 ± 0.005 
  0.100 ± 0.0005 
0.124 ± 0.013 
0.134 ± 0.004 
 
 
178 
 
 
 
 
 
 
 
Figure 7: Bfd dependent iron release from G145V (red) and wild type (blue) BfrB. 
Consequently, heme can transfer electrons to the iron core of G145V BfrB much faster than that 
of wild type and therefore, within a given period of time, the number of reduced iron ions in the 
core of G145V BfrB is higher than that of in the wild type.  Hence more iron is observed o 
release from the G145V BfrB than that of from wild type.  On the other hand, since a smaller 
amino acid residue Gly has been mutated to larger amino acid Val, the possible “breathing” 
motions of the 4-fold pore may have become slower and consequently the duration that the pore 
remains open is longer than that of a typical 4-fold pore of wild type BfrB.  Therefore, the rate of 
iron release can be higher than that of wild type BfrB.  Althoug  additional kinetic and structural 
investigations are required to elucidate the mechanism and the pathway of iron release, it is clear 
that the G145V mutation has caused significant structural and hence functional changes in the 4-
fold pore and its surroundings which resulted in much higher rates of iron release than that 
observed in wild type.  Therefore, according to the results of our preliminary experiments, 4-fold 
pores can be one of the most possible routes of iron release from the inner core of BfrB.
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CHAPTER V 
Summary 
  Many pathogenic bacteria, including Pseudomonas aeruginosa require iron for 
successful colonization (infection) of mammalian hosts [1]. Therefore these bacteria have 
developed efficient strategies to acquire and store iron in a readily available form.  Among other 
ferritin-like iron storage proteins, Bacterioferritins can be considered as the main iron storage 
proteins in bacteria.  These proteins store iron as a solid ferric oxide mineral (~4500 iron ions) 
inside the protein shell and release to the bacterial cytoplasm when needed for various cellular 
metabolic processes.   
  BacterioferritinB (BfrB) plays an important role in the metabolism and pathogenicity 
in Pseudomonas aeruginosa.  P.aeruginosa being an aerobic bacterium requires iron for its 
aerobic respiration as iron is a key component in most of the respiratory enzymes.  Therefore, 
under iron depleted conditions, P aeruginosa cannot survive inside a host organism [2].  
Consequently, it is believed that inhibiting pathways of iron acquisition would be an effective 
way of preventing P.aeruginosa infections.  However, in order to implement that in vivo, a better 
understanding of the structure, function and the protein-protein interactions that facilitate iron 
uptake and release inside the bacterial cell, is essential.  To achieve these goals, we carried out 
our investigations on Pa BfrB using many bio analytical techniques and h d the opportunity to 
have many new discoveries about this protein.  Based on our experimental results, our findings 
on Pa BfrB and the conclusions drawn can be summarized as follows. 
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1. Recombinant Pa-BfrB was overexpressed, purified and crystallized. 
  Recombinant Pa-BfrB was overexpressed, and purified to homogeneity a d it is 
noteworthy that Pa BfrB purified in our laboratory was the first bacterioferritin to be purified 
with a fully assembly of heme (12 hemes/protein).   
 Pure Pa BfrB formed red prismatic crystals from various cry tallization conditions.  
Basically four types of crystal structures of Pa-BfrB were solved: (a) BfrB as isolated, (b) 
mineralized, (c) iron soaked and (d) double soaked crystal structure.  Th se structures were 
solved to a resolution of 2.07, 2.10, 2.25 and 2.80 Å respectively (Table 1 of Chapter 2) and 
these crystallographic data were used to obtain many important information regarding the 
structure of Pa BfrB.   
 Pa BfrB is a symmetric (432 octahedral) molecule composed of 24 subunits assembled 
as a hollow sphere with an external diameter of ~118 Å and an interal diameter of ~73 Å.  One 
Pa BfrB molecule can bind 12 heme groups where each heme group is axially coordinated by 
two adjacent subunits via bis-methionine (Met52) ligation.  Six 4-fold channels and eight 3-fold 
channels are symmetrically distributed in the molecule and these channels are located along the 
non-crystallographic 3- and 4-fold axis, respectively.  In addition, another type of channels called 
B pores (12channels/molecule) are also found at the interfaces of two subunits.  However, the 
physiological functions carried out by each of these pores are yet to be determin d. 
2. The ferroxidase center of Pa-BfrB is unstable. 
  Ferroxiadse center of Pa-BfrB is located in the middle of each subunit and made 
of six amino acid residues which are highly conserved among all bacterioferritins of known 
structure (Figure 2-1A of Chapter 2).  The ferroxidase center of Pa-BfrB was found to be a labile 
ferroxidase center which functions as a gate to uptake iron ions into the protein.  To investigate 
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the structure, function and the nature of the ferroxidase center of Pa BfrB, many structural and 
solution investigations were carried out.  To this end, crystal structure of as isolated Pa BfrB was 
studied in detail and it revealed that the ferroxidase center of the ‘as-isolated’ BfrB was empty.  
However, when those crystals were soaked in a crystallization solution containing 50 mM Fe2+ 
ions (iron soaked) ferroxidase center with two iron atoms coordinated by the ferroxidase ligands 
was observed.  On the other hand, double soaked crystal structure obtained by soaking the Fe-
soaked crystals in the crystallization solution without iron ions, reveal d a ferroxidse center 
devoid of iron, (Figure 2-9A of Chapter 2) implying that the ferroxidase center of BfrB is not 
stable.  The kinetic experiments carried out using the stopped-flow spectrophotometer clearly 
shows that the ferroxidase center of Pa BfrB does not saturate upon addition of ~50 iron atoms to 
the protein, which is in clear contrast with the results obtained from the experiments of Ec-Bfr 
with a stable ferroxidase center (Figure 2-21A, B and 2-22A, B in Chapter 2).  Therefore, the 
results obtained from both crystallographic and kinetic studies clearly indicate that the 
ferroxidase center of Pa-BfrB is unstable. 
3. Crystal structure of Pa BfrB suggests a gated mechanism of iron uptake via the 
ferroxidase center. 
  According to the crystal structure of iron soaked Pa BfrB, it is thought that Fe2+ 
ions enter the Pa BfrB molecule via the ferroxidase pore (Figure 2-13 in Chapter 2) which is 
thought to be the main route for the uptake of iron from the outside.  When these Fe2+ ions reach 
the ferroxidase center, the side chain of His130 moves toward the ferroxidase center and binds 
the incoming Fe2+ ions (gate-closed conformation).  However, upon oxidation of Fe2+ ions to 
Fe3+ ions, His130 moves away from the ferroxidase center (gate-open conformation), and 
subsequently the oxidized Fe3+ ions are released and move towards the inner cavity (Figure 2-9 
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in Chapter 2).  These observations from the crystallographic studies elegantly show that His 130 
at the ferroxidase center of Pa BfrB acts as a gate to in uptake of iron ions.  As mentioned above, 
the results obtained from the stopped flow experiments also suggest a ated mechanism of iron 
uptake and indicate that the rates/kinetics of the three phases of the Pa-BfrB iron uptake 
mechanism is clearly different from that of E.coli iron uptake mechanism.  Therefore it can be 
concluded that the observed mechanism of iron uptake is unique to Pa-BfrB due its unique 
molecular architecture. 
4. Binding of apo-Bfd to Pa BfrB facilitates the heme mediated mobilization of core 
iron. 
  The iron uptake mechanisms of ferritin-like molecules have been studied 
extensively in some ferritins and bacterioferritins.  However, much less is known about the 
mechanisms of iron release of these molecules.  Based on the observations of the global 
transcriptional response of iron-starved cultures of P.aeruginosa [3], it was hypothesized that Pa 
Bfd and Pa Fpr are the physiological partners of Pa BfrB in the mobilization of iron from the 
mineral core.  Initially it was thought that Pa Bfd is functioning as a classical ferredoxin to 
transfer electrons from Fpr/NADPH to Pa BfrB core.  However, our experimental results 
indicate that the apo form of Pa Bfd can efficiently facilitate the mobilization of iron from the 
core which negates the need of bacteria to produce 2Fe-2S cluster on aining holo Bfd under 
iron depleted conditions.  In addition, results of our additional experiments show that 12 Bfd 
molecules bind to one Pa BfrB molecule forming a protein complex to mobilize iron from the 
inner core (Figure 3-9 and 3-10 in Chapter 3).  The presence of hme groups in BfrB is 
characteristic to all bacterioferritins.  However, the exact function of these heme groups in Bfrs 
has been a mystery.  Although, it has been speculated that the heme groups of Bfrs may have a 
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function in transferring electrons to the inner core, it has not been experimentally demonstrated.  
According to the results obtained from our experiments (Figure 3-11 in Chapter 3), we were 
able to show that the physiological function of heme in BfrB is the transfer of electrons from the 
reductase into the mineral core.  In addition, it was also found out that heme group is reduced 
only in the presence of Pa Bfd, which further proves the idea that Pa BfrB and Pa Bfd are in fact 
the physiological partners in the mobilization of core iron from Pa BfrB. 
5. Four fold pores are the dominant pathway of iron release from the mineral  
core of Pa BfrB. 
 To test our hypothesis on iron release through the four fold pores, sit directed 
mutagenesis studies were carried out and some of the residues at the 4-fold pore, that were 
thought to be important in the process of iron release from the mineral core were mutated.  
Subsequently, the effect of those mutations on the process of iron release from Pa BfrB was 
assessed by comparing the rates of iron release of the mutants with that of wild type BfrB.  
First, two Asp residues (Asp 157 and 158) located at the very end of the C-terminus of the 
protein forming the inner end of the 4-fold pore, were removed by truncating the protein up to 
Glu156.  These two Asp residues cannot be seen in the crystal structure of Pa BfrB as they are 
disordered.  Therefore, Elastic Network Model studies were used to model these two residues in 
the structure of Pa BfrB (Figure 4-1B in Chapter4).  Comparative iron mobilization experiments 
carried out with truncated and wild type BfrB clearly showed that reduced iron ions are released 
faster from truncated BfrB than that from wild type BfrB.  In addition, additional experiments 
carried out with truncated BfrB indicated that although the core iron was reduced by reducing 
agents, iron ions were trapped inside the core and released only in the presence of Bfd, 
suggesting that Bfd is required to open the pores of BfrB.  Further, ENM calculations revealed 
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that highly fluctuating residues are found in the 4-fold region of BfrB, including Asp 157,158 
and His155, indicating that these residues are significantly important in the process of iron 
release from BfrB.  As shown in figure 4-13 in Chapter 4, reduced iron ions are thought to be 
moving via a network of negatively charged residues towards the 4-fold pore and are 
subsequently coordinated by His155 and 153.  However, upon binding of Bfd to BfrB, the 
amplitudes of the motions of Asp157 and 158 residues and particularly His155 are thought to be 
increased, and as a result iron ions are released from His residues.  Subsequently, those iron 
ions released from His residues enter the 4-fold pores and may exit the protein through these 
four fold pores.  ENM studies together with the results of our solution experiments strongly 
suggest that Bfd facilitates the opening of four fold pores and consequently reduced iron ions 
are released through the 4-fold pores of BfrB.  
 We were able to achieve many findings on bacterioferritin from P.aeruginosa by 
biochemically and structurally characterizing the protein.  In addition, the experiments aiming at 
the protein-protein interactions of BfrB, eventually led us to find the physiological partners of 
BfrB in the process of iron release, which is an important molecular function of BfrB.  All these 
discoveries we have made by studying Pa BfrB in the molecular level, will be a great 
contribution to the effort of constituting a new class of antibiotic to prevent pseudomonas 
infections. 
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